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Human PARP-1 is a nuclear protein containing six functional domains that
catalyzes the poly(ADP-ribosyl)ation of a variety of protein substrates including itself.
This process involves consumption of NAD+ as the ADP-ribose donor for forming the
poly(ADP-ribose) (i.e., PAR). PARP-1 utilizes this polymerization reaction to effect its
regulatory role in many important biological processes including transcription and DNA
repair.
Activation of PARP-1 self-modification requires the presence of damaged DNA.
Activity levels of PARP-1 differ depending on the type of DNA lesion. It is proposed that
the differences in activity level of PARP-1 are related to the binding stoichiometry of
PARP-1 to DNA. Using double and single stranded break DNA mimics, stoichiometric
analyses of PARP-1 were performed using sedimentation velocity techniques. In both
cases, PARP-1 forms both 1:1 and 2:1 protein:DNA complexes, consistent with protein
dimer formation.
Correlation of PARP-1 activity with the DNA structure it encounters can also be
explained by the utilization of different functional domains for DNA recognition. To
vii
investigate this hypothesis, DNA-binding domain AB was labeled with the Cy3
fluorophore, and a Cy5-labeled DNA with a double stranded break, was used as its
interaction counterpart. Protein-DNA interactions were monitored by single molecule
fluorescence colocalization. It was observed that a 2:1 protein:DNA complex is formed.
Furthermore, recognition of double stranded DNA breaks by domain AB involves two
different binding steps with distinct dissociation kinetics. Finally, two FRET states were
observed as domain AB interacted with DNA. This suggests that domain AB utilizes
different regions to interact with DNA during the recognition process.
After activation, PARP-1 synthesizes poly(ADP-ribose) through three catalytic
processes: initiation, elongation and branching. To study the domain requirements for
polymer synthesis, truncated PARP-1 constructs ABC and DEF were tested. It was
observed that initiation and elongation of short polymers requires the presence of DEF,
ABC and DNA. As the polymer gets larger, DEF itself is capable of adding ADP-ribose
onto the PAR polymers. Current data is consistent with a mechanistic proposal where
automodification of PARP-1 happens intramolecularly and PAR elongation takes place at
the distal end of the growing polymer.
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1Chapter 1. Background and Significance
1.1. POLY (ADP-RIBOSE) (PAR): A NOVEL NUCLEIC ACID LIKE POLYMER
1.1.1. A short story of poly(ADP-ribose) discovery
The earliest discovery of poly(ADP-ribose) formation was reported in 1963 by
Chambon et al. (1). It was observed that 14C-labeled ATP was incorporated into the acid-
insoluble fraction of prepared chicken liver nuclei upon the addition of nicotinamide
mononucleotide (NMN). This reported activity was DNA-dependent, and the resulting
product was insensitive to treatment with DNase, RNases or proteases. Therefore, it was
suspected that the observed product was polyadenine (poly(A)) (1). This result was
confirmed by a later study carried out by Fujimura et al. using nuclei from rat liver and
hepatoma cells (2).
Further investigation performed by Chambon et al. showed that 32P-NMN could
also be incorporated into the polymer (3). Therefore, the previously observed stimulating
effect of NMN could be ascribed to its capability to serve as either the substrate or the
biosynthetic precursor of the substrate for polymer formation. Further investigation
suggested that nicotinamide adenine dinucleotide (NAD+), which is a known biosynthetic
product of NMN and ATP, is the immediate substrate for polymerization (3).
The structure of the polymer residues was first studied by degrading the polymer
using alkaline hydrolysis, snake venom pyrophosphatase and acid hydrolysis. This led to
a mixture of adenine, ribose and phosphate with a ratio of 1:2:2, respectively, implying
an isomer of ADP-ribose as the polymeric unit (3). This result was quickly confirmed by
Nishizuka et al. (4), Reeder et al. (5) as well as other research groups (6, 7). The study
carried out by Reeder et al. also suggested that the ADP-ribose unit is connected through
ribose-ribose linkages to form a linear homopolymer (5).
21.1.2. Structural details of poly(ADP-ribose)
Extensive studies done in the 1970s provided more structural detail regarding the
chemical nature of poly(ADP-ribose) (Fig.1-1). 13C NMR studies carried out by Miwa et
al. revealed that the ADP-ribose unit is connected through an α-(1''-2')-ribose-ribose
glycosidic linkage (8). Upon enzymatic treatment with snake venom phosphodiesterase,
the major unit released from the polymer is 2'-(5''-phosphoribosyl)-5'-AMP (PRAMP) as
the elongation monomeric unit (9-10), along with a lesser amount of 5'-AMP, which is
derived from the polymer termini (11). Thus, it was proposed that poly(ADP-ribose) is a
linear polymer (10).
Polyacrylamide gel electrophoretic methods had been used to resolve poly(ADP-
ribose) polymers with a size resolution of one residue. Enzymatic digestion was also used
to provide additional information about the chain length of poly(ADP-ribose) polymers
by comparing the number of elongation units (PRAMP) and the 5'-AMP terminal units
(11). In 1978, Tanaka et al. reported an interesting observation: polymers with
proximately 65 total residues have an average chain length of about 30 residues,
indicative of a branched polymeric structure with multiple 5'-AMP termini (12). Further
studies by the same group provided structural details of the branching unit, which is O-α-
D-ribofuranosyl-(1'''→2')-O-α-D-ribofuranosyl-(1''→2')-adenosine-5',5'',5'''-
tris(phosphate) (13-14), abbreviated as (PR)2AMP, and presented direct evidence
regarding the morphology of the branched poly(ADP-ribose) polymer using electron
microscope (15) (Fig.1-1).
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Figure 1-1. A. Basic structure of branched poly(ADP-ribose); B. An electron microscopic
image of branched polymers (adapted from Hayashi et al., Biochem. Biophys. Res.
Commun. 1983, 112: 101-107).
As shown in the electron micrograph in Figure 1-1, the polymers appear to be
dendritic. But a defined versus random frequency of branching unit formation is difficult
to discern. By quantitating the numbers of different monomeric units generated after
phosphodiesterase treatment and using equations 1 and 2 (see Figure 1-1), it was reported
that the average branching frequency is every 20 to 50 ADP-ribose units (16). Similarly,
the size distribution of poly(ADP-ribose) polymers produced either in vivo or in vitro is
highly heterogeneous judging from the polyacrylamide sequencing gel results (12,15-16).
4Soon after the discovery of poly(ADP-ribose), Nishizuka et al. revealed that
poly(ADP-ribose) was associated with histones in forms ranging from monomers to
oligomers (17) and may be linked covalently as a result of a post-translational
modification process. This finding was further confirmed and elaborated on by numerous
investigations carried out both in vivo and in vitro (18-20). Since then, more and more
functional proteins have been characterized as being poly(ADP-ribosyl)ated (21-23). The
most salient covalent linkage between polymer and protein has been ester formation
involving side chain carboxyl group of glutamic and aspartic acid residues as shown in
Figure 1-1 (24). More recent studies have suggested that lysine can also serve as the
acceptor residue for poly(ADP-ribosyl)ation (25).
1.1.3. Metabolism of poly(ADP-ribose)
Poly(ADP-ribosyl)ation is an important post-translation modification that results
in the covalent attachment of ADP-ribose polymer to amino acid residues of a protein
acceptor. This in turn changes its physico-chemical properties of the modified protein.
This process appears to be highly dynamic and reversible in living cells. Long polymers
have a half-life of less than 1 min, and short polymer has a half-life of 7.7 h in vivo (26).
Furthermore, the substrate NAD+, being consumed in this process, is an essential cofactor
for energy metabolism as well as maintenance of cellular redox potentials (24). The
interdependence between the cellular levels of NAD+ and poly(ADP-ribose) is therefore a
factor influencing cell survival. In order to maintain a physiological balance, metabolism
of poly(ADP-ribose) is highly regulated in eukaryotes (24).
5Poly(ADP-ribose) polymerase-1 (PARP-1) is an abundant nuclear protein capable
of catalyzing initiation, elongation and branching reactions when synthesizing poly(ADP-
ribose) polymer (PAR) conjugated with different acceptor proteins including itself (24).
Its activity is responsible for more than 90% of PAR generated in living cells (26).
Currently, 17 proteins have been identified belonging to the PARP family (27), but only
PARP-1, PARP-2, and tankyrases have been shown to carry out poly- and oligo-(ADP-
ribosyl)ation (28).
Degradation of poly(ADP-ribose) is catalyzed by two enzymes: poly(ADP-ribose)
glycohydrolase (PARG) and ADP-ribosyl protein lyase (24) as shown in Figure 1-2.
PARG has both exo- and endo-glycosidase activities (29-30). This results in the
hydrolysis of the ribose-ribose bonds within PAR polymers leading to smaller oligomers
and eventually the complete degradation to ADP-ribose monomers. The expected
cleavage sites of PARG are shown in Figure 1-1. However, PARG cannot cleave the
proximal ADP-ribose residues that are directly linked to the modified protein. ADP-
ribosyl protein lyase is the enzyme responsible for catalyzing hydrolysis of the ester bond
linking this most proximal ADP-ribose residual to the protein (Fig.1-1) (24). Not much is
known about this enzyme until recently when Sharifi et al. identified a terminal ADP-
ribose protein glycohydrolase (TARG1) that possesses such activity and is encoded by
the c6orf130 gene (31).
6Figure 1-2. Metabolism of poly(ADP-ribose).
1.1.4. Biological importance of poly(ADP-ribosyl)ation
PARP-1 is a key factor for cell survival owing to its participation in different
DNA repair machineries, such as the base excision repair (BER) pathway and double
stranded break (DSB) repair pathways. When cells experience low to moderate levels of
DNA damage, such as single or double stranded breaks, PARP-1 interacts with the DNA
lesions and is activated. Upon activation, PARP-1 modifies a wide array of DNA repair
proteins including itself with poly(ADP-ribose). The interactions between the highly
negatively charged PAR polymers, histones and DNA relax chromosomal structure,
which renders the lesion site accessible to repair proteins (32-33). Furthermore, PARP-1
associates with DNA repair proteins like XRCC1, DNA polymerase β and DNA ligase III
through protein-protein interactions as well as protein-poly(ADP-ribose) interactions,
7thereby contributing to the formation of base excision repair (BER) specific multi-protein
complex (24,34-36). PARP-1 also acts in double stranded break DNA repair pathways. It
does so by interacting with DNA protein kinase (DNA-PK), which is involved in double
stranded break repair via non-homologous end joining (NHEJ) (37-38).
Activation of PARP-1 facilitates the assembly of repair machinery at the site of a
DNA lesion. At the same time, PARP-1 itself is also modified with negatively charged
PAR polymers through the process of automodification (24). This eventually makes
PARP-1 lose its affinity for DNA (24). As a result, PARP-1 dissociates from DNA and
its activity returns to basal level (33). It is also believed that this dissociation process
allows access of the DNA repair proteins (24). As a key contributor to the DNA repair
machinery, inhibition of PARP-1 can further potentiate the therapeutic effect of DNA-
damaging agents used in cancer therapy. Therefore, identification of new PARP-1
inhibitors is an active area of research for better cancer drugs (28, 40).
When the level of DNA damage is moderate, which may be caused by UV
radiation or reactive species generated from metabolism (39), PARP-1 serves as a
safeguard against genomic aberrations; however, when the level of DNA damage is
excessive, high levels of poly(ADP-ribosyl)ation become a hallmark for DNA damage-
induced cell death. It has been shown that poly(ADP-ribosyl)ation is a critical event
affecting the NAD+ level in cells. Wielckens et al. observed that the Ehrlich ascites cell
line is capable of converting 10 nmol of NAD+ to ADP-ribose per minute per 108 cells
(41). This rapid consumption is sufficient to deplete the entire cellular NAD+ pool within
10 minutes (24). Depending on the biosynthetic route one considers, one molecule of
NAD+ would require an input of at least two molecules of ATP (42-43). Furthermore,
exhaustion of the cellular pool of NAD+ would shut down glycolysis pathway (44), which
in turn would slow down the regeneration of ATP. Taken together, NAD+ depletion
8would cause a dramatic drop in the cellular level of ATP. While depletion of NAD+
caused by extensive poly(ADP-ribosyl)ation would cause cell apoptosis soon after
excessive DNA damage (44-45), subsequent depletion of ATP could lead to necrotic cell
death (24).
It should be noted that there are distinct biochemical and morphological
differences between apoptotic and necrotic cell death. Apoptotic cells tend to become
more compact and can be rapidly cleared from body tissues by macrophages. In the case
of necrosis, the plasma membrane of the necrotic cells disintegrates, and the cellular
contents are released into the surroundings, which may cause further tissue injury (28).
Established evidence suggests that PARP-1 is hyperactivated during various
pathophysiological conditions such as stroke, myocardial infarction, heart transplantation,
hemorrhagic shock and acute respiratory distress syndrome (28). These observations have
spurred the development of PARP-1 inhibitors in drug discovery as part of protective
medicines: inhibition of PARP-1 would help to maintain the NAD+ and ATP pool within
cells under the aforementioned disease conditions, thereby attenuating the progress of
necrosis which may cause further organ dysfunction (28).
In addition to the biological roles of poly(ADP-ribosyl)ation discussed above,
accumulating evidence now suggests that poly(ADP-ribosyl)ation is also involved in the
modulation of chromatin structure and controlling DNA replication, transcription, cell
division and development, as well as maintaining genomic stability (24, 46-47). As
poly(ADP-ribose) is also present in mitochondria, its participation in mitochondrial
function and metabolic regulation is currently under active investigation (48-49). As
poly(ADP-ribosyl)ation related research continues to advance at a fast pace, new
functions of PARP-1 are expected to emerge. Therefore, it is important to fully
understand how PARP-1 contributes to various biological pathways in terms of nucleic
9acid and protein substrate recognition. Learning how these different interactions may
translate into the observed activity level, as well as their effects on the size and branching
patterns of poly(ADP-ribose) synthesized by PARP-1 in specific biological contexts may
provide fundamental insight as to how regulation of PARP-1 is achieved.
1.2. FUNCTIONAL ASPECTS OF PARP-1
1.2.1. The domain architecture of human PARP-1
PARP-1 is the first and the best characterized enzyme for poly(ADP-ribose)
formation in eukaryotes. It is a 113 kDa nuclear protein composed of six domains
identified based on homology with reported functional modules (Figure 1-3) (50).
Figure 1-3. Functional domains of PARP-1.
Beginning at the N-terminus of PARP-1, domain A contains two unique zinc
finger motifs (CX2CX28/30HX2C), zinc finger I (FI) and zinc finger (FII), that recognize
different structural DNA lesions with high binding affinity as opposed to specific
nucleotide sequences (51-52). This protein-DNA interaction subsequently triggers PARP-
1 activation. In addition to its DNA binding ability, zinc finger I has also been established
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to be important for PARP-1 activation, whereas zinc finger II is the main segment
participate in DNA recognition (24, 53).
The domain B region contains a bipartite nuclear localization signal (NLS)
encoded in the form of KRK-X(11)-KKKSKK (amino acids 207-226). This short
sequence is essential for targeting PARP-1 to the nucleus (54). The X(11) linker region
between two basic amino acid clusters in NLS harbors a caspase-3 cleavage site
(D211EVD214). After cleavage of PARP-1 by caspase-3, only a basal level of PARP-1
activity is retained, and the truncated enzyme can no longer be activated by nicked DNA
(55). The proteolytic processing of PARP-1 is an early event for apoptosis, which helps
to maintain the cellular energy pool by preventing rapid NAD+ consumption (55).
Domain C contains a zinc-binding motif (CX2CX12CX9C) with a structurally novel
zinc-ribbon fold (56). Unlike the previously discussed zinc fingers I and II in domain A,
zinc finger III (FIII) within domain C does not bind to DNA. Instead, it was demonstrated
to interact with poly(ADP-ribose) (56). Studies of a domain C deletion mutant and
several PARP-1 mutants with point mutations within domain C region revealed that
domain C is essential for DNA-dependent PARP-1 activation (56-68). The importance of
domain C in PARP-1 activation may be due to its involvement in interdomain
interactions as well as stabilizing the active conformation of the PARP-1/DNA complex
(56, 58). An NMR study indicated that domain C exists in monomeric form in free
solution (56), whereas a dimeric structure was demonstrated by X-ray crystallography
(58). The disparity may be due to the slight differences in the protein constructs used as
well as the effects of crystal packing. During activation, whether PARP-1 functions as a
dimer or a monomer remains an unresolved question awaiting additional investigation by
the PARP community.
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When poly(ADP-ribosyl)ation takes place, PARP-1 itself is actually the major
acceptor of the PAR polymer. Domain D was first named as the automodification domain
due to the high abundance of glutamic acid residues within this region which can
potentially be ADP-ribosylated (59-61). Recently, a number of automodification sites
within this region have been confirmed by MS studies. These include D387, E488 and
E491 (62), as well as D461 and E456 (63). However, the acceptor sites of PARP-1 for
ADP-ribosylation are not limited to domain D, as they can also be found in domains A, E
and F (63). In addition, domain D contains a BRCT motif which is critical for mediating
protein-protein interactions in the case of heteromodification as well as cellular signaling
(64).
Domain E contains a WGR motif, which is an abbreviation for the conserved
amino acid sequence Trp-Gly-Arg (65). Huambachano et al. has demonstrated that the
WGR region can interact with poly(ADP-ribose) and short RNAs (66). The same
research group also identified a loop between the BRCT and the WGR regions that
functions as the double stranded DNA binding domain (DsDB) and may also be involved
in DNA-dependent PARP-1 activation (66).
The active site for poly(ADP-ribosyl)ation is located at the C-terminal region of
PARP-1 (domain F) and is responsible for the initiation, elongation and branching
reactions of poly(ADP-ribose) formation (Figure 1-4). In human PARP-1, the region
spans amino acid residues 859 to 908, and is phylogenetically well conserved (67), which
constitutes part of the so-called “PARP signature” (50). The signature region harbors the
NAD+ binding site as a β-α-loop-β-α structural fold as well as the essential residues
involved in the three reactions of PAR polymer formation (67). At the N-terminal region
of domain F, there is a so-called PARP regulatory domain (68-69). However, the function
of this region has not been fully established.
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Figure 1-4. Initiation, elongation and branching reactions carried out by PARP-1.
1.2.2. The PARP superfamily
While structural and functional studies of PARP-1 are still ongoing, 16 genes in
the human genome have been assigned to encode protein members of the PARP family
based upon sequence homology to the “PARP signature” in the catalytic site of PARP-1
(Figure 1-5) (40,71). However, when more stringent criteria are applied based on the
definition of poly(ADP-ribose) polymerase (i.e., the ability to form poly(ADP-ribose)
chains), only four proteins can be characterized as true poly(ADP-ribose) polymerases:
PARP-1, PARP-2, tankyrase 1 and tankyrase 2 (71). Studies have shown that PARP-1
and PARP-2 are capable of forming long branched polymers (16, 72); whereas tankyrase-
1 can form linear polymers (73). Tankyrase-2 is also capable of forming long polymers,
but its ability to introduce branching units has not been established (74). Currently, not
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much mechanistic information is available with respect to how the single active site of
PARP coordinates and regulates the three different reactions of initiation, elongation and
branching required for polymer formation. Detailed biochemical and structural
investigation of these four enzymes, which appear to generate polymer with different
structural patterns, together with the mono-ADP-ribosyltransferases will be discussed
later, and have shed some light on the mechanism of poly(ADP-ribose) biosynthesis.
Based on mutagenesis and structural studies of the PARP-1 catalytic domain, it
has been suggested that the so-called H-Y-E triad is important for substrate binding and
polymer elongation (75). This triad is well-conserved within the PARP family. The
histidine and tyrosine residues are essential for NAD+ binding, and the glutamic acid
residue (E988 in human PARP-1) has been shown to be important for polymer formation
(76). PARP-6 to PARP-16 do not have the conserved glutamic acid residue, which is
instead replaced with an isoleucine, leucine or tyrosine residue. For this reason, these
latter members of the PARP family are believed to be mono(ADP-ribosyl)transferases
(40).
Nevertheless, whether the presence of an active site glutamate is the sole
determinant for polymer formation is still arguable and worthy of further investigation. It
is likely that determinants of polymer formation are not relegated solely to features of the
active site, but may also be dependent on adjacent domains within the protein
architecture. Consistent with this hypothesis is the fact that the catalytic domains of
PARP-1 and PARP-2 show structural homology to the active site of the bacterial ADP-
ribosylating Corynebacterium diphtheriae toxin (Figure 1-6), where the H-Y-E triad is
present, but the toxin is not capable of forming poly(ADP-ribose) (71). Likewise, PARP-
3 also contains the conserved triad, whereas its ability to catalyze polymer formation has
yet to be established (40).
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Figure 1-5. Members of PARP superfamily (adapted from Schreiber et al., Nat. Rev. Mol.
Cell. Biol. 2006, 7: 517-528).
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A. B.
Figure 1-6. A. Structural alignment of chicken PARP-1 (2PAW, blue), mouse PARP-2
(1GS0, magenta) and Corynebacterium diphtheriae toxin (1TOX, yellow) catalytic
domains. NAD+ binding site was identified from co-crystallization of NAD+ (red) with
diphtheria toxin. Poly(ADP-ribose) acceptor site was deduced based on the ADP-moiety
from bound carba-NAD+ (1A26, green), with the 2'-OH group from the ribose staying
close to the catalytic residue E988 (orange). B. The overlayed carbon α-backbone of
chicken PARP-1 (2PAW, blue) and mouse PARP-2 (1GS0, magenta) catalytic domains.
Two structures are highly conserved, except the extend loop region of PARP-2, as
indicated by the arrow. Adapted from Schreiber et al., Nat. Rev. Mol. Cell. Biol. 2006, 7:
517-528.
1.3. DNA BINDING PROPERTIES OF PARP-1
1.3.1. Differential recognition by DNA-binding motifs of PARP-1
Interaction with damaged DNA can stimulate PARP-1 activity over 500-fold than
its basal activity (26). This robust response toward DNA damage is mediated in large part
by the two unique zinc fingers FI and FII within domain A. In addition to the rich
contents of basic amino acid residues, which are likely to contribute to the DNA
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interaction, this region also displays novel features that are only observed in the case of
DNA ligase III (77) and 3'-DNA phosphodiesterase from Arabidopsis thaliana (AtZDP)
(78). First, the zinc ion is coordinated with a Cys-Cys-His-Cys motif; second, the zinc
fingers have 28 and 30 residues, which can facilitate larger surface contact when
compared with typical zinc fingers having 12-13 amino acid residues. Furthermore, they
recognize special structural features of DNA instead of specific nucleotide sequences
(24).
The two zinc fingers exhibit differential roles when recognizing different DNA
lesions. Using full-length PARP-1 protein, Ikejima et al. demonstrated that when PARP-1
encounters a single stranded break within plasmid DNA, both FI and FII are required for
full activity; however, in the case of a double stranded break, only zinc finger I is
required for PARP-1 activation (79). In contrast to this result, Gradwohl and colleagues
used a truncated PARP-1 construct containing two zinc fingers to show that mutations in
FII dramatically affect the recognition of nicked DNA, which mimics single stranded
breaks, whereas FI mutations are much less important (51). Using DNA foot-printing,
they also demonstrated that the site of interaction is at the nicked region of the DNA
construct (51).
The inconsistency between the above two studies may be due to the different
proteins and DNA constructs used. However, the two studies may not be as inconsistent
as they seem, because each research group was looking at a different aspect of PARP-1
activity: PARP-1 enzymatic activity versus DNA binding ability. It is possible that in the
case of single stranded breaks, zinc finger II is required for protein-DNA interactions,
whereas the N-terminal zinc finger I is important for activation of the PARP-1 activity,
possibly through conformational changes. This hypothesis can explain why both zinc
fingers are required for activity, though only zinc finger II is the main contributor to
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DNA recognition. Currently, detailed studies on how the two zinc fingers cooperate and
contribute to DNA-dependent activation of PARP-1 remain few in number. Crystal
structures of the two zinc fingers may provide additional insight to this matter and will be
discussed in a later section. DNA recognition studies described in Chapter 3 address the
hypothesis discussed here.
A double-stranded DNA binding domain (DsDB) located between the BRCT and
the WGR domains was recently identified by Huambachano et al. (80). The authors also
suggested that the DsDB domain may regulate the size of poly(ADP-ribose) being
synthesized, because a protein construct possessing the WGR and catalytic domains
preferentially forms long PAR polymers in the presence of double stranded DNA,
whereas a protein construct containing the DsDB, WGR and catalytic domains leads to
shorter polymer formation (80). Even though the DsDB domain can interact with double
stranded DNA, the interaction appears to be relatively weak when compared that with the
zinc fingers (80). In the case of full-length PARP-1, it is possible that the DsDB domain
helps to stabilize binding to DNA that is distant from the lesion site, while the two zinc
fingers directly interact with the DNA at the lesion site. It would be interesting to
investigate the role of the DsDB domain within the context of full-length protein in terms
of DNA binding versus polymer formation, which has yet to be done.
1.3.2. Interaction with different DNA structures
PARP-1 can interact with different DNA lesions, but the binding affinities toward
different DNA structures can vary significantly. Being a DNA-damage “sensor,” PARP-1
shows strong affinities toward nicked DNA (81), 3'-single base overhangs as well as
blunt end DNAs. The interaction is much weaker when considering DNAs with long 5 '-
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or 3'-overhangs (82). However, polymerase activity seems to be inversely correlated with
the DNA binding affinities: DNAs with long overhangs typically have larger apparent
Vmax values (reported as unit per mg protein) when compared with those of blunt DNA
and single base 3'-overhangs (82). In a more systematic study carried out by Pion et al.,
DNA constructs with 3'-overhangs exhibited higher PARP-1 activities when compared
with 5'- overhangs and blunt end DNAs (83). Therefore, the 5'- recessed end of the
damaged DNA may be the specific recognition site for PARP-1 activation. Based on
fluorescence anisotropy measurements, higher activities may be attributable to the
dimerization of PARP-1 at lesions involving a 5'-recessed end, whereas in the case of a
3'-recessed end and double stranded DNAs, PARP-1 binds to DNA in a 1:1 stoichiometry
(83). Again, these results suggest that PARP-1 may adapt different recognition modes
based on the DNA structures it encounters.
In addition to DNA damage, the presence of certain DNA sequences, such as the
palindromic sequence of a Not I restriction site or a telomeric repeat, can further enhance
the PARP-1 activity (83). Palindromic sequences like the Not I restriction site can form
hairpin structures (84). This may explain the observed interaction between PARP-1 and a
specific DNA sequence. Consistent with this hypothesis, PARP-1 has been shown to
interact with numerous other non-B DNA structures in the absence of DNA breaks such
as hairpins, three or four-way junctions, as well as bent and looped DNAs (52). It was
also observed that PARP-1 interacts with DNA-adducts formed by crosslinking with
DNA-alkylating agents such as cisplatin (85).
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1.3.3. Structural evidence for DNA interaction with zinc fingers
As discussed above, studies of PARP-1/DNA interactions are complicated by the
different domains involved and the variable binding stoichiometries depending on the
nature of the DNA. Therefore, structural snapshots of PARP-1 interacting with DNAs
have been valuable for investigating the matter, despite being a challenging task for the
PARP community.
In 2011, the crystal structures of blunt end DNA complexed with each individual
zinc fingers, FI and FII, were first reported by Langelier et al. (86). Using short, blunt
end DNA as the mimic for a double stranded break, FI and FII were observed to exhibit
similar binding modes when interacting with the duplex DNA (Figure 1-7). The mode of
interaction can be characterized in terms of two distinct features, which are similar for
both zinc fingers: 1. a conserved “base stacking loop” caps the 3'-end of the DNA lesion
site, and 2. a “phosphate backbone grip” is in contact with the minor groove of the DNA
(86).
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Figure 1-7. Crystal structures of PARP-1 zinc fingers complexed with a DNA duplex. A.
Zinc finger I complexed with 10-bp DNA (PDB ID: 3OD8); B. Zinc finger II complexed
with 8-bp DNA (PDB ID: 3ODC); C. Structural details of the base stacking loop and
phosphate backbone grip of the zinc finger I/DNA complex; D. Structural details of the
base stacking loop and phosphate backbone grip of the zinc finger II/DNA complex.
Adapted from Langelier, J. Biol. Chem. 2011, 286: 10690-106701.
Based on the crystal structures shown in Figure 1-7, the interactions between
DNA and the two zinc fingers appear similar. However, as discussed previously, their
functional roles are significantly different in the context of full-length PARP-1. While FII
has strong affinity toward blunt end DNA, an FII deletion mutant of PARP-1 can be
activated by DNA to a similar extent as wild-type protein whether in vitro or in vivo (86).
In contrast, when FI is deleted, the automodification activity is completely abolished even
though DNA binding affinity is not significantly affected (86).
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Later on, Ali and colleagues solved the crystal structure of a single peptide
containing both zinc fingers complexed with an 11 base pair DNA duplex containing a
single-base 5' overhang on each end (87). This structural complex was intended to mimic
a single strand break and provide some insight as to how the two zinc fingers cooperate in
recognizing DNA lesions. It was observed that FII interacts with DNA in a fashion
similar to that when FI is absent (Figure 1-8, B and C). In contrast, the binding behavior
of FI is different in the presence versus absence of FII. When in isolation, FI interacts
with the same DNA lesion site as FII by capping the 3'- end (Figure 1-7C and 1-8A).
Unlike its isolated form, however, the phosphate backbone grip of FI in the presence of
FII is in contact with the major groove of the DNA while the base stacking loop is placed
on top of the overhanging 5'-end (Figure 1-8 C) (70, 87). It was also observed that the
two zinc fingers interacting at the same lesion site are not part of the same peptides,
suggesting an intermolecular dimerization at the damage site of DNA.
Furthermore, the authors established that both zinc fingers are needed for PARP-1
localization at the site of DNA damage in vivo (87). Together with the observations
reported by Langelier et al. (86), it is clear that FI is important for both DNA recognition
and activation of PARP-1, whereas FII is mainly involved in recognizing DNA damage
but not stimulating polymerase activity. When FII is mutated, its DNA binding ability
can be partially substituted by FI, due to the similar interaction interfaces between the
two zinc fingers (Figure 1-7). This substitution is not very efficient since the FII mutant
of PARP-1 experiences a delay in localization to sites of DNA damage (70).
Nevertheless, FI alone is still able to mediate DNA-dependent activation of PRAP-1
though at a suboptimal level.
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Figure 1-8. Crystallographic snapshots of PARP-1 zinc fingers complexed with a DNA
duplex. A. Zinc finger I complexed with 10-bp blunt end DNA (PDB ID: 3OD8) solved
by Langilier et al. (86); B. Zinc finger II complexed with 8-bp blunt end DNA (PDB ID:
3ODC) solved by Langilier et al. (86); C. Two zinc fingers complexed with 11-bp 5'
overhang DNA (PDB ID: 4AV1) solved by Ali et al. (87). Adapted from Hassler et al.,
Curr. Opin. Struct. Biol. 2012, 22: 721-729.
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1.4. ACTIVATION OF PARP-1
1.4.1. DNA-dependent activation of PARP-1
The best studied mode of activation for PARP-1 is the DNA-dependent pathway.
Crystallographic studies of PARP-1 domains complexed with DNA have provided
valuable structural information that allows investigators to envision how activation can
be achieved in this manner. As shown in Figure 1-8, the observed dimerization of two
zinc fingers with a single base 5'-overhang DNA led Ali et al. to propose an
intermolecular model for the activation of PARP-1 in the presence of DNA lesions
(Figure 1-9) (87).
Figure 1-9. Proposed mechanism of trans-activation of PARP-1 by damaged DNA. A.
and B. Model for single stranded DNA break; C. Model for double stranded DNA break.
Adapted from Ali et al., Nat. Struct. Mol. Biol. 2012, 19: 685-692.
The model suggests that two PARP-1 molecules interact at the lesion site via the
N-terminal zinc fingers. This dimerization is stabilized by protein-protein interactions
between zinc finger I of one protein molecule and zinc finger II from the second PARP-1
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molecule. This DNA induced dimerization then activates PARP-1 by inducing
conformational changes in the adjacent domains. This also allows the catalytic domain of
one PARP-1 protein to access the polymer acceptor sites at the BRCT domain in the
second PARP-1 molecule resulting in intermolecular modification. Therefore, the
proposed model requires PARP-1 dimer formation and intermolecular automodification.
Due to its large size and structural flexibility, it is difficult to crystallize full-
length PARP-1 with DNA. The first successful attempt in crystallizing near full-length
PARP-1 with DNA was accomplished by Langelier et al. in 2012, and the result is shown
in Figure 1-10. The crystal structure was obtained using a 26 bp DNA duplex and three
protein peptides: zinc finger I (FI), zinc finger III (FIII) and the WGR-CAT domain.
These three components represent the minimal functional requirements for reconstituting
DNA-dependent activation of PARP-1 (88). As shown in Figure 1-10, the WGR domain
is in contact with FI, FIII, the CAT domain and DNA, which serves as the coordinating
component for the domain-domain interactions as well as protein-DNA interactions.
Thus, FI binds to the DNA in a fashion similar to its isolated form (see Figure 1-7), while
FIII and the WGR domain also interact with the DNA duplex: FIII contacts the DNA
backbone, and the WGR domain interacts with the 5' end of the DNA. It is worth noting
that FIII in isolation does not interact with DNA (56). Upon binding to DNA, both FI and
FIII interact with only one face of the WGR domain, whereas the regulatory HD domain
of the CAT fragment is in contact with the opposite face of the WGR domain. Overall,
this crystal structure implies that PARP-1 interacts with the DNA lesion only in a
monomeric form.
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Figure 1-10. A. The crystal structure of PARP-1 domains/DNA complex. B. A proposed
model for DNA-dependent activation of PARP-1. Adapted from Langelier et al., Science
2012, 336: 728-732.
Based on the structural evidence (Figure 1-10A) in combination with a series of
mutational studies, Langelier et al. proposed an intramolecular DNA-dependent
activation model for PARP-1 automodification (see Figure 1-10B). In the absence of
DNA, PARP-1 exists in an elongated, “beads-on-a-string” conformation, and the catalytic
ART domain is in a closed and rigid conformation that is regulated by the adjacent HD
domain. This results in a low basal level of PARP-1 activity. When PARP-1 encounters a
DNA lesion, FI, FIII and the WGR domain aggregate together into close contact about
the DNA to form a compact complex at the site of the lesion. The interdomain
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interactions perturb the interaction between the HD and ART domains thereby
destabilizing the closed conformation of the ART domain. The result is a more flexible
catalytic domain, which allows the BRCT domain to approach closer to the active site.
This leads to stimulation of PARP-1 activity and automodification at the BRCT domain
(88-89).
As discussed, the two mechanisms proposed for DNA-dependent activation of
PARP-1 differ in terms of protein stoichiometry and intra- versus intermolecular
automodification. Therefore, these opposing models serve as interesting hypotheses that
are worthy of further testing. Studies to be described in Chapter 2 and Chapter 3 of this
dissertation are intended to provide information for addressing the issues of stoichiometry
and DNA-protein interaction dynamics.
1.4.2. DNA-independent activation of PARP-1
In addition to the DNA-dependent activation pathway of PARP-1, accumulating
evidence suggests that PARP-1 can also be activated through alternative pathways that do
not involve DNA. As demonstrated by Huambachano et al., single stranded RNAs such
as poly(rA), poly(U) and poly(rC) alone can activate the WGR-CAT domain for
automodification in the absence of DNA (66). Furthermore, PARP-3, which is a mono-
ADP-ribosylase within the PARP family, can interact with PARP-1 and act as an
activator for PARP-1 automodification (90). Interestingly, the WGR domain seems to
play an essential role in both scenarios. In the case of PARP-1, the WGR domain is
important for facilitating interactions with RNA (66), while the WGR domain of PARP-3
is important for activating PARP-1 in the absence of DNA (90).
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Another interesting discovery is that PARP-1 can also be activated by the
phosphorylated-ERK2 kinase in the absence of DNA. DNA competition assays
performed by Cohen-Armon et al. suggested that phosphorylated-ERK2 (p-ERK2) may
interact with PARP-1 in the same region as where DNA binds, with p-ERK2 being a
stronger activator in comparison with DNA (91). This result has raised the question as to
whether there is any similarity in the modes of interaction between PARP-1 and p-ERK2
versus DNA. Both activating species contain phosphate groups that may serve as the key
component for PARP-1 activation upon binding. Furthermore, PARP-1 can be
phosphorylated by free ERK2, and this results in enhanced automodification activity in
the presence of DNA; however, phosphorylation alone is not strong enough to activate
PARP-1 in the absence of DNA (92). Phosphorylation of PARP-1 may, therefore, be a
potentiating switch that still requires the participation of DNA.
1.5. REACTION MECHANISM OF PARP-1
In contrast to the extensive studies of PARP-1 activation, information regarding
the PARP-1 reaction mechanism is still quite limited. This may be ascribed to the
heterogeneity of poly(ADP-ribose) products generated during catalysis, and the uncertain
number of automodification sites within PARP-1. Few details are known regarding how
PARP-1 utilizes a single active site to catalyze the separate reactions of initiation,
elongation and branching during poly(ADP-ribose) formation.
1.5.1. Catalytic mechanism of PARP-1
PARP-1 catalyzes poly(ADP-ribosyl)ation using NAD+ as the donor of polymer
residues. PARP-1 itself can also serve as the substrate for modification with polymer.
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PAR polymer formation occurs via three different reaction processes: initiation,
elongation and branching (see Figure 1-4). Initiation involves the formation of a covalent
linkage between ADP-ribose and the carboxyl group of a glutamic or aspartic acid
residue on the protein substrate via displacement of nicotinamide from NAD+ (93). Based
on a QM/MM computations carried out by Bellocchi et al., PARP-1 is believed to
catalyze cleavage of the nicotinamide-ribosyl bond through a SN2 mechanism (94). The
initiation reaction can also utilize lysine as the acceptor residue in the protein substrate,
though this appears to be less common (25).
The distinction between initiation, elongation and branching essentially depends
on the identity of the acceptor unit. Whereas a protein residue serves as the acceptor for
initiation, the 2'-OH of the adenine-ribose moiety of the terminal unit serves as the
acceptor during elongation reactions. In branching reactions, however, the 2''-OH of a
nicotinamide-ribose moiety in the polymer becomes the acceptor site for the incoming
ADP-ribose moiety (93). The majority of the PARP family members are mono-ADP-
ribosylases (71), which effectively only catalyze initiation reactions. The mechanistic
question of PARP-1 catalysis is how PARP-1 can utilize three different acceptor
substrates and catalyze polymer synthesis with a single active site.
Before crystal structures of the PARP-1 catalytic domain became available,
mutagenesis studies carried out by Marisischky et al. identified E988 as an important
amino acid residue involved in poly(ADP-ribose) elongation (76). E988Q and E988A
mutants could carry out initiation, but polymer formation was reduced by more than
2000- fold when compared with the wild type enzyme. Likewise, the E988D mutation
decreases polymer formation by about 20-fold. These observations led to the proposal
that E988 acts as a general base to activate the 2'-OH group of the terminal adenine-
ribose of the nascent poly(ADP-ribose) during the elongation (Figure 1-11B).
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Furthermore, by co-crystallizing the catalytic domain of PARP-1 with a carba-NAD
substrate analog, Ruf et al. observed that E988 forms a hydrogen bond with the 2'-OH
group of the adenine-ribose moiety (95). The role of E988 in initiation is apparently less
significant because E988 mutants have relatively little effect on chain initiation.
Nevertheless, it could still serve in initiation by positioning the acceptor nucleophile of
the protein substrate through hydrogen bonding (Figure1-11A) (76). Experiments
described in Chapter 4 address the regulatory elements of polymer synthesis by
considering the involvement of different domains of PARP-1.
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Figure 1-11. The role of Glu988 in initiation and elongation of poly(ADP-ribose)
synthesis. A. Initiation. B. Elongation. C. Crystal structure of PARP-1 catalytic domain in
complex with carba-NAD (PDB ID: 1A26). Adapted from Marsischky et al., J. Biol.
Chem. 1995, 270: 3247-3254 and Ruf et al., J. Mol. Biol. 1998, 278: 57-65.
Study of the branching reaction is hampered due to the relatively low abundance
of branching units, which amounts to approximately 2 to 5% of polymerized residues
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(24). Furthermore, branching unit formation is irregular and depends on the size of the
polymers (15), which is hard to control based on current techniques. Nevertheless, the
crystal structure described previously in Figure 1-12 A and B revealed that position of the
pyrophosphate group of ADP is fixed by an extensive hydrogen bonding network,
whereas the adenine-ribose moiety is more flexible and lying at the open end of the active
site. The presumably weak interactions between the adenine-ribose region of the polymer
and the exposed surface groove of PARP-1 have led researchers to propose the model in
Figure 1-12 C to explain how branching takes place.
According to this model, the bound NAD+ is fixed within the catalytic domain. It
is the recognition of the pyrophosphate moieties of the polymer rather than the terminal
adenine-ribose that renders the nascent polymer be more flexible and be able to orient
differently within the active site. Catalysis proceeds through elongation or branching
reactions depending on whether the terminal adenine-ribose or the internal nicotinamide-
ribose moiety is closer to the NAD+ binding site (95). Consistent with this hypothesis,
early random mutation studies carried out by Rolli et al. identified the Y986 residue as an
important residue for modulating the branching frequency. Y986 is in close proximity to
both E988 and the pyrophosphate moiety of an ADP-ribose in the crystal structure (PDB
ID: 1A26). While a Y986H mutant retained about 10% of the enzymatic activity as the
wild-type, the branching frequency was about 15-fold higher (96). It is possible that
Y986 may interact with the adenine ribose moiety of the incoming polymer and thereby
position the nicotinamide ribose close to E988, which would thus be activated for a
branching reaction (Figure 1-12).
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A. B.
C.
Figure 1-12. A. Residues involved in hydrogen bonding with the pyrophophosphate
moiety (PDB ID: 1A26). B. The binding pocket of the ADP moiety of carba-NAD+ is
relatively open. C. Proposed mechanism for elongation and branching reactions of
PARP-1 (modified based on Ruf, J. Mol. Biol. 1998, 278: 57-65).
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1.5.2. Automodification of PARP-1
The intriguing aspects of PARP-1 catalysis are not limited to the three reaction
steps discussed above. As PARP-1 itself is the major acceptor during poly(ADP-ribose)
synthesis, there are several questions regarding how PARP-1 automodification takes
place. One question is the role of each individual PARP-1 molecule in the
automodification process. As discussed previously, it is possible that automodification
takes place after dimerization of PARP-1, such that one protein molecule serves as the
catalytic enzyme, with the other being the acceptor substrate (Figure 1-9). In such a
scenario, automodification would be an intermolecular process. Alternatively, a single
PARP-1 protein could serve as both catalyst and substrate in an intramolecular
mechanism as shown in Figure 1-10.
In attempting to address this question, Mendoza-Alvarez et al. reported the
observation of the second order kinetics when the initial rate of PARP-1 automodification
was measured as a function of PARP-1 concentration. This is consistent with the
formation of activated dimers during intermolecular PARP-1 automodification (97).
However, the above conclusion is questionable because the kinetic measurements were
based on total NAD+ incorporation. Furthermore, it was generally believed that
automodification of PARP-1 must be an intermolecular process if PARP-1 forms a dimer.
However, this is not necessarily true, since activation and automodification steps are two
separate processes. While not much information is available, one can image that
activation may require dimer formation at the DNA lesion site (Figure 1-9), but the
subsequent automodification reaction can be either an intra- or intermolecular process. If
the later hypothesis is true, then it would be hard to distinguish whether automodification
takes place intra- versus intermolecularly based on a simple kinetic analysis alone.
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Another interesting question regarding PARP-1 automodification pertains to the
topology of poly(ADP-ribose) extension. For example, the incoming ADP-ribose may be
added to the terminal end of the growing polymer, which is termed distal addition, or it
could be added to the site where the polymer linked to the protein substrate, which is
termed as proximal addition (Figure 1-13). Several research groups have tried to answer
this question by carrying out pulse-chase experiments. Despite the same fundamental
designs, different conclusions were reached (98-101). With data interpreted as support for
both proximal and distal elongation in the literature, this question clearly remains
unresolved. Therefore, a modified version of pulse-chase experiment described in
Chapter 4 is aimed to provide additional insight into this question.
Figure 1-13. Schematic diagram of two possible mechanisms of polymer elongation.
1.5.3. Heteromodification of PARP-1
Poly(ADP-ribosyl)ation of acceptor substrates other than PARP-1 itself is called
heteromodification. The best studied substrate for heteromodification is histone H1,
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which is one of the first identified PARP-1 substrates. Since PARP-1 itself is the major
acceptor substrate for poly(ADP-ribose)ation, it is of interest to learn how PARP-1
selects and modifies heterosubstrates. One possibility is that PARP-1 transfers polymers
synthesized via automodification en masse to an acceptor residue of a heterosubstrate.
Alternatively, PARP-1 may initiate polymer formation directly onto a heterosubstrate in a
manner analogous to automodification. Using histone H1, it has been shown that pre-
established polymers are unlikely to be transferred from PARP-1 to histone H1 (61,102).
This is consistent with the hypothesis that modification of heterosubstrates by PARP-1
follows a process of initiation, elongation and branching much like automodification.
Heteromodification requires a mechanism for substrate recognition by PARP-1,
and the pre-established polymer of automodified PARP-1 may play a role.
Heterosubstrates such as histone H1 can bind with PAR polymers (103). This leads to the
hypothesis that automodification may be a pre-requisite for heteromodification: the pre-
established PAR polymers on automodified PARP-1 may function as a locus of
interaction for histone H1 thereby increasing its effective concentration near the PARP-1
active site. Furthermore, a specific size of the polymer may be required for optimal
heteromodification activity. For example, if the polymer is too large, it may prevent the
heterosubstrate to bind close to the catalytic domain of PARP-1 for effective initiation
and elongation. Under typical in vitro conditions, levels of histone H1 modification are
relatively low when compared with levels of PARP-1 automodification. However, it has
been reported that when a small amount of PARG is added to the reaction, the observed
level of histone modification increases (104). This is consistent with the hypothesis that
there is an optimal size of the pre-established PAR polymer required for efficient
heteromodification.
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1.5.4. Inactivation of PARP-1
While DNA stimulates PARP-1 activity over 500-fold from its basal level (24),
the net negative charges on PARP-1 are rapidly increased due to the subsequent
automodification. Zaharadka et al. monitored the sedimentation patterns of DNA with
PARP-1 and found that after automodification of PARP-1, the pre-bound DNA was
released (105). When PARG is also present during automodification, however, the DNA
remained bound with PARP-1 (105). These results indicate that polymer formation leads
to a decrease in the affinity between DNA and PARP-1 and support an inactivation model
called “PARP shuttling” (24). This model predicts that the level of modification will
eventually reach to a “point of repulsion”, the interaction between PARP-1 and DNA
becomes destabilized due to the negative charges on both DNA and PAR polymer, and at
which point, leading to the dissociation of DNA from PARP-1. As a result, PARP-1
activity is returned to its basal level (24). While large PAR polymers can cause PARP-1
inactivation, under physiological condition, another factor which could affect the size of
PAR polymer in PARP-1 automodification is the presence of PARG, which can
hydrolyze the polymers to smaller size. When PARG is present, automdofication activity
of PARP-1 can be sustained without inactivation (106). Therefore, PARG has an essential
role in maintaining PARP-1 activity in vivo, and how this process being regulated is
currently unknown.
1.6. THESIS STATEMENT
Work presented in this dissertation provides additional insight into the
mechanisms of DNA-dependent activation of PARP-1 and poly(ADP-ribose)
biosynthesis. Chapter 2 describes analytical ultracentrifugation as a technique to
investigate the oligomerization states of PARP-1 proteins bound to different DNA
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constructs. The results obtained from sedimentation velocity experiments indicate that
PARP-1 as well as the DNA binding domains AB associate with DNA lesions as dimers.
In addition, a secondary DNA binding site within the WGR motif is characterized. In
Chapter 3, single molecule fluorescence colocalization experiments were performed to
investigate the interaction dynamics of DNA recognition by domain AB. It was observed
that recognition of double strand breaks by domains AB includes two different steps that
exhibit distinct dissociation kinetic behaviors and involve different regions of the
domains AB based on FRET efficiency analyses. Consistent with the results obtained
from sedimentation velocity experiments, total intensity analyses indicate dimer
formation with the double stranded break. In Chapter 4, the domain requirements for
initiation and elongation processes of poly(ADP-ribose) synthesis were investigated
using the truncated PARP-1 constructs ABC and DEF. Data support the requirement of
both ABC and DEF for both initiation and short polymer formation. When protein-
conjugated polymers become longer, the DEF construct alone is capable of incorporating
NAD+ in the absence of ABC. Based on results from a series of biochemical studies
together with the available crystal structure of PARP-1 domains in complex with DNA
(see Figure 1-10), an automodification model of PARP-1 has been proposed. One aspect
of the proposed model is that polymer elongation happens through distal addition. In
Chapter 4, pulse-chase experiments as well as polymer transfer assays are described as
intended to test this proposed model. These results are consistent with distal elongation.
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Chapter 2. DNA Recognition of Human PARP-1
Part I: Investigation of Binding Stoichiometry and Characterization of
the Secondary DNA Interaction Site
2.1. INTRODUCTION
As discussed in Section 1.2, human PARP-1 is a multi-modular protein which
exerts its biological function through protein-protein and protein-DNA interactions. With
regards to PARP-1 automodification, it was believed that the activation process requires
dimer formation based on kinetic studies carried out by Mendoza-Alvarez et al. (1). The
proposed dimerization process allows two PARP-1 protein molecules to modify each
other intermolecularly. Therefore, it is of interest to understand the oligomeric states of
human PARP-1. Furthermore, it has been well-established that interaction with damaged
DNA is one of the prerequisites for PARP-1 activation (2). This leads to the question of
whether this proposed dimerization process requires the presence of activating molecules
such as DNA.
The requirement of dimer formation for PARP-1 activity still remains
controversial despite more than 35 years of research efforts. An early study of native
PARP-1 purified from Ehrlich ascites tumor cells indicated a molecular weight greater
than 500 kDa suggesting the formation of oligomers (3). Later on, PARP-1 purified from
bovine thymus was shown to be a monomer in solution as demonstrated by gel filtration
chromatography and analytical ultracentrifugation (4). In the 1990s, studies done by Prof.
Ernest Kun’s research group suggested that PARP-1 purified from calf thymus existed in
a monomer-dimer equilibrium using gel filtration, cross-linking and native gel
electrophoretic analysis (5,6). They also found that the DNA-binding domain and the
automodification domain were important for the self-association process (5-6). In 2004,
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Mendoza-Alvarez et al. heterologously expressed the catalytic domain of human PARP-1
and used ultrafiltration studies to demonstrate the ability the catalytic domain to self-
associate in the absence of DNA (7). While the studies discussed here suggested that
different functional domains are involved in the self-association process, it should be
noted that all of these functional domains were observed using NMR structural
experiments to be present in solution as monomers (8).
To further test the hypothesis that PARP-1 undergoes self-association,
sedimentation velocity (SV) experiments were carried using human full-length PARP-1
and its DNA-binding domain AB. SV data analyses demonstrated no self-association
under the tested conditions and thus suggest that both domain AB and full-length PARP-
1 remain monomeric in solution in the absence of DNA.
Whether the presence of DNA would induce PARP-1 dimerization is another
interesting hypothesis that remains to be fully tested. Known as a “nick sensor,” PARP-1
has been shown to produce a symmetric pattern of protection at sites of nicked DNA
during DNAse footprinting experiments (9). Intrinsic tryptophan fluorescence studies
carried out by Pion et al. have indicated that the PARP-1 DNA-binding domain AB
interacts with DNA at 5'-recessed ends in a dimeric form, whereas in the case of 3'-
recessed ends and double stranded DNA, domain AB forms a 1:1 protein-DNA complex
(10). In agreement with the biochemical studies of blunt end DNA, crystal structures
reported by Langelier et al. showed that the individual zinc fingers I and II interact with
the blunt end region of double stranded DNA as a monomer, as shown in Chapter 1,
Figure 1-7 (11). In contrast, when two zinc fingers are present in a single protein and are
co-crystallized with a DNA construct with a single base 5'-overhang, then dimer
formation could be observed as shown in Chapter 1, Figure 1-8 (12). The cause of the
observed differences between the biochemical and crystallographic data is still unclear.
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To further investigate the putative dimerization process of PARP-1,
stoichiometric analyses of PARP-1 and domain AB in the presence of DNA were
conducted using sedimentation velocity techniques. When a 66bp double stranded DNA
(66DS) was used, both 1:1 and 2:1 protein-DNA complexes were observed in the case of
PARP-1. Both protein-DNA complexes were also observed when a 66bp DNA construct
with a single base gap (66G1) was used. Interestingly, in the case of domain AB, higher
oligomeric states of 3:1 and 4:1 protein-DNA complexes were observed with the 66DS
and 66G1 DNA constructs, respectively. The results presented in this section may
provide additional information for the DNA recognition mechanism of PARP-1.
While PARP-1 is a relatively large protein composed of six functional domains,
data obtained from SV experiments indicated that PARP-1 alone has an elongated
conformation in solution. Questions arise as to how DNA binding at the N-terminal
domain leads to activation of the catalytic domain F at the C-terminus. It is possible that
upon DNA binding, the PARP-1 structure may undergo conformational change and leads
to activation. Consistent with this notion, based on the frictional ratio obtained from SV
experiments, PARP-1/DNA complexes have more compact shapes when compared with
PARP-1 alone in solution. Since there is no crystal structure of full-length PARP-1
complexed with DNA currently available, our previous group member Dr. Steven
Mansoorabadi was interested in understanding changes in PARP-1 conformation during
DNA-dependent activation. Utilizing small-angle X-ray scattering and molecular
dynamics simulations, a structural model of PARP-1 complexed with 8-mer DNA was
constructed (13). In addition to the N-terminal DNA-binding zinc fingers, another DNA
interaction site within the WGR domain was proposed. In the present study, the DNA
binding ability of the PARP-1 C-terminal domains (i.e., DEF) was investigated, and the
involvement of the WGR domain in DNA binding was confirmed using a deletion mutant
49
DEF∆. Compared with domain ABC, DEF demonstrated a weaker DNA binding ability,
and its influence in DNA binding was less substantial when it was investigated in the
context of full-length PARP-1. However, deletion of the proposed DNA-contact region
within the WGR domain caused a dramatic drop in PARP-1 activity, indicating an
important role in the DNA-dependent activation of PARP-1 (13).
2.2. MATERIALS AND METHODS
2.2.1. Cloning, expression and purification of human PARP-1 protein constructs
AB, ABC and DEF
DNAs encoding amino acid residues 1–232 [domains A and B (AB)], 1–373
[domains A-C (ABC)] and 374–1014 [domains D-F (DEF)] of the human PARP-1
protein were each cloned into the MalE-pET vector generated in house by Dr. Peng Gao
at the NdeI and XhoI restriction sites (14). Construction of MalE-pET was accomplished
by modifying a pET-24b(+) vector (Novagen) so that the cloned protein constructs would
be expressed as a fusion proteins with a decahistidine tagged maltose-binding protein
(MBP) at the N-terminus. A TEV protease cleavage site was also engineered into the
constructs to allow removal of the MBP.
The MalE-pET vectors with the cloned protein constructs were used to transform
Escherichia coli BL21 Codon-Plus (DE3)-RP competent cells (Stratagene). Cells were
grown at 37 °C in 6 L Luria-Bertani (LB) broth containing 50 μg/mL of kanamycin and
35 μg/mL of chloramphenicol. IPTG was added to 0.2 mM when the OD600 reached 0.6,
and the culture was grown at 18 °C for another 20 h. Cells were harvested by
centrifugation at 4500 x g for 15 min, and stored at –80 °C until purification.
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Cells were thawed and re-suspended in lysis buffer containing 20 mM HEPES,
300 mM NaCl, 10 mM imidazole, 1 mM β-mercaptoethanol and 10% glycerol at pH 7.5,
and ruptured by sonication. Cell debris was then removed by centrifugation at 20000 x g
for 30 min, and the resulting supernatant was incubated at 4 °C for 1 hr with 10 mL of
Ni-NTA agarose resin (Qiagen), which had been pre-equilibrated with the lysis buffer.
The mixture was then loaded onto a column, drained and washed with the wash buffer
containing 20 mM imidazole and 1 M NaCl. The MBP fusion protein was eluted with
buffer containing 250 mM imidazole and 300 mM NaCl. The fractions containing eluted
protein were pooled and dialyzed against the lysis buffer. After 2 h of dialysis, the
dialyzed MBP-protein was incubated with 5% (w/w) His6-tagged TEV protease for 24 hr
at 4 °C to cleave the His10-MBP tag. The protein mixture was then slowly passed through
a column containing 10 mL of Ni-NTA agarose resin. The protein recovered in the flow
through was concentrated using an Amicon ultra-15 centrifugal filter unit with a 10000
Da cut off (Millipore). Due to the TEV protease digestion site, the cleaved protein
constructs contained two additional amino acids residues, GH, at the N-terminus. Further
purification was achieved by size-exclusion chromatography using a Superdex 200
column and an AKTA FPLC system (GE Healthcare). The elution buffer included 10
mM sodium phosphate, 100 mM NaCl and 10% glycerol at pH 7.5. Protein was flash-
frozen with liquid nitrogen and stored at –80°C.
2.2.2. Cloning, expression and purification of human full-length PARP-1 using
baculovirus expression system
Because cDNA for full-length PARP-1 contains an NcoI restriction site, it can not
be directly cloned into the donor vector. Instead, an intermediate pFastbacTMHT B/MBP-
Tev vector was first generated. To do so, pFastbacTMHT B vector (Invitrogen) was
linearized by double digestion with NcoI and XhoI restriction enzymes, and the same was
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done with recombinant MBP-TEV-ABC/pET vector. Both the linearized pFastbacTMHT
B vector and the DNA fragment encoding MBP-TEV-ABC were purified using 0.8%
agarose gel and ligated using T4 ligase. The ligated recombinant DNA was used to
transform Escherichia coli DH5α competent cells (Novagen), and the resulting
pFastbacTMHT B/MBP-Tev-ABC plasmid was amplified and recovered from the bacteria.
To generate the pFastbacTMHT B/MBP-Tev vector, the ABC fragment was removed by
digestion using NdeI and XhoI restriction enzymes followed by treatment with CIP (calf
intestinal alkaline phosphatase). The resulting pFastbacTMHT B/MBP-Tev fragment was
agarose gel purified and used for subsequent steps.
To generate pFastbacTMHT B/MBP-Tev-PARP recombinant plasmid, the
recombinant PARP-1/pET28(b+) plasmid was digested with NdeI and XhoI restriction
enzymes. The DNA fragment encoding the PARP-1 gene was agarose-gel purified and
ligated with the linearized pFastbacTMHT B/MBP-Tev fragment using T4 ligase. The
ligated product was then transferred DH5α Escherichia coli competent cells for plasmid
amplification and purification.
To generate the recombinant bacmid, which is the baculovirus shuttle vector for
the MBP-Tev-PARP-1 construct, the pFastbacTMHT B/MBP-Tev-PARP recombinant
plasmid was used to transform the MAX Efficiency® DH10BacTM Escherichia coli
competent cells according to instructions in the manual for the Bac-to-Bac® Baculovirus
Expression System (Invitrogen). Transformant was plated on LB agar containing with 50
μg/mL kanamycin, 7 μg/mL gentamicin, 10 μg/mL tetracycline, 100 μg/mL Bluo-gal, and
40 μg/mL IPTG for blue/white colony selection. The plates were incubated at 37 °C for
48 h. Following the incubation, white colonies were selected, re-streaked on a fresh LB
plate containing the same additives as before, and incubated at 37 °C overnight to
confirm the white colony phenotypes. A single white colony was then selected and used
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to inoculate a liquid culture containing 50 μg/mL kanamycin, 7 μg/mL gentamicin and 10
μg/mL tetracycline. The culture was subsequently incubated at 37 °C overnight with
shaking at 250 rpm. The resulting recombinant bacmid DNA was isolated using the
PurelinkTM HiPure Plasmid DNA Miniprep Kit (Invitrogen) and analyzed using PCR
based on the protocol from the manufacturer.
Once the inserted MBP-PARP gene was confirmed, the bacmid DNA was used to
transfect Sf21 insect cells using Cellfectin® II Reagent (Invitrogen). When the cells
showed signs for the late stage of infection roughly 72 h after transfection, the medium
was collected by centrifugation at 500 x g for 5 min. The resulting P1 viral stock was
used to infect Sf21 cells grown in suspension to generate P2 viral stock.
To express the MBP-PARP protein, P2 viral stock was used to infect Sf21 insect
cells grown in serum-free SF-900 II SFM medium at 27 °C with shaking at 220 rpm. At
96 h post infection, the infected insect cells were harvested by centrifugation at 4000 x g
for 10 min. Cells were re-suspended and washed with PBS buffer twice. The harvested
cells were stored at –80 °C until purification.
To purify PARP-1 protein, the harvested cells were thawed and re-suspended
using lysis buffer containing 20 mM HEPES, 1 M NaCl, 10 mM imidazole, 1% Triton
X100, 1 mM β-mercaptoethanol and 10% glycerol at pH 7.5. The cells were lyzed by
sonication and the cell debris was removed by centrifugation at 20000 x g for 30 min.
The subsequent purification steps for PARP-1 were similar to those previously described
for the domain AB construct.
2.2.3. Preparation of DNA ligands for sedimentation velocity experiments
Single-stranded DNA primers were purchased from Integrated DNA
Technologies, Inc. (IDT). Sequences of the single stranded DNA primers are listed in
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Table 2-1. To generate double stranded 66-mer DNA duplex as well as the double
stranded 66-mer DNA duplex with a base gap at the center (66G1), the corresponding
single stranded primers were mixed, and each primer was diluted to 20 μM final
concentration in annealing buffer at pH 7.5 with 100 mM sodium phosphate and 100 mM
NaCl. The samples were heated to 95 °C for 5 min, and cooled slowly to 4 °C. DNA
samples were stored at –20 °C until further usage.
Table 2-1.  DNA primers used for sedimentation velocity experiments.
DNA
duplex
DNA
primers
used
Primer sequence
66bpF 5'-CCAGGACCAGGGCGCAGATCACCTTGTTCTCCAGCCCACAGCAGGGTCCACAGCAGCCTTGCCCTT-3'66DS
66bpR 5'-AAGGGCAAGGCTGCTGTGGACCCTGCTGTGGGCTGGAGAACAAGGTGATCTGCGCCCTGGTCCTGG-3'
66bpR 5'-AAGGGCAAGGCTGCTGTGGACCCTGCTGTGGGCTGGAGAACAAGGTGATCTGCGCCCTGGTCCTGG-3'
33bp-2 5'-GCCCACAGCAGGGTCCACAGCAGCCTTGCCCTT-3'66G1
32bp 5'-CCAGGACCAGGGCGCAGATCACCTTGTTCTCC-3'
2.2.4. Sedimentation velocity experiments
Sedimentation velocity (SV) experiments were carried out using a Beckman XL-
A ultracentrifuge at the Core Facility of the Institute for Cellular and Molecular Biology
at The University of Texas at Austin. To study the oligomerization state of PARP-1
proteins, samples of domain AB and full-length PARP-1 were dialyzed into 10 mM
sodium phosphate buffer at pH 7.5 with 100 mM NaCl before data collection. Samples
with 450 μL of protein analyte at different concentrations were prepared based on
absorbance at 280 nm. Optimal data signals correlated with the absorbance range of 0.2
to 1.5 at 280 nm. To ensure protein was stable throughout the experiments, as judged by
checking possible protein precipitation at the end of the experimental runs, data
collection for domain AB was performed at 20 °C and at 4°C for PARP-1. SV
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experiments were run at 42000 rpm using standard 2-channel centerpieces in an AN-60Ti
rotor. Data were collected in absorbance mode with scanning at 280 nm.
For protein-DNA interaction studies, protein samples were freshly dialyzed into
100 mM sodium phosphate buffer with 300 mM NaCl at pH 7.5. DNA duplex at 1 μM
was mixed with various concentrations of protein (0, 1, 2, 5 and 10 μM) in the presence
of 1 mM TCEP. Samples were run under the same instrumental settings as described
above. Data was collected in absorbance mode with scanning at 230, 250 or 280 nm.
Criteria of selecting a given absorbance wavelength were based on maximizing the signal
to noise ratio for a given experiment and maintaining the absorbance signal within the
range of 0.2 to 1.5.
2.2.5. Data analyses of sedimentation velocity experiments
The sedimentation profile of samples containing only protein solutes was
analyzed using c(s) analysis provided in the Sedfit program (15) to obtain sedimentation
coefficients, s, for each protein species. The basic c(s) analysis requires estimation of a
frictional ratio for each given data set. This makes it less ideal when a given data set
corresponds to analytes with different frictional ratios due to their different shapes. When
globular protein species and a linear DNA construct are both present in the solution, each
individual sedimenting species would exhibit a different frictional ratio. Therefore, for
protein-DNA interaction studies, the Ultrascan II program (version 9.9) was implemented
for data analyses. Hydrodynamic correction for buffer conditions and the partial specific
volume, ῡ, of proteins were determined using Ultrascan II. The ῡ value of both DNA
duplex was estimated to be 0.52 mL·g-1. The data was first analyzed using the enhanced
van Holde-Weischet (vHW) method to characterize the distribution of sedimentation
coefficients represented by a given data set (16). The observed meniscus position from
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the data as well as time- and radially-invariant noise components were first extracted
from a given SV data set by an initial round of two-dimensional spectrum analysis (17).
The noise corrected data was then fitted again through a second 2DSA analysis. The
2DSA results were then further refined using genetic algorithm (GA) optimization. A
total of 50 Monte Carlo iterations were used in the 2DSA and GA analyses to obtain 95%
confidence intervals for each of the fitted parameters (17).
2.2.6. Cloning, expression and purification of the DEFΔ and PARP-1Δ mutants
To investigate the newly identified DNA binding site within domain DEF, a
DEFΔ mutant which lacks amino acid residues 626–645, was constructed using the
Quikchange Site-Directed Mutagenesis Kit (Stratagene). To generate the DEFΔ/MalE-
pET construct by mutational PCR, 5'-CACTTCATGAAATTATATGAAGAAAA-
AACCGGGAACGCTGGCCAGGATGAAGAG-3' and 5'-CTCTTCATCCTGGCCA-
GCGTTCCCGGTTTTTTCTTCATATAATTTCATGAAGTG-3' were used as the
primers and the DEF/MalE-pET plasmid as the template. To generate the PARP-1Δ
mutant which also lacks amino acid residues 626–645, both DEFΔ/MalE-pET and PARP-
1/MalE-pET plasmids were digested with PstI and XhoI restriction enzymes. The small
DNA fragment was purified from the DEFΔ/MalE-pET vector digestion, and the larger
DNA fragment was isolated from the digested PARP-1/MalE-pET plasmid by 0.8%
agarose gel electrophoresis. The two purified DNA fragments were ligated together using
T4-ligase (NEB) to generate the PARP-1Δ/MalE-pET construct. The mutation region was
confirmed by sequencing carried out by the DNA Sequencing Core Facility at The
University of Texas at Austin.
Expression of DEF, DEFΔ, PARP-1 and PARP-1Δ mutants was accomplished
using Escherichia coli BL21 Codon-Plus (DE3)-RP competent cells (Stratagene).
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Transformation, expression and purification processes were performed in manner similar
to those described in Section 2.2.1.
2.2.7. Electrophoretic mobility shift assay (EMSA)
To compare the DNA binding properties of ABC, DEF and PARP-1, as well as
the corresponding deletion mutants, single stranded 8-mer DNA (5'-GGAATTCC-3'), 22-
mer DNA (5'-GGCTAGCTGGCCGCGACCTCGC-3') and 44-mer DNA (5'-CGGTCGA-
TCGTAAGATCCACCGGCGCTGGAGCTTGCTCCAGCGC-3') were purchased from
IDT. The corresponding 8-mer and 22-mer DNA duplexes, as well as 44-mer nicked
dumbbell DNA was prepared based on a similar protocol as described in Section 2.2.3
using an annealing buffer containing 100 mM NaCl and 10 mM Tris-HCl at pH 7.5. To
set up the assay, 150 pmol of DNA duplex was incubated with the purified protein
constructs at various protein:DNA ratios in a total volume of 8 μL. The samples were
then equilibrated on ice for 30 min and run on a 1.5% agarose gel. Gel visualization was
done by ethidium bromide staining and UV transillumination. Images were processed
using ImageJ software (NIH).
2.2.8. Automodification activity assay
To compare the automodification activities of wild type PARP-1 and PARP-1Δ
mutant, a reaction mixture containing 1 μM protein, 1 μM 8-mer DNA, 5 mM NAD+, 50
mM NaCl, 7.5 mM MgCl2, in 20 mM Tris buffer at pH 7.5 (total volume: 6 uL) were
prepared and incubated at room temperature. For all samples, NAD+ was added last to
initiate the reaction. The reaction was quenched at different time points using 2X SDS-
PAGE loading buffer including 50 mM EDTA. As a negative control, 8-mer DNA was
omitted, and the reaction mixture was quenched after 5 min of incubation. After
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quenching, the automodified protein samples were analyzed by SDS-PAGE
electrophoresis and visualized by staining with Coomassie Brilliant Blue.
2.3. RESULTS
2.3.1. Sedimentation velocity experiments of full-length PARP-1 and the DNA
binding domain AB
To study the oligomeric state of PARP-1 and its DNA binding domain AB under
native conditions, PARP-1 and domain AB were first over-expressed and purified as
determined by SDS-PAGE (Figure 2-1). The oligomeric states and the potential self-
association of PARP-1 and domain AB in solution under native condition were studied
through sedimentation velocity (SV) experiments using different protein concentrations.
A.   B.
Figure 2-1. A. SDS-PAGE gel showing typical protein purities of domain AB (lane 2),
ABC (lane 3) and PARP-1 (lane 4) after purification. B. SDS-PAGE gel showing protein
purity of PARP-1 after Superdex 200 size-exclusion chromatography.
In an SV experiment, where rotor speeds of 40000 rpm or greater are employed,
the analytes in solution will sediment toward the bottom of the centrifugation cell over
the experimental time course (18). When mixtures of different biomolecules are used in
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the experiments, the different components will sediment at different rates that depend
both on their sizes and shapes.
The sedimentation process is governed by three forces: the gravitational force, the
buoyancy, and the hydrodynamic friction. At constant velocity where the sum of all
forces are equal to zero, the Svedberg equation can be derived as shown in equation (3),
and the definitions of each parameter are shown in Figure 2-2 (18). Here, the
sedimentation coefficient is expressed as s = v/ω2, where v is the absolute migration
velocity and ω is the rotor angular velocity. The sedimentation coefficient is a molecular
constant measured in units of Svedberg, S, with one Svedberg equal to 10–13 s. The
frictional force component of the sedimentation process is expressed as Ff = s(kT/D)ω2r,
with k as the Boltzmann constant, T as the absolute temperature, D as the diffusion
constant and r as the distance from the center of rotation. Ff is dependent on the absolute
migration velocity as well as the translational frictional coefficient f, with f = kT/D. In
practice, the translational frictional properties of a given molecule are expressed as the
ratio of the frictional coefficient for that molecule versus that of a smooth sphere with the
same molecular mass and density. This ratio denoted as the frictional ratio f/fo. The value
of f/f0 provides low-resolution information on the shape and the Stoke’s radii for a given
molecule or complex (18).
Figure 2-2. The Svedberg equation and definitions of parameters.
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SV experiments generate data showing a change of concentration versus position
over time. Typical raw data for a sedimentation profile of full-length PARP-1 as well as
domain AB from SV experiments are shown in Figure 2-3. The concentration profiles
shown here were obtained in absorbance mode for a given wavelength, and an important
feature observed is the moving sedimentation boundary represented by the sigmoid-shape
of the data. As shown in Figure 2-3, each data scan represents a moving boundary at a
given time. A sedimentation boundary was formed between the region where solute was
depleted and the region where solute was evenly distributed. The displacement of the
midpoint positions of boundaries with time determines the sedimentation coefficient (s),
and the change of the broadening of the curves over time is governed by the diffusion
coefficient D (18). Non-interacting molecules with different sizes and shapes in solution
will generate individual time-dependent concentration curves (i.e., sedimentation profile)
during ultracentrifugation. Thus, SV experiments allow characterization of these
molecules in terms of their sedimentation and diffusion coefficients which relate
information regarding molecular size and shape.
A. Full-length PARP-1    B. Domain AB
Figure 2-3. A. Typical sedimentation velocity raw data for full-length PARP-1. B.
Typical sedimentation velocity raw data for DNA-binding domain AB.
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To see if any self-association of PARP-1 constructs takes place, sedimentation
profiles with increasing protein concentrations were generated from a series of SV
experiments. The experimental design is based on the theoretical work of Tiselius
characterizing how interacting solutes behave in a moving transport system such as
sedimentation velocity experiments (19). When both protein monomer and dimer are
present in solution, and they are in rapid equilibrium when compared with the rate of
sedimentation, the sedimentation boundaries of protein monomers can not be resolved
from those of protein dimers; instead, weight-average sedimentation boundaries of the
two species would be observed (19). In the case of SV experiments, this would result in a
concentration-dependent increase in the observed weight-average s value, sw, for a given
protein if self-association process occurs (15). Therefore, the changes in sw values
observed with increasing protein concentrations for domain AB and PARP-1 can help to
determine whether self-association happens.
The weight-average sedimentation coefficient sw was extracted from each data set
using differential sedimentation coefficient distribution (i.e., c(s)) analysis by the Sedfit
program (15). This analysis assumes that the change in the sedimentation boundary for a
single species over time during an SV experiment using a sector-shaped ultracentrifugal
cell can be modeled by the Lamm equation (4). The Lamm equation for a single solute is
shown in Figure 2-4 (20), where the s and D values can be obtained directly by fitting the
experimental data through solving the Lamm equation, and the molar mass M can be
calculated indirectly according to the Sverberg equation using the experimental s and D
values (3).
Figure 2-4. The Lamm equation (4) and definitions of parameters.
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When multiple non-interacting solutes are present, c(s) analysis fits the SV data
containing superimposed sedimentation boundaries arising from all individual species
with different sw values (15). In addition, the c(s) analysis estimates diffusion coefficients
of the individual species by assuming that all species have the same frictional ratios f/f0,
which is input by the user as a fixed parameter. The experimental data was then modeled
with Lamm equations with different s values. After 100 iterations of data modeling, the
c(s) analyses provides the weight-average s (sw) and the weight-average f/fo for the fitted
solutes. The weight-average values resulted from data fitting of the non-interacting solute
alone, or between the monomeric and dimeric forms if rapid self-association occurs when
compared with the experimental time scale.
Details of the fitted SV parameters are reported in Table 2-2 for full-length
PARP-1 and Table 2-3 for domain AB. The values of sw were plotted against the tested
concentrations for PARP-1 and domain AB. As displayed in Figure 2-5, none of tested
protein constructs showed an increasing trend among the sw values as the loading
concentration increased. This observation indicated that both PARP-1 and domain AB
were present in monomeric form in solution and no self-association had occurred under
the tested conditions.
A. B.
Figure 2-5. Analyses of the concentration dependency of the observed weight-average
sedimentation coefficients sw for full-length PARP-1 (A) and domain AB (B).
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Table 2-2. Fitted results from full-length PARP-1 sedimentation velocity experiments
Loading
Concentration
(μM)
Sedimentation
coefficient
(s20,w)
Weight-average
sedimentation
coefficient
(sw)
Frictional
Ratio
(f/fo)
Experimental
MW (kDa)
Oligomerization
 State
1.51 5.62 3.73 1.43 99.0 monomer
3.2 4.92 4.29 1.55 103.0 monomer
6.1 4.87 4.32 1.56 102.4 monomer
7.6 4.85 4.61 1.64 110.1 monomer
12.2 4.84 4.28 1.58 103.9 monomer
15.1 4.80 4.22 1.55 99.5 monomer
notes: a. Calculated MW for full length PARP-1: 113.3 kDa
b. s20,w is an observed value that is standardized at 20 °C in water
Table 2-3.  Fitted results from domain AB sedimentation velocity experiments
Loading
Concentration
(μM)
Sedimentation
coefficient
(s20,w)
Weight average
sedimentation
coefficient
(sw)
Frictional
Ratio
(f/fo)
Experimental
MW (kDa)
Oligomerization
 State
3.23 2.25 2.46 1.426 26.5 monomer
6.5 2.27 2.44 1.306 23.4 monomer
16.8 2.25 2.42 1.419 26.3 monomer
25.9 2.24 2.42 1.424 26.3 monomer
38.8 2.22 2.23 1.463 26.9 monomer
note: Calculated MW for AB: 26.2 kDa
2.3.2. Sedimentation velocity studies of PARP-1 constructs in the presence of DNA
2.3.2.1. Enhanced van Holde-Weischet (vHW) analysis
As mentioned in Section 2.3.1, c(s) analysis requires a single f/fo frictional ratio
value for a given data set for diffusion estimation used as an input parameter and assumes
that all solutes within a given data set have similar f/fo values. This is generally true for
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most proteins (21). Therefore, c(s) analysis is good for studying homogenous samples or
an interacting system where the sedimenting species have similar f/f0 values. In cases
where both proteins and long DNA duplexes are present together in solution, c(s) analysis
becomes less suitable, because the free protein species, the DNA molecule and the
protein/DNA complex may exhibit different morphologies in solution. This results in
multiple frictional ratios characterizing the same system.
Instead, the Ultrascan II program (version 9.9) was utilized to study binding
stoichiometry of PARP-1 and domain AB toward different DNA lesions. A two-
dimensional spectrum analysis (2DSA) provided by the program allows for heterogeneity
in both s and f/fo parameters in a given data set. This is done by performing a two
dimensional search over a certain range of s and f/fo that are defined by the user (17).
Data was first analyzed using the enhanced van Holde-Weischet (vHW) method
in Ultrascan II in order to check for heterogeneity and get an rough estimation about s
and f/fo ranges within a given protein-DNA sample. In this analysis, no prior knowledge
of the interaction model was assumed, and the effect of diffusion was considered
negligible. This is based on the fact that displacement of the sedimentation boundary due
to sedimentation is linear with time, while boundary displacement due to diffusion
proceeds proportionally to the square root of time (16). Therefore, as time approaches to
infinity, the sedimentation boundary change due to sedimentation outweighs the change
due to diffusion. (16). In the vHW analysis, the reported sw,20 values are resulted from
analyzing a specific portions of boundary fractions across different data scans, and then
being extrapolated to infinite time; therefore, the effect due diffusion is minimal in the
reported sw,20 values.
Here, sedimentation boundaries are divided into multiple boundary fractions by
horizontally slicing the SV raw data, as shown in Figure 2-6A; and the total boundary
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fractions are plotted in percentages in the Y-axis in the final reported data, as shown in
Figure 2-7. For a given boundary fraction i, the change of the intercepting radial position
ri at time tj is compared with the reference point (i.e., solvent meniscus at radial position
ra at the beginning of the experiment (to), and the apparent s*i,j was calculated using
equations shown in Figure 2-6B. When all the calculated s*i,j values are plotted against
(tj)^-0.5, the diffusion corrected sw,20 value for a given boundary fraction i can be
extrapolated as shown in Figure 2-6C. The diffusion corrected sw,20 values for each
individual boundary fractions as extrapolated in Figure 2-6C are then plotted as the
boundary fraction percentage versus sw,20 to give an integral distribution of sedimentation
coefficient G(s) plot (16).
The resulting integral distribution of sedimentation coefficient G(s) plots from the
analyses by the enhanced vHW method are shown in Figure 2-7. Here, the overall shape
of the given G(s) plot provides information on the homogeneity and reversibility of the
system (22). A nearly vertical G(s) plot indicates a homogenous, non-interacting species,
as shown in the case of domain AB alone in Figure 2-7. The slight curvature of the G(s)
plots in the case of DNA alone comes from the noise fluctuation within the data set.
Rapid interaction kinetics compared with the experimental time scale could produce a
gradual increase in sw,20 values as the boundary fraction % increases. This results in a G(s)
plot with a half-parabola shape. It is also noted that, this half- parabolic plot has a greater
curvature when compared with the G(s) plot from DNA alone (22). This was observed in
the cases where domain AB interacts with 66DS and 66G1 DNA (Figure 2-7 A and C). In
the case where slow interaction kinetics take place or non-interacting species are present,
the sw,20 values become better separated, as shown in the case where PARP-1 interacts
with 66DS and 66G1 DNA (Figure 2-7 B and D).
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A.
B.
C.
Figure 2-6. A. Demonstration of dividing SV data into a number of boundary fractions
(n) that are analyzed by enhanced van Holde-Weischet (vHW) method. B. equations used
to calculate the apparent sedimentation coefficient, s*i,j at the intercept of boundary
fraction i with data scan at time tj (17). C. Extrapolation of the diffusion corrected sw,20
values for all boundary fractions; this is done by plotting a collection of calculated
apparent sedimentation coefficients s*i,j against their corresponding time tj in forms of
(tj)^-0.5.
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A. B.
C.                   D.
E. F.
Figure 2-7. G(s) plots generated from diffusion-independent data analysis using the
enhanced van Holde-Weischet (vHW) method.
The 66DS and 66G1 DNA constructs (Figure 2-7 E and F) served as mimics for
double and single stranded breaks, respectively, and were used to test the binding
stoichiometry of PARP-1 toward these DNA lesions. In these experiments, a fixed
concentration of DNA (1 µM) was used, and either domain AB or PARP-1 was titrated
in. When compared with DNA alone, increasing concentrations of domain AB or PARP-
1 caused gradual increases of sw,20 values. The observation of a increasing trend of sw,20
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values compared with DNA suggested the formation of protein-DNA complexes (Figure
2-7).
2.3.2.2. Two-dimensional spectrum analysis (2DSA)
As the diffusion corrected van Holde-Weischet (vHW) method provides a good
estimate of the sw,20 range within a given data set, it helps to set the lower and upper
limiting values of sw,20 during data fitting by two-dimensional spectrum analysis (2DSA)
provided by the Ultrascan II program (17). A 2DSA analysis can help to identify the
different solute species represented by a given data set that may have different sizes and
shapes, because it does not post constraints on the f/fo parameter as in the case of c(s)
analysis (17). Furthermore, this method does not require a pre-established model of
protein-DNA interaction, and it searches over a range of sw,20 and f/fo values. Therefore, a
2DSA analysis is suitable for the studies of PARP-DNA interactions where the protein,
DNA, and the corresponding protein-DNA complex in the solution are expected to have
different sw,20 values and shapes as characterized by f/fo.
Similar to the case of c(s) analysis, the 2DSA method also tries to fit the
sedimentation boundaries by solving the sum of Lamm equations L through simulation.
First, a two-dimensional grid of frictional ratios and sedimentation coefficients is
generated based on the provided range of the two parameters from the user (Figure 2-8).
As the diffusion coefficient can be parameterized in terms of f/fo using equation (8), each
grid point can be then assigned with a unique value of s and D. One grid point represents
a potential solute species, and its associated s and D values are used to simulate the
sedimentation velocity data by solving the Lamm equation (17). The combined
simulation data generated from multiple grid points can then be used to fit the
experimental data. At the same time, the total concentration of all solutes was also
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determined based on the observed absorbance signal from a given data set, and assigned
as 100%. The partial concentration of each fitted solute species can also be simulated in a
similar manner using the observed signal intensity at a specific radial position in a given
time during the sedimentation process (17). Furthermore, the program also accounts for
and removes the time and radially invariant noise components from an experimental data
set. Data fitting can be further optimized by genetic algorithm (GA) analysis (23). A
Monte Carlo approach is implemented to characterize the confidence intervals for the
determined solutes in both the 2DSA and GA analyses steps (23).
Figure 2-8. Generation of two dimensional grid points with sedimentation coefficients
and diffusion coefficients for data simulation in the 2DSA analysis.
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The fitted sw,20 values of the major sedimenting species identified by 2DSA
analysis were plotted as shown in Figure 2-9. The fitted details for each solute are
presented in Tables 2-5 to 2-9, and they are discussed further in the later sections. Here,
the red dots correspond to species with the highest solute concentration percentage within
a given data set. Table 2-4 provides a reference for the expected molecular weights (kDa)
of the potential solute species.
A.  B.
C.  D.
Figure 2-9. Sedimenting species identified from 2DSA analyses were plotted based on
the fitted sw,20 values for each protein-DNA ratios. Here, the red dots correspond to
species with the highest solute concentration percentage within a given data set. A.
domain AB vs. 66DS DNA; B. PARP-1 vs. 66DS DNA; C. domain AB vs.66G1; D.
PARP-1 vs. 66G1 DNA.
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Table 2-4 A-B.  Tables of calculated molecular weights for the potential protein-DNA
complexes identified from the SV experiments: A. 66DS DNA; B. 66G1 DNA.
A. 66DS DNA B. 66G1 DNA
For comparison, SV experiments of 66DS and 66G1 DNA alone were analyzed,
and the results for the major solutes are presented in Table 2-5. While 66DS DNA
contains no discontinuous region within the double helix, 66G1 DNA has a discontinuous
gap at the center of the duplex, which mimicks a double stranded break. These two DNA
constructs differ by a single nucleotide base. Consistent with their similar calculated
molecular weights, both DNA constructs have similar sedimentation coefficients (sw,20).
The partial concentration listed for each identified solute (i.e., average solute
concentration % obtained from 50 iterations of data simulations) was used to determine
whether the corresponding solute truly exists or it is due to noise or fitted errors in the SV
data. This value is obtained by simulating the concentration of a given solute species that
are identified from data fitting. It was first simulated in terms of absorbance and then
converted to a percentage concentration. Here, the total absorbance signal within a given
data set was assigned as 100%, and the percentage conversion was done by the Ultrascan
II program at the end of the fitting. Generally, the percent solute concentrations should
sum to 100% when all solutes present in the solution are considered; however, the fitted
Tested
protein/DNA
pair
Protein:
DNA
complex
Calculated
Molecular
Weight (kDa)
66DS only 40.7
1:1 66.9
2:1 93.1
AB
vs.
66DS
3:1 119.3
1:1 154.0
2:1 267.3
PARP-1
vs.
66DS 3:1 380.6
Tested
protein/DNA
pair
Protein:
DNA
complex
Calculated
Molecular
Weight (kDa)
66G1 only 40.3
1:1 66.5
2:1 92.7
AB
vs.
66G1
3:1 118.9
1:1 153.6
2:1 266.9
PARP-1
vs.
66G1 3:1 380.2
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result for a system containing a single solute species is usually less than 100% as shown
in the case of DNA (Table 2-5). There are few factors contributing to this problem. First,
the 2DSA analysis cannot account for the time- and radial- dependent noise signals in the
experimental data. Second, many solutes may undergo conformational changes when
they are in solution. While one conformation is dominant and the other is not, the minor
conformation can also be resolved from the data set, but with less confidence due to the
low absorbance signal associated with it. When a species has a solute concentration of
less than 5%, it is not considered as one of the solutes in this study, because it can not be
differentiated from the noise or the fitted error.
When considering the stoichiometries of the protein-DNA complexes, the
reported ratios shown in Tables 2-6 to 2-9 were based on a comparison of the observed
molecular weights of a given solute to the references shown in Table 2-4. In the case of
PARP-1, 1:1 and 2:1 protein-DNA complexes were observed for both 66DS and 66G1
DNA constructs (Table 2-6 and Table 2-8); and the formation of the 2:1 complex was
observed as protein concentration increased. In contrast, higher oligomeric states (i.e., 3:1
and 4:1 protein-DNA complexes) were observed when domain AB was tested. Using
66DS DNA as the counterpart, in addition to the 1:1 and 2:1 protein-DNA complex, a 3:1
protein-complex was observed with increasing protein concentration (Table 2-7). In the
case of 66G1 DNA, a 4:1 protein-DNA complex was observed when protein
concentration was in excess (Table 2-9).
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Table 2-5. Fitted parameters of the SV experiments with only DNA using 2DSA analyses
with 95% confidence intervals.
DNA 66DS 66G1
Fitted sw,20 (S) 4.24
(4.21, 4.27)
4.25
(4.25, 4.25)
Fitted f/fo 2.00
(1.99, 2.01)
1.69
(1.68, 1.69)
Experimental MW (kDa) 42.6
(42.1, 43.2)
32.4
(32.4, 32.6)
Calculated MW (kDa) 40.7 40.3
Average solute
concentration %
52% 79%
Table 2-6. Fitted parameters of the SV experiments with PARP-1 and 66DS DNA using
2DSA analyses with 95% confidence intervals
Protein:DNA
ratio
1:1 2:1 5:1
sw,20 (S) 4.44
(4.43, 4.45)
7.68
(7.66, 7.70)
10.10
(10.06,10.12)
8.69
(8.62, 8.75)
11.7
(11.7, 11.8)
8.55
(8.52, 8.59)
11.0
(10.9, 11.1)
f/fo 1.17
(1.15, 1.19)
1.00
(1.00, 1.00)
1.00
(1.00, 1.00)
1.08
(1.07, 1.10)
1.00
(1.00, 1.00)
1.21
(1.19, 1.23)
1.00
(1.00, 1.00)
MW (kDa) 57.7
(56.2, 59.3)
103.8
(103.4, 104.2)
156.4
(155.7, 157.2)
140.5
(136.8, 144.2)
196.1
(195.5, 196.7)
162.7
(158.8, 166.7)
178.2
(176.4, 180.1)
Average solute
concentration %
37% 30% 14% 28% 14% 30% 20%
Protein-DNA
complex
n/a 1:1 1:1 1:1 2:1 1:1 2:1
Table 2-7. Fitted parameters of the SV experiments with domain AB and 66DS DNA
using 2DSA analyses with 95% confidence intervals
Protein:DNA ratio 66DS only 1:1 2:1 5:1
sw,20 (S) 4.24
(4.21, 4.27)
5.22
(5.22, 5.22)
4.51
(4.49, 4.53)
4.80
(4.77, 4.83)
5.59
(5.52, 5.66)
f/fo 2.00
(1.99, 2.01)
1.00
(1.00,1.00)
1.34
(1.33, 1.35)
1.47
(1.46, 1.48)
1.57
(1.56, 1.59)
MW (kDa) 42.6
(42.1, 43.2)
54.8
(54.8, 54.8)
68.2
(67.5, 68.9)
86.3
(84.7, 87.8)
119.7
(117.1, 122.3)
Solute concentration % 52% 20% 56% 54% 22%
Protein-DNA complex n/a 1:1 1:1 2:1 3:1
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Table 2-8. Fitted parameters of the SV experiments with PARP-1 and 66G1 DNA using
2DSA analyses with 95% confidence intervals
Protein:DNA ratio 1:1 2:1 5:1 10:1
sw,20 (S) 7.77
(7.76, 7.78)
7.40
(7.38, 7.42)
11.19
(11.04, 11.35)
11.65
(10.21, 13.08)
14.17
(13.69, 14.65)
f/fo 1.23
(1.20, 1.25)
1.34
(1.32, 1.35)
1.00
(1.00, 1.00)
1.01
(0.88, 1.13)
1.00
(1.00, 1.00)
MW (kDa) 143.2
(139.1, 147.4)
151.8
(149.6, 154.0)
182.6
(178.8, 186.4)
196.1
(139.3, 253.0)
260.2
(246.8, 273.28)
Solute concentration % 28% 31% 33.4% 31% 11%
Protein-DNA complex 1:1 1:1 2:1 2:1 2:1
Table 2-9. Fitted parameters of the SV experiments with domain AB and 66G1 DNA
using 2DSA analyses with 95% confidence intervals
66G1: AB ratio
Protein:DNA ratio 66G1 only 1:1 2:1 5:1 10:1
sw,20 (S) 4.25
(4.25, 4.25)
4.45
(4.43, 4.46)
4.52
(4.48, 4.56)
5.31
(5.27, 5.36)
5.79
(5.75, 5.82)
f/fo 1.69
(1.68, 1.69)
1.52
(1.51, 1.53)
1.58
(1.56, 1.60)
1.85
(1.78, 1.92)
1.67
(1.65, 1.68)
MW (kDa) 32.4
(32.4, 32.6)
80.9
(80.1, 81.7)
88.0
(85.9, 90.0)
141.7
(132.4, 151.0)
137.8
(136.6, 138.9)
Solute concentration % 79% 36% 43% 40% 22%
Protein-DNA complex n/a 2:1 2:1 4:1 4:1
2.3.3. Characterization of a secondary DNA-binding site in PARP-1
2.3.3.1. Comparison of DNA-binding ability of truncated PARP-1 constructs ABC and
DEF
Based on the structural model of PARP-1 bound with 8-mer DNA built from the
small angel X-ray scattering (SAXS) and molecular dynamics studies, the WGR motif
within domain E was proposed to interact with DNA. To further investigate this
hypothesis, the DNA-binding ability of DEF was tested. The domain ABC served as a
positive control in the electrophoretic mobility shift assays (EMSA), because it showed
strong binding affinities toward different DNA lesions (24). A double stranded 22-mer
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DNA served as a mimic for a double stranded break in these experiments. Likewise,
DNA with a single strand nick was generated using the 44-mer dumbbell DNA.
Results from the EMSA assays were shown in Figure 2-10. Based on protein-
DNA complex formation represented by retention at the top of the agarose gel, it was
clear that DEF has the ability to bind DNA when either 22-mer duplex or nicked DNA is
used. To estimate the dissociation constants (Kd) of ABC and DEF with different DNA
constructs, the fraction of protein bound DNA was quantified and plotted against the
loaded protein concentrations, as shown in Figure 2-11. The plotted data was fitted using
the equation (8) with KaleidaGraph 4.0 software, and the Kd values were reported in
Figure 2-11. Due to the smearing effect resulted from dissociation of the protein-DNA
complex during electrophoresis, the quantification here are rough estimations only.
Nevertheless, it still provides a way for comparisons under the same experimental
conditions. Based on the fitted Kd values, DEF exhibited weaker binding affinities than
ABC when either 22-mer DNA or nicked DNA was used.
A. 22-mer DNA B. Nicked DNA
Figure 2-10. Comparison of DNA binding abilities of domain ABC and DEF based on
EMSA assays, with protein-DNA loading ratios increasing from left to right (0:1, 1:1,
2:1, 3:1, 4:1, 5:1 and 6:1). A. Using a 22-mer DNA duplex. B. Using a nicked DNA
construct.
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A.   B.
C.
Figure 2-11. Binding affinity comparisons of domain ABC and DEF based on EMSA
results with different DNA constructs. A. Using a 22-mer DNA duplex. B. Using a
nicked DNA construct. C. A simple model of protein-DNA interaction is provided
together with the equation used for data fitting (25).
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2.3.3.2. Characterization of the DNA-binding region within DEF
Figure 2-12. A. SDS-PAGE gel showing typical protein purities of domain DEF (lane 1),
DEF∆ (lane 2), PARP-1 (lane 3) and PARP-1∆ (lane 4) in concentration of 3 mg/mL.
Based on the structural model of PARP-1 and 8-mer DNA, it was proposed that a
flexible loop region within residues 626 to 645 of PARP-1 is brought into contact with 8-
mer DNA. Therefore, a deletion mutant of DEF lacking this flexible loop, namely DEF∆,
was prepared (Figure 2-12, lane 2) and its DNA-binding ability was compared with wild
type DEF.
A. 22-mer DNA     B.8-mer DNA        C. Nicked DNA
Figure 2-13. Comparison of DNA binding abilities of wild type DEF and DEF∆ mutant
based on EMSA assays with protein-DNA loading ratios increasing from left to right
(0:1, 1:1, 2:1, 3:1, 4:1, 5:1 and 6:1). A. Using a 22-mer DNA duplex. B. Using an 8-mer
DNA duplex. C. Using a nicked DNA construct.
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A. B.
Figure 2-14. Binding affinity comparisons of DEF and DEF∆ mutant based on EMSA
results with different DNA constructs. A. Using a 22-mer DNA duplex. B. Using a
nicked DNA construct.
Based on the EMSA results shown in Figure 2-13, the lower UV signal intensity
showing on top of the agarose gel indicated lower protein-DNA complex formation with
the DEF∆ mutant when compared with wild-type DEF for both 22-mer DNA (Figure 2-
13A) and the nicked DNA (Figure 2-13C) constructs. Kd values were obtained for the
DEF∆ mutant both DNA constructs using equation (9), and the fitted results were shown
in Figure 2-14. In both cases, DEF∆ mutant exhibited weaker DNA-binding affinities
than the wild type DEF. However, the DNA-binding affinity was affected more
significantly in the case of nicked DNA, as shown in Figure 2-14B; whereas in the case
of 22-mer DNA, the effect of mutation was less substantial.
An EMSA assay was also performed using the 8-mer DNA duplex, because the
proposed DNA interaction site in DEF was based on the structural studies of PARP-1/8-
mer DNA. When the DEF∆ mutant was tested for binding with 8-mer DNA, a similar
conclusion was drawn as in the case of 22-mer DNA due to the low observed intensity
arising from the protein-DNA complex (Figure 2-13B). A Kd value was not obtained in
78
the case of 8-mer DNA due to the low signal within this data set. Based on results from
the mutation studies, it was concluded that, domain DEF harbors a secondary DNA-
binding site within the WGR motif, with a stronger binding influence on the single
stranded DNA break.
2.3.3.3. Effect of the secondary DNA-binding site on PARP-1 activity
Figure 2-15. Comparison of binding ability of wild type PARP-1 and PARP-1∆ mutant
toward nicked DNA. The protein:DNA loading ratios increase from left to right (0:1, 1:1,
2:1, 3:1, 4:1, 5:1 and 6:1).
To study the influence of the WGR motif on DNA-binding affinity as well as the
automodification activity in the context of full-length enzyme, amino acid residues 626 to
645 were deleted from PARP-1, and the resulting PARP-1∆ mutant was isolated (Figure
2-12, lane 4). Its DNA-binding affinity was compared with that of wild type PARP-1
using the nicked DNA. The EMSA result is presented in Figure 2-15. It was observed
that the PARP-1∆ mutant had a binding affinity toward the nicked DNA similar to that of
wild type PARP-1. This observation indicated that deletion of the flexible loop region
within WGR domain of PARP-1 has little effect on the overall DNA binding ability of
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PARP-1. This observation is consistent with the results shown in Figure 2-10, where
domain ABC exhibits a stronger DNA binding affinity than DEF. Taken together, these
results suggest that domain ABC plays a critical role in binding DNA lesions, whereas
domain DEF plays a subsidiary role in stabilizing the conformation of protein-DNA
complex.
To see whether the deletion would have any effect on the automodification
activity of PARP-1, a time course assay was carried out using both wild type PARP-1 and
PARP-1∆ mutant in the presence of 8-mer DNA. The activity level of the enzymes was
estimated by determining the amount of protein band shift toward the top of the SDS-
PAGE gel, and the result is shown in Figure 2-16. Wild type PARP-1 demonstrated a
protein band shift within 10 sec of adding the NAD+ substrate, but there was no
detectable band shift of the PARP-1∆ mutant even after 5 min. These results indicate that
the flexible loop region of the WGR motif participates in the DNA-dependent activation
of PARP-1.
Figure 2-16. Levels of automodification activity are compared between wild type PARP-
1 and PARP-1∆ mutant. Wild type PARP-1 was added in lanes 1 to 6, and lane 13;
PARP-1∆ mutant was added in lanes 7-12, and lane 14.
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2.4. DISCUSSION
2.4.1. Full-length PARP-1 and the DNA binding domain AB exist as monomers in
solution
In the case of full-length PARP and domain AB, SV experiments were done by
varying the concentration of proteins to test if reversible self-association occurs in
solution. If formation of protein monomer and dimer is in rapid equilibrium as compared
to the rate of sedimentation during experiments, these two species can not be resolved
into two separated sedimentation boundaries (12). Instead, a weight-average
sedimentation coefficient sw of monomeric and dimeric species is obtained from the SV
data. This coefficient is increased when protein loading concentration becomes higher
(13). In the case where the equilibrium favors the formation of protein dimers, formation
of the dimer should be well-resolved as a distinct species with a larger sw value as
compared to the monomer. Finally, when only a monomeric form is present in solution,
and there is no self-association occurs, a single solute species with the same weight-
average sw value in different tested protein concentrations would be observed.
Based on the results shown in Figure 2-5, in the cases of PARP-1 and domain AB,
the observed weight-average sedimentation coefficients sw are similar under different
protein loading concentrations. There is no increasing trend among the sw values as the
protein loading concentration increased. This is consistent with PARP-1 and domain AB
present as monomers in solution.
Values of the frictional ratio f/fo provide information on the molecular symmetry
of an analyte. An f/fo value of 1 suggests a symmetric, globular shape for a
macromolecule (16). Since both PARP-1 and domain AB have average f/fo values of 1.55
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and 1.41, respectively, the observed values suggest that both proteins have an elongated
conformation in solution.
2.4.2. Sedimentation velocity studies of DNA constructs
Prior to the protein-DNA interaction studies, SV experiments were carried out
using DNA alone. It served as a reference point for comparison when proteins were
titrated in. The 66DS and 66G1 DNA were used to mimick the double and single-
stranded breaks, respectively (Figure 2-7 E and F). These two 66bp DNA constructs have
similar molecular weights, and are only different by a single nucleotide base. In the case
of 66G1, a discontinuous gap is introduced in the middle of the double helix, as shown in
Figure 2-7F. Based on 2DSA analyses, 66DS DNA has a sw,20 value of 4.24 S, and the
66G1 DNA has a sw,20 value of 4.25 S.
While the two DNA constructs have similar observed sw,20 values, the overall
shapes of the two constructs are different (Table 2-5). In the case of 66DS, there is no
discontinuous region within the double helix; therefore, the majority of the molecules is
present as a long rod shape in solution as indicated by the f/fo value of 2.00. In
comparison, 66G1 DNA has an f/f0 value of 1.69, indicating that the overall shape is more
compact when compared with 66DS. Based on these observations, it is clear that
introducing a discontinuous break within a DNA duplex has an impact on its overall
shape in solution.
It should be mentioned that the fitted molecular weights for both 66G1 and 66DS
DNA duplexes deviated from their calculated molecular weights based on the DNA
sequences. This is because SV experiments provide direct measurements through Lamm
equation modeling on the sedimentation coefficients and diffusion coefficients, but not
for molecular weights (Figure 2-4, equation (4)).  While the experimental molecular
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weights can be extracted from the fitted results of the sw,20 and f/fo values based on the
Sverberg equation (Figure 2-2, equation (3)), it is highly dependent on the noise level of
the data, the purity, and heterogeneity of a given sample. As the last two factors would
cause further broadening of the sedimentation boundary in addition to diffusion, the
resulted experimental molecular weights would be underestimated (20). Hence, the fitted
molecular weight obtained from SV experiments are rough estimations, and it holds true
for the later discussion of protein-DNA interactions where samples are highly
heterogeneous.
2.4.3. Sedimentation velocity studies of PARP-1 in the presence of DNA
When PARP-1 was used for protein-DNA interaction studies, the current results
suggest that PARP-1 forms a 1:1 and 2:1 protein-DNA complex when either 66DS or
66G1 DNA is used. This conclusion was drawn based on the observed G(s) plots from
the enhanced van Holde-Weischet analysis in Figure 2-7 B and D, and it was further
confirmed by the 2DSA analysis.
In the case of 66G1 DNA, a two step increase in the sw,2o value was clearly
observed in the G(s) plots as PARP-1 loading concentration increased, as shown in
Figure 2-7D. Compared with DNA alone, when PARP-1:DNA loading ratio was 1:1,
30% of the boundary fraction was associated with the s20,w value near 7 S. It was well-
separated from the boundary fraction at about 4 S for the DNA species. Good separation
between the two species indicates the occurrence of slow dissociation kinetics (18),
where formation of DNA-protein is less favored than DNA being alone when equal
amounts of protein and DNA were used. As PARP-1:DNA loading ratio increased to 2:1,
higher percentage of the boundary fraction was associated with 7 S. This indicated that
more 1:1 protein-DNA complex was formed under this condition as compared to a 1:1
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protein:DNA loading ratio. Interestingly, when PARP-1 concentration was in 5 and 10
folds excess, in addition of the observed 7 S species, a 12 S species was also observed,
indicating the formation of a 2:1 PARP-1: 66G1 complex.
The conclusion drawn here was further confirmed by the 2DSA analysis for these
protein-DNA pairs. The 1:1 and 2:1 protein-DNA complexes were well-resolved by data
fitting. As presented in Figure 2-9 D, the 1:1 complex was observed as a major species
under 1:1 and 2:1 protein: DNA loading ratios. With an s20,w value of 7.6 S for this
complex, the observed molecular weight was in good agreement with the expected
molecular weight (Table 2-8). When 10-fold excess of PARP-1 was loaded, a minor
solute species was observed with an s20,w value of 14.17 S. This species correlated well
with a 2:1 protein-DNA complex based on its observed molecular weight (Table 2-8).
Furthermore, when protein concentration was in excess, a species of 11 S was also
observed as the major species. This species represents a weight-average species of the 1:1
and 2:1 complex which was not well-resolved from the sedimentation boundaries due to
fast kinetics. Taking all these together, the current data suggest that in the presence of
66G1 DNA, which mimicks a single stranded break, PARP-1 can form 1:1 and 2:1
protein-DNA complex depending on the protein/DNA ratio of the solution. The
interconversion between the 1:1 and 2:1 complex was fast, thus resulted in a weight-
average solute species of 11 S from the SV experiments.
In contrast, the 1:1 protein-DNA complexes formed by PARP-1 and 66DS DNA
was less well-resolved in the G(s) plots as shown Figure 2-7B. For different PARP-1
loading concentrations, all of them showed a smooth transition over a wide range of s20,w
values, indicative of rapid transition between complex formation and the free DNA.
Increasing PARP-1 concentration caused a gradual shift of the G(s) plots toward a s20,w
value of 8 S and stabilized at that region, indicative of the 1:1 protein-DNA complex
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formation. This was further confirmed by the 2DSA analysis. As shown in Figure 2-9B
and Table 2-6, a species with the s20,w value of 8.6 S was observed as a major species
when 2 or 5-folds of PARP-1 was used. When equal amount of protein and DNA were
used, instead of observing a distinct 1:1 protein-DNA complex, a weight-average species
of a free DNA and the 1:1 protein-DNA complex was observed, with an s20,w value of
7.68 S for the 1:1 protein-DNA complex. This can be explained by the fast kinetic
process for the complex formation, as indicated by the smooth curve in the G(s) plot.
The formation of a 2:1 protein-DNA complex was less apparent by solely looking
at the G(s) plots in Figure 2-7B. This was due to the low percentage of boundary fraction
associated with higher s20,w values. Nevertheless, data obtained from the 2DSA analyses
also suggested a 2:1 protein-DNA complex formation. As shown in Figure 2-9B, a minor
11 S species was observed in the case of 2 and 5 folds of protein loading, indicative of a
2:1 protein-DNA complex. In addition, a solute species of 10.1 S was observed when
equal concentrations of protein and DNA were used. This is likely to be the weight
average species resulting from the 1:1 and 2:1 protein-DNA complex. Based on the
discussions above, it is concluded that, in the presence of 66DS DNA, PARP-1 indeed
forms a 1:1 and 2:1 protein-DNA complex.
While the data presented here suggest a 2:1 protein-DNA complex formation in
the case of full-length PARP-1, it is not consistent with the recently published SV data
reported by Langelier et. al (26), where PARP-1 forms a 1:1 complex with 8-mer DNA.
The discrepancy may be explained by the differences in terms of experimental set up and
data analysis methods. First, considering the DNA constructs used in these studies, both
8-mer DNA and 66DS are mimicks for double stranded breaks. In the case of 66DS
DNA, the presence of the 2:1 protein-DNA complex was confirmed based on a series of
protein titration experiments, and by two different data analysis methods: enhanced van
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Holde-Weischet and 2DSA. In the case of 8-mer DNA SV experiment reported by
Langelier et. al. (26), only 1:1 protein-DNA loading ratio was tested, and the SV data
was analyzed using c(s) analysis.
As discussed in the Results section, the enhanced van Holde-Weischet (vHW)
analysis minimizes the effect of diffusion and provides a range of the s values within the
protein-DNA sample. The diffusion process is dependent on the f/f0 parameter, or the
shape of the molecule (Figure 2-8, equation 8). Therefore, result obtained from the vHW
analysis provides information of the numbers of solute species regardless of their
different shapes. In contrast, the 2DSA analysis allows data fitting in both the s and the
f/fo dimensions and searching for solute species with different f/f0 values. Therefore, the
2DSA accounts for the heterogeneity in terms of f/fo within a given data set. However, the
c(s) analysis can not accurately account for the effect of species with different f/f0 values
because it requires an input of a single f/fo estimation by the users. Based on the
discussion above, it is likely that the 2:1 protein-DNA complex is not well-resolved in the
study of PARP-1 interaction with 8-mer DNA carried out by Langlier et al. (26) based on
the experimental set up and the data fitting methods.
However, it should be mentioned that, when 2:1 protein-DNA complex is
observed in the case of PARP-1 interacting with DNA, it is not sure which region of
DNA is recognized and interacts with PARP-1. As shown in Figure 2-7 E, 66DS DNA
contains two blunt ends, representing two individual double stranded break lesions. In the
case of 66G1 DNA (Figure 2-7 F), in addition to the two blunt ends, 66G1 DNA also
contains a gap site in the center, with a total of three lesions that can be potentially
recognized by PARP-1. With DNA molecules which have more than one lesion sites, it is
not certain how many PARP-1 molecules interact with a single lesion site.
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Different DNA constructs harboring only one lesion site was considered when
designing the experiments, these types of DNA constructs are usually large plasmids and
often containing other secondary structures such as hairpin loops, which can also be
recognized by PARP-1. Therefore, SV experiments with these DNA constructs were not
pursued.
Finally, it was observed that PARP-1 undergoes a conformational change upon
DNA binding. When only PARP-1 is present in solution, it adapts an elongated
conformation, indicated by an observed f/fo value of 1.55. When DNA is added, the
observed protein-DNA complexes have f/fo values ranging from 1.0 to 1.2, depends on
the oligomeric states as well as the DNA it encounters. The observed decreases in f/fo
values suggest that the PARP-DNA complex adapts a more compact conformation.
2.4.4. Sedimentation velocity studies of domain AB in the presence of DNA
The oligomeric state of AB-DNA complex was less well defined when compared
with the case of full-length PARP-1. Although higher orders of AB oligomerization were
observed upon binding to DNA, this is inconsistent with the results obtained from the
case of PARP-1. Discussion of the results and explanations for the discrepancies between
two protein constructs will be provided in more details below.
When double stranded DNA 66DS was incubated with domain AB, there was a
two step increase in the sw,20 values as protein concentration increased, indicated by the
G(s) plots (Figure 2-7A). As the protein:DNA ratios were maintained at 1:1 and 2:1, most
of the boundary fractions shifted from about 4 S to 4.5 S in comparison with free DNA.
When a ratio of 5:1 of protein:DNA was used, majority of the boundary fraction
associated with sw,20 values of 5 S. Furthermore, individual G(s) plot associated with
different protein:DNA loading ratios showed a smooth change within a narrow range of
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sw,20 values, indicative of a rapid interconversion between protein-DNA complex and free
DNA. A similar phenomenon was also observed in the G(s) plots generated from the
experimental data of 66G1 DNA with domain AB (Figure 2-7C).
Two step increases of the sw,20 values as protein loading concentration becoming
higher indicated the formation of 1:1 and 2:1 protein-DNA complexes. However, the
change in the sw,20 values between different protein:DNA loading ratios was relatively
small, which made it hard to conclude whether the protein-DNA complex is 1:1 or higher
when solely based on the enhanced van Holde-Weischet analysis.
When domain AB versus 66DS data set was further analyzed by 2DSA analysis, a
1:1 and 2:1 AB-DNA complex was observed (Table 2-7). The 1:1 protein-DNA complex
has a sw,20 value of 4.51 S, and the 2:1 complex corresponds to the 4.80 S species.
Consistent with the observation from the G(s) plots in Figure 2-7A, the difference of sw,20
values between two protein-DNA complex is rather small.
Furthermore, when 5:1 protein:DNA ratios was used in the experiments, a third
complex was formed. This complex had an experimental molecular weight that matches
well with the 3:1 protein-DNA complex, with a sedimentation coefficient of 5.59 S. This
is different than the case of full-length PARP-1, where no 3:1 protein-DNA complex was
observed.
Considering that PARP-1 interacts with 66 DS DNA to form a 2:1 protein-DNA
complex, two possible scenarios can be envisioned to account for the binding
stoichiometry of PARP-1 toward each blunt end site. One possible binding mode is that
one PARP-1 molecule interacts with one lesion site, and the 2:1 protein-DNA complex is
resulted from the occupancy of both lesion ends in the 66DS DNA. Another possible
binding mode is that two PARP-1 molecules form a dimer at a single blunt end site. As
discussed in Chapter 1, there is crystallographic evidence supporting either of the two
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scenarios (Figure 1-8) (8). However, the SV experiments only provide stoichiometric
information of the protein-DNA complex; therefore, these results can not help to
distinguish between the two possibilities. While the observed 3:1 AB-66DS complex may
be due to the non-specific binding of the third protein molecule, one cannot exclude the
possibility that two AB molecules bind to one lesion site, and the third protein molecule
interacts with the second lesion site.
In the SV experiments of domain AB and 66G1 DNA, a 2:1 and a 4:1 protein-
DNA complex were identified from 2DSA analyses (Table 2-9). This is again different
from the case of PARP-1 when the same DNA construct was used. Although both PARP-
1 and domain AB contain the DNA-binding zinc fingers I and II, the sizes of these two
proteins are quite different. In the case where a DNA construct such as 66G1 contains
both lesions, both the gap site as well as the two blunt ends may be accessible for PARP-
1 binding, since PARP-1 zinc fingers are known to recognize both double and single
stranded breaks (10). While a DNA construct with 66bp may not be able to accommodate
large proteins like PARP-1 at all three lesion sites, small size protein like domain AB
may be able to access those lesion sites in solution. This may explain why higher
oligomeric states were observed when domain AB was tested in SV experiments.
2.4.5. Characterization of the secondary DNA-binding site in human PARP-1
As demonstrated by Alvarez-Gonzalez et al., PARP-1 activity can be increased
over 500-fold from its basal level in the presence of damaged DNA (2). Two zinc fingers
at the N-terminus are critical for both DNA recognition and PARP-1 activation. This
implies that interactions with DNA at the N-terminus can be relayed to the distant
catalytic site in the C-terminal domain F in some manner that may involve a
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conformational change. In attempting to gain insight into the conformational state of
PARP-1 upon DNA binding, a structural model of PARP-1 bound with 8-mer DNA was
constructed by our previous group member Dr. Steven Mansoorabadi using SAXS and
molecular dynamics. In addition to the two zinc fingers, a flexible loop region within the
WGR motif in domain E was predicted to be in contact with the 8-mer DNA as shown in
Figure 2-17.
Figure 2-17. Proposed structural model of PARP-1 complexed with 8-mer DNA. Two
molecules of 8mer DNA are displayed in cyan, and a color scheme for the individual
domains is also provided. Adapted from Mansoorabadi et al., Biochemistry 2014, 53:
1779–1788.
To test whether the predicted secondary DNA binding site in the loop region of
the WGR motif has any DNA-binding capability, a truncated protein representing domain
DEF was first examined. Based on the EMSA assays shown in Figure 2-10, domain DEF
was indeed capable of interacting with either double stranded blunt end DNA or a nicked
DNA. When the loop region within the WGR motif was removed, the resulting DEF∆
mutant showed a lower level of protein-DNA complex formation as compared with the
wild type DEF (Figure 2-13 and Figure 2-14). These results indicate that the loop region
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within the domain E likely involves in DNA interactions as predicted by the structural
model.
However, when compared with domain ABC, the DNA-binding affinity of DEF is
relatively weak (Figure 2-11). Hence, unlike what ABC does in the process of DNA
recognition, DEF is not the major determinant in sensing the DNA lesion. However, since
DEF has DNA-binding capability, this weak protein-DNA interaction at the C-terminal
region can help to support the active conformation of PARP-1 bound with DNA by
providing further assistance to stabilize the protein-DNA complex in addition to the N-
terminal domain ABC. Furthermore, as the WGR motif is located next to the C-terminal
catalytic domain F, protein-DNA interaction at the WGR region brings the catalytic
domain close to DNA. As a result, it relays the “DNA-activating” signal to the catalytic
domain and triggers PARP-1 activity.
This hypothesis was further supported when the DNA-binding ability of this loop
region was assessed in the context of full-length PARP-1. When the loop region was
deleted from the full-length PARP-1, the resulting PARP-1∆ mutant showed similar
extent of DNA-binding as compared with the wild type protein (Figure 2-15). This again
implies that the flexible loop within the WGR motif is less critical for recognition of
DNA lesion. To test whether the DNA-binding loop participates in the DNA-dependent
activation process of PARP-1, automodification activity was examined in a time-
dependent manner using both PARP-1 and the PARP-1∆ mutant. As shown in Figure 2-
16, the PARP-1∆ mutant did not show any band shift which is indicative of
automodification. Removal of the DNA-binding loop within the WGR motif apparently
abolished the automodification activity of the mutant protein, suggesting a critical role in
forming an activated complex between PARP-1 with DNA.
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While this work was in progress, a crystal structure of near full-length PARP-1 in
complex with DNA was reported by Langelier et al. (Figure 1-10) (26). By co-
crystallizing zinc finger I, domain C and WGR-CAT peptides with DNA, it was shown
that the WGR motif is important for establishing the active conformation of PARP-1.
One side of the WGR motif interacts with DNA, zinc finger I and domain C, whereas the
other side of the WGR motif is in contact with the regulatory domain PRD near domain
F. Multiple sites of interaction centered about the WGR motif lead to structural
compaction and result in a catalytically competent conformation of PARP-1 upon DNA
binding. This is consistent with the observations from the SAXS and SV experiments
discussed herein, where PARP-1 was noted to become more compact in the presence of
DNA (13). Therefore, the structural model shown in Figure 2-17 correctly predicted the
WGR interactions with both DNA and the regulatory region in domain F.
Interestingly, it has also been recently demonstrated that the WGR motif can
interact with poly(ADP-ribose) (27). Since the automodification domain is located next to
the WGR motif, poly(ADP-ribose) generated by extensive automodification may result in
charge repulsion and competition with DNA for binding at the WGR motif. This may
cause destabilization of the activated complex even though DNA may remain bound via
the N-terminal DNA binding region and lead to inactivation of PARP-1.
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Chapter 3. DNA Recognition of Human PARP-1
Part II: Single Molecule Fluorescence Colocalization Studies
3.1. INTRODUCTION
Protein-DNA interactions represent an important molecular process which
regulates a broad range of fundamental biological functions that are critical for the
survival of an organism. This type of interaction may look simple as many of the DNA-
binding proteins interact with DNA molecules in a sequence specific manner. However,
this is not true in many cases, especially for those enzymes which participate routinely in
transcription and DNA repair pathways. In eukaryotes, to interact with the DNA
promoter region during transcription initiation, RNA polymerase II forms a multi-protein
complex at the promoter region, with each protein subunit (i.e., specificity factor)
interacting with a specific promote element (1). Here, DNA recognition of RNA
polymerase II at a given promoter region is governed by its interacting specificity factors
within the complex. In the base excision repair pathway, members of the glycosylase
enzyme family can recognize different types of base damages based on their chemical
structures (2).
Human PARP-1 is an enzyme that interacts with different DNA molecules and
involves in the processes of DNA repair and transcription regulation (3). PARP-1
interacts with DNA in a sequence independent manner. DNA binding by PARP-1 often
happens when it encounters a specific structural feature within the DNA molecule.
Different forms of DNA damage can be recognized by PARP-1, such as single and
double stranded breaks as well as DNA overhangs (4). The binding affinity of PARP-1
towards DNA depends on the structure of the DNA lesion, with stronger affinities for the
single strand nicked or blunt end DNA (4).
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In addition, PARP-1 activation is stimulated by the presence of DNA. However,
the induced activity levels are different depending on the type of DNA lesions it
encounters. As proposed by Pion et al., the difference in enzymatic activity of PARP-1
may arise from the different binding stoichiometries of PARP-1 toward different DNA
lesion structures, and has little to do with the DNA binding affinities (5). This proposal
was based on a series of biochemical studies, where Pion et al. concluded that PARP-1
forms a 1:1 complex with DNA molecules containing a double stranded break or a 3'-
recessed end and results in low levels of activity. In the case where DNA contains a 5'-
recessed end, PARP-1 forms a 2:1 protein-DNA complex, with a comparably higher level
of enzymatic activity (5). In the case of blunt end DNA, this proposal is supported by
crystallographic studies of the individual PARP-1 zinc fingers bound with DNA, as
discussed in Section 1.3.3 (Figure 1-7). However, when a DNA molecule with a 3'-
recessed end is used for crystallization, dimer formation is observed and both zinc fingers
interact directly with the lesion (Figure 1-8).
Correlation between activity level and DNA structure can also be explained by
engaging different functional domains of PARP-1 in DNA binding. If different DNA
structures interact with different regions of PARP-1, this may perturb the overall protein
conformation in different ways. Thus, PARP-1 may be able to adopt various active
conformations in a DNA-specific manner resulting in different activity levels. This
hypothesis is based on the fact that several domains within PARP-1 are known to interact
with DNA. As discussed in Chapter 1, the N-terminal zinc fingers I and II are the primary
sites for recognition of DNA damage. In the case of a single stranded break, Ikejima et al.
demonstrated that both zinc fingers I and II are needed for PARP-1 activity (6). However,
when a double stranded break is present, only zinc finger I is needed for full activation of
PARP-1 (6). Therefore, it seems that PARP-1 utilizes different sets of zinc fingers for
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activity when encountering different types of DNA damage. Recently, a so-called double
stranded DNA binding domain (DsDB) was also identified. It is located in a loop region
between the BRCT and the WGR motif (7). As presented in Chapter 2, the WGR motif is
also involved in DNA interactions, and the flexible loop responsible for DNA interaction
is important for PARP-1 activity (8). Currently, how the DsDB and WGR motifs
participate in promoting an active conformation of PARP-1 is still not well understood.
Taking all the above evidence together, the two hypotheses put forth argue that
there are at least three essential factors determining the activity levels of PARP-1 upon
DNA binding: 1. the specific DNA structure; 2. the protein-DNA binding stoichiometry;
3. the protein regions that are in contact with the bound DNA. While many published
biochemical and structural studies discussed in this thesis provide valuable insight
regarding these questions, in many cases the results are contradictory among themselves.
Therefore, it is hard to draw a clear conclusion regulating the DNA-dependent PARP-1
activity.
Human PARP-1 is one of the first enzymes to recognize and localize at a site of
DNA damage, and its activity is essential for the recruitment of other related DNA repair
enzymes at the same site (9). This makes PARP-1 an attractive drug target for cancer
therapy (10). Since PARP-1 also binds to undamaged DNA and influences other
fundamental biological functions, understanding the DNA recognition process of PARP-1
and how it relates to the corresponding enzyme activity level is essential for drug
development to regulate DNA repair pathways.
In order to understand how PARP-1 interacts with a specific DNA structure in
details, a single molecule fluorescence colocalization technique was utilized in this
protein-DNA interaction study. This single molecule platform allows direct visualization
of individual protein molecule interacting with a single DNA molecule in real-time. By
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collecting data over hundreds of binding events on a molecule-by-molecule basis, instead
of an ensemble average from multiple protein-DNA states, the distribution of each
individual protein-DNA interaction state can be identified and measured directly. Thus,
potential transient intermediates in the protein-DNA interaction dynamics may be
identified in this way.
Here, the protein-DNA interaction process of PARP-1 is directly visualized by the
colocalization of two fluorescent signals at the same spot. These two fluorescent signals
are arised from the Cy3 fluorophore labeled PARP-1 DNA-binding domain AB and the
Cy5 fluorophore labeled double stranded break DNA mimic which are immobilized onto
a glass surface. Upon laser excitation of Cy3 fluorophores, protein binding events can be
monitored in real-time by the increase in fluorescent intensity coming from Cy3 (no
FRET (Förster resonance energy transfer)) or Cy5 (high FRET transfer) fluorophore
emission. Duration of the colocalized Cy3 and Cy5 fluorescent intensity signal were
collected from each binding event and analyzed. Dissociation kinetic analyses revealed
that there are two distinct protein-DNA binding complexes in the DNA recognition
process by domain AB: a long-lived, stable binding complex and a less stable binding
complex which rapidly dissociates. Furthermore, results obtained from analyses of total
fluorescent intensity difference between individual protein-DNA complex, and the
observation of multi-step photobleaching process in many protein binding events indicate
that protein dimerization occurs in the presence of DNA having double stranded break.
Finally, the choice of Cy3 and Cy5 fluorophores here are capable of Förster
resonance energy transfer (FRET) process, with Cy3-labeled domain AB being the
fluorescence donor and the Cy5-labeled DNA being the energy acceptor. Since Cy3 was
labeled close to the zinc finger II of domain AB, direct excitation of the Cy3 fluorophore
resulted in the detection of two distinct FRET states. The observed high FRET state
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reveals that zinc finger II is in close proximity to the DNA lesion; whereas the low FRET
state suggests that zinc finger I binds close to the lesion site. The observation of two
distinct FRET states indicates that both N-terminal zinc fingers are involved in
recognizing DNA double stranded break.
Information obtained from these single molecule studies has shed light on the
mechanisms by which domain AB interacts with a double stranded DNA break. Results
from dissociation kinetics, protein binding stoichiometry as well as FRET state analyses
lead to a mechanistic proposal in regarding how PARP-1 recognizes a double stranded
break lesion.
3.2. MATERIALS AND METHODS
3.2.1. Site directed mutagenesis for introduction of a genetically encoded aldehyde
tag into AB constructs
A bioorthogonal method developed by Carrico et al. was applied (11) to introduce
a reactive aldehyde functional group into the DNA binding domain AB. This method
involves insertion of the six-amino-acid consensus sequence LCTPSR, which is known as
the “aldehyde tag,” at a selected site. The aldehyde tag can then be recognized by a
formylglycine generating enzyme (FGE) which catalyzes oxidation of the inserted
cysteine residue in the “aldehyde tag” to a formylglycine.
Using the AB/MalE-pET vector as the mutation template, an aldehyde tag was
introduced according to the Quikchange site-directed mutagenesis protocol (Stratagene)
to generate different site specific protein constructs. The aldehyde tag was introduced at
the N-terminus of domain AB using the forward (5'-CATGAAAACCTGTATTTTCA-
GGGACTGTGCACCCCGAGCCGTTCGGATAAG-3') and reverse (5'-CTTATCCGA-
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ACGGCTCGGGGTGCACAGTCCCTGAAAATA-CAGGTTTTCATG-3') primers, and
the resulting recombinant DNA construct was named Fgly-AB/MalE-pET. A similar
insertion was introduced at the C-terminus of AB using forward (5'-GACAAGGAT-
AGTCTGTGCACCCCGAGCCGTTAACTCGAGCACC-3', with the inserted sequence
underlined) and reverse (5'-GGTGCTCGAGTTAACGGCTC-GGGGTGCACAG-
ACTATCCTTGTC-3') primers to give the final Fgly-AB-CT/MalE-pET construct. When
the aldehyde tag was positioned internally, it was introduced by substitution using the
cysteine residue at position 151 of domain AB. The Fgly-150AB/MalE-pET was
constructed using the forward (5'-GAAGATGGTGGACCCGGAGAAGCTGTGC-
ACCCCGAGCCGTGACCGCTGGTACCATCCAGG-3') and reverse (5'-
CCTGGATGGTACCAGCGGTCACGGCTCGGGGTGCACAGCTTCTCCGGGTCCA
CCATCTTC-3') primers. Plasmids with the desired mutation were confirmed by
sequencing carried out by the DNA Sequencing Core Facility at The University of Texas
at Austin.
3.2.2. Generation of aldehyde functionalized Fgly-AB constructs in vivo by
coexpression with formylglycine generating enzyme (FGE)
To convert the cysteine residue within the aldehyde tag of the FGly-AB protein
construct to the formylglycine (Fgly) functional group, a modified coexpression system
of FGE and the Fgly-AB protein constructs was developed based on the published
protocol by Carrico et al. (11).
The coexpression system was created by cloning both FGE and the MBP-Fgly-
AB constructs to a single expression vector. Specifically, the FGE gene was first obtained
from a DNA plasmid containing the encoded Mycobacterium tuberculosis FGE enzyme
in the pBAD/myc-his A vector (Addgene). The FGE gene, which was located between
the NcoI and XhoI restriction sites, was cut out by double digestion using the
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aforementioned restriction enzymes. The agarose gel purified FGE gene was then ligated
into the pET-28b vector that had been treated with the same restriction enzymes to
generate the His6-FGE/pET expression vector.
The MBP-Fgly-AB gene in the construct of Fgly-AB/MalE-pET lies between the
XbaI and XhoI restriction sites within the MalE-pET vector. Therefore, both the Fgly-
AB/MalE-pET and His6-FGE/pET plasmids could be treated with XbaI and XhoI
restriction enzymes in order to cut and insert the MBP-Fgly-AB gene into the His6-
FGE/pET vector. However, this approach could lead to loss of the FGE gene during the
restriction enzyme treatment. To keep the FGE gene in place, a SpeI digestion site was
introduced between the stop codon of the FGE gene and the neighboring XhoI digestion
site. As the flanking region (3'-GATC-5') generated by the SpeI restriction enzyme
digestion is complementary to the flanking region (5'-CTAG-3') generated from the XbaI
enzyme, this allowed the MBP-Fgly-AB gene to be cleaved out by the treatment with the
XbaI and XhoI restriction enzymes, whereas the His6-FGE/pET vector could be linearized
by treatment with the SpeI and XhoI restriction enzymes without losing the FGE gene.
Subsequent ligation of the MBP-FGly-AB and the linearized His6-FGE/pET DNA
fragments generated the final His6-FGE/MBP-Fgly-AB/pET expression vector construct.
In order to insert the SpeI digestion site into the His6-FGE/pET vector, the FGE
gene was cloned from the His6-FGE/pET vector by PCR using the forward (5'-
GGAATTCCATATGCTGACCGAGTTGGTTGACC-3') and reverse (5'-CCGCTC-
GAGACTAGTCTACCCGGACACCGG-3') primers, where the SpeI site within the
reverse primer is shown underlined. The PCR product was subjected to NdeI and XhoI
restriction enzyme digestion, and further purified by QIAprep Spin Miniprep Kit
(Qiagen). The purified product was cloned into the pET/28 vector that had been
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linearized by the same set of restriction enzymes. The insertion of the SpeI site within the
final His6-FGE-SpeI/pET plasmid was confirmed by sequencing.
To generate the coexpression vector, the His6-FGE-SpeI/pET vector was
linearized by first treating with SpeI and XhoI restriction enzymes followed by CIP. The
high molecular weight DNA fragment was purified by 0.8% agarose gel electrophoresis.
The MBP-Fgly-AB insert was obtained by treating the Fgly-AB/MalE-pET vector using
XbaI and XhoI restriction enzymes, and the low molecular weight DNA fragment was
purified similarly as described before. Ligation was then carried out to generate the His6-
FGE/MBP-Fgly-AB/pET vector. The same method was applied to generate the following
expression constructs: His6-FGE/MBP-Fgly-AB/pET, His6-FGE/MBP-Fgly-AB-CT/pET
and His6-FGE/MBP-Fgly-150AB/pET.
3.2.3. Expression and purification of Fgly-tagged domain AB constructs
Coexpression and purification of the His6-FGE and the Fgly-AB proteins was
done in a manner similar to that described for the wild type PARP protein constructs in
Section 2.2.1. The formyglycine within the Fgly-AB protein was formed in vivo, and the
expressed His6-FGE enzyme was readily removed during the purification process.
Therefore, the resulting purified proteins were formylglycine functionalized: Fgly-AB,
Fgly-AB-CT and Fgly-150AB.
3.2.4. Confirmation of the formylglycine (Fgly) functional group within the protein
constructs by biotin-hydrazide labeling
The N-terminal Fgly-AB construct was used as a prototype, and the wild type AB
protein was used as the negative control to confirm that the Fgly functional group was
generated in vivo. In a 200 μL reaction mixture, 50 or 100 μg of protein was incubated
with 300 μM of DMSO solublized biotin hydrazide (Sigma Aldrich) in 100 μM MES
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buffer, pH 5.5. The reaction mixture was incubated at 37 °C for 2 h. The unreacted biotin
hydrazide was removed by filtering the reaction mixture using the 10 kDa Cutoff
Amicon® ΜLtra 0.5 mL filters (Millipore) and then washed 10 times with 300 μL of 100
mM HEPES and 10% glycerol at pH 7.5. The samples were resolved using 12% SDS-
PAGE gels. Detection of the biotinylated proteins was performed using western blot with
HRP-conjugated Streptavidin antibody (Pierce). Colorimetric development was done
using 1-step TMB-Blotting substrate solution (Pierce).
3.2.5. Cy3-labeling of Fgly-tagged AB protein constructs
Initially, Alexa Fluor® 555 Hydrazide (Life Technologies) was chosen for protein
labeling due to its commercial availability and high photostability. However, it was
observed that this fluorescent probe has poor photostability under the experimental
condition of single molecule studies. Later on, the choice of fluorescent dye was switched
to Cy3-hydrazide (GE Healthcare), and it was used as the FRET donor fluorophore for
protein labeling. Typically, 30 μM of Fgly protein was incubated with 480 μM of Cy3-
hydrazide in 100 μM MES buffer at pH 5.5 (total volume: 200 μL). To stabilize the
proteins, 10% glycerol was also added in the buffer, and the reaction mixture was
incubated at 37 °C for 2 h. Next, the sample was dialyzed against 20 mM HEPES, 300
mM NaCl, and 10% glycerol at pH 7.5. Three changes of the 500 mL dialysis buffer were
performed for each Cy3-labeled protein construct. The final concentration of both the
protein and Cy3 dye was determined by UV absorbance using a nanodrop
spectrophotometer (Nanodrop). A typical labeling efficiency was about 60%. The protein
sample was flash frozen with liquid nitrogen and stored at –80 °C before usage.
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3.2.6. Preparation of fluorescent DNA ligands
All single stranded DNA ligands were purchased from IDT. Individual sequence
information is listed in Table 3-1. The complementary DNA strands were annealed under
similar conditions as described in Section 2.2.7 in order to produce the single stranded
break mimic, which is a DNA duplex with a gap in the middle of the sequence (66G), and
the double stranded break mimic 32B. Information about the biotinylated and Cy5-
labeling sites is shown in Figure 3-1.
Table 3-1.  DNA primers used for fluorescence experiments.
DNA
duplex
DNA
primers
used
Primer sequence
66bpR 5'-AAGGGCAAGGCTGCTGTGGACCCTGCTGTGGGCTGGAGAACAAGGTGATCTGCGCCCTGGTCCTGG-3'
33bp 5'-GCCCACAGCAGGGTCCACAGCAGCCTTGCCCTT-3'66G
32bp 5'-CCAGGACCAGGGCGCAGATCACCTTGTTCTCC-3'
32bp 5'-CCAGGACCAGGGCGCAGATCACCTTGTTCTCC-3'
32B
32bp-2 5'-GGAGAACAAGGTGATCTGCGCCCTGGTCCTGG-3'
Figure 3-1. A. Nomenclature of the DNA constructs used in the fluorescence assay, with
positions of biotin and Cy5 labels being specified for each tested construct.
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3.2.7. Electrophoretic mobility shift assay (EMSA)
Different amounts of AB or Fgly-AB protein constructs (0 to 2.048 μM) were
incubated with 4 nM of Cy5-labeled DNA duplex on ice for 20 min in 15 μL of 20 mM
Tris buffer, pH 8.0, containing 150 mM KCl, 5 mM MgCl2, 50 μM ZnCl2, 0.1% Nonidet
P40, 2 mM DTT and 10% glycerol. The samples were then mixed with 6X DNA loading
buffer (0.25% bromophenol blue and 15% Ficoll 400) and subjected to electrophoresis in
a dark room. An 8% native polyacrylamide gel (acrylamide/bisacrylamide ratio 75:2) was
prepared with tris-glycine buffer (24.9 mM Tris/191.8 mM glycine, pH8.3) and used for
the EMSA assay. The gel was pre-run at 100 V for 2 hrs at room temperature with an ice
water cooling system before sample loading. After electrophoresis, the gel was visualized
using a Typhoon Trio Scanner (GE Healthcare) with red laser excitation (633 nm), and
the image was processed using Quantity One software (Bio-Rad).
3.2.8. Single molecule fluorescence colocalization experiments
3'-Biotinylated Cy5-DNA duplexes were immobilized onto a quartz slide surface
through streptavidin conjugation. This was done by first preparing the biotinylated quartz
slide through passivation with a mixture of methoxy polyethylene glycol (mPEG) and
biotinylated mPEG (1-2%), which allowed streptavidin immobilization on the glass slide.
A typical imaging chamber (about 0.5 cm x 1.5 cm) sealed with double-sided tape was
formed between the quartz slide surface and a cover slip. Typically, a 50 μL sample of 50
pM DNA duplex in the loading buffer containing 50 mM Tris, pH 8.0 and 250 mM NaCl
was loaded onto the glass surface that had been pre-treated with streptavidin. Unbound
DNA was washed out using loading buffer. Various concentrations of Cy3-labeled Fgly-
AB proteins in a buffer containing 50 mM Tris, pH 8.0, 25 mM NaCl, 22.5 mM DTT and
22.5 mM MgCl2 was loaded onto the chamber for imaging. To slow down the
photobleaching process, an oxygen scavenging system was mixed with the Cy3-labeled
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proteins during imaging. The oxygen scavenging system consisted of 0.6 mM Trolox, 8%
glucose, 0.05 mg/mL catalase and 0.1 mg/mL glucose oxidase. PEGylated glass slides,
the oxygen scavenging system, and access to a total internal reflection (TIR) microscope
platform were all provided by Prof. Rick Russell in the Institute for Cellular Molecular
Biology at The University of Texas at Austin.
Protein-DNA complex formation events were imaged by mounting the imaging
chamber beneath the prism-type total internal reflection (TIR) microscopy which consists
of an inverted Olympus IX-71 microscope connected to an I-PentaMAX IIC CCD camera
with a cooling unit (Princeton Instruments). For the colocalization experiment, the Cy3-
labeled protein was directly excited with a 532 nm laser (Crystalaser). This was
conducted through continuous Cy3 excitation with 10 frames/s data acquisition for 90 s,
or it was done with 2 s on/2 s off pulse excitations for a total excitation time of 300 s with
1 frame/s data acquisition. At the end of each movie, the Cy5 dye was excited with a 637
nm laser (Coherent) for 10 s to locate the positions of the immobilized DNA and confirm
protein colocalization with Cy5-labeled DNA. Movies were taken randomly from several
fields of view for each protein concentration.
3.2.9. Single molecule fluorescence colocalization data analyses
Fluorescence signals generated from each field of view were splitted into Cy3
(donor) and Cy5 (acceptor) intensity signals by a pair of dichroic mirrors. Colocalized
signals from Cy3 and Cy5 dyes were matched using an affine transformation that was
based on predetermined fiducial markers using fluorescent nanobeads (12). Raw intensity
time traces of the colocalized Cy3 and Cy5 signals were generated for each movie using
the single molecule data analysis program written by Dr. Brian Cannon. For the pulse-
excitation experiments, individual binding events were identified based on the appearance
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and disappearance of the Cy3 and Cy5 signals above background threshold. For each
individual binding event, the intensity changes of the Cy3 and Cy5 signals as well as the
dwell time for each binding event were extracted for kinetic, total intensity and FRET
analyses.
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3.3. RESULTS
3.3.1. Generation of formylglycine (Fgly)-tagged AB constructs
To generate a domain AB protein construct that can be labeled with a fluorescent
dye in a site specific manner for the single molecule fluorescent study, a genetically
encoded formylglycine (Fgly) tag was utilized based on the method developed by
Carrico, et al. (9). Specifically, the six-amino-acid sequence LCTPSR, which represents
the “aldehyde” tag, was introduced into a defined region within domain AB. This short
amino acid sequence can be recognized by the formylglycine generating enzyme (FGE)
from Mycobacterium tuberculosis, and the cysteine residue within this aldehyde tag is
converted to a formylglycine functional group by FGE. Generation of the Fgly functional
group in the domain AB constructs allow modification with hydrazide functionalized
probes, such as biotin hydrazide or Cy3-hydrazide (Figure 3-2).
Figure 3-2. In vivo generation of the Fgly functional group within AB constructs and
subsequent labeling with hydrazide functionalized fluorescent probes used in this study.
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Formation of the formylglycine functional group within an Fgly-AB construct
took place in vivo during coexpression of the Fgly-AB and His6-FGE proteins. After that,
the His10-maltose binding protein (i.e., MBP-His10) was cleaved from the MBP-Fgly-AB
constructs and removed along with the His6-FGE protein by Ni-NTA resin (Figure 3-2).
The purities of the resulting Fgly-AB protein constructs are shown in Figure 3-3A.
A.     B.
Figure 3-3. A. An SDS-PAGE gel showing typical protein purities of domain AB wild
type (lane 2), Fgly-AB (lane 3), Fgly-AB-CT (lane 4), Fgly-150AB (lane 5) and Fgly-
210AB (lane 6) after purification. B. Indication of the internally labeled Fgly-tag position
within zinc finger II (PDB ID:2CS2).
To study the DNA recognition of PARP-1 zinc fingers toward DNA lesions by
single molecule experiments, the protein-DNA pairs used were designed to exhibit
Förster resonance energy transfer (FRET) once positioned in close proximity. To obtain
good FRET response, the location of the fluororphore labeling sites within the protein
and DNA are important. It was expected that, upon excitation of the Cy3 donor labeled
domain AB which binds to the lesion site of the DNA labeled with the acceptor
fluorophore Cy5, the close proximity between the Cy3 and Cy5 fluorophores should
allow energy transferred from Cy3 to Cy5, producing FRET signal. The FRET signal
could be detected by monitoring the increase in Cy5 fluorescent intensity. The potential
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fluctuation in FRET signal would provide information of the protein-DNA interaction in
terms of the proximity of protein binding relative to the lesion sites, as well as the binding
kinetics for the protein-DNA complex formation.
In addition to the N- and C-terminally labeled domain AB protein constructs, a
formylglycine functional group was also introduced within zinc finger II. This was done
because of the strong binding affinity of zinc finger II toward DNA lesions. Its direct
interaction with DNA is expected to give an easily detected signal. It should be noted
that, at the beginning of this project, there was no crystallographic information available
on how PARP-1 or individual domains interact with DNA lesions that can serve as
guidance for the design of the fluorescent labeled protein. Therefore, the choices of
formyglycine labeling positions within zinc finger II were based on the preliminary
small-angel X-ray scattering data and the molecular dynamics simulations of PARP-1 and
8-mer DNA kindly provided by Dr. Steven O. Mansoorabadi. The internal labeling sites
for formylglycine in zinc finger II are shown in Figure 3-3 B.
3.3.2. Confirming the presence of the formyglycine (Fgly) group within Fgly-AB
To confirm whether the Fgly functional group was generated in vivo from the
coexpression system described above, a labeling test was done using the N-terminal
tagged Fgly-AB construct and biotin hydrazide. After the conjugation reaction, the
biotinylated protein was detected by HRP-conjugated Streptavidin antibody and western
blot. As shown in Figure 3-4, lanes 8 and 9, biotin was conjugated into Fgly-AB
successfully, indicating that the formylglycine functional group was present in the Fgly-
AB construct. No biotin signal was detected in the case of wild type domain AB
incubated with biotin hydrazide under the same condition (Figure 3-4: lanes 4-5). Based
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on the observations discussed here, introduction of the formylglycine tag into domain AB
was successful using the coexpression system; and the biotin labeling was specific to the
Fgly-tagged domain AB.
Figure 3-4. Existence of the Fgly-tag within domain AB was confirmed by biotin
hydrazide labeling assay. Details of labeling conditions for each sample lane are listed.
Noted that lanes 2 and 6 are protein samples taken directly from stocks. Lanes 3 and 7 are
protein samples undergoing the whole labeling process to test for potential protein
degradation.
Figure 3-5. Fgly-AB protein labeled with Alexa Fluor® 555 hydrazide. Coomassie blue
staining of the SDS-PAGE gel is shown on the left. Presence of the fluorescent probe in
the SDS-PAGE gel was detected by a 532 nm laser excitation using a Typhoon scanner,
and the resulted in-gel fluorescence is shown on the right.
Once the coexpression system proved to be working, domain ABs with Fgly-tag
inserted at different positions were expressed and purified. They were then labeled with
appropriate fluorescent dyes that serve as the FRET donor. Alexa Fluor® 555 hydrazide
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was chosen for protein labeling here due to its commercial availability and high
photostability. An example of successful fluorophore labeling of Fgly-AB is shown in
Figure 3-5. To check if the protein-fluorophore linkage is covalent, proteins used for in-
gel fluorescence were denatured with SDS and boiling before loading onto the gel.
Association of the fluorescent signal with a correct molecular weight band of Fgly-AB
suggested that the fluorophore-protein conjugation is covalent. It should be noted that
there is a fluoresecent protein band likely coming from protein contaminants in the Fgly-
AB samples (Figure 3-5). This band is hardly seen using Coomassie blue staining, and its
identity remains elusive. While fluorescent labeling of the contamination protein band
may indicate that the labeling protocol is nonspecific, it is also possible that this protein
band may be a degraded fragment of the MBP-Fgly-AB construct during protein
purification based on the following reasons. Before trying the coexpression system
discussed above, two other methods were tried but unsuccessful in generating the
formyglycine functional group within the Fgly-AB construct. One of them was in vitro
generation of formylglycine by incubating the Fgly-AB construct with purified His6-FGE
enzyme. Another method was the coexpression method reported by Carrico et al. which
utilized two plasmids harboring the Fgly-AB and the FGE genes separately (11). While
the generation of formylglycine was not successful in these two cases, no fluoresecent
labeled protein could be detected after filtering out the unreacted dyes from the reaction
mixture, and the biotin hydrazide labeling tests were also failed in these two cases.
Secondly, based on the biotin hydrazide labeling test shown in Figure 3-4, wild-type AB
without the Fgly-tag is not labeled, suggesting that the biotin labeling is specific to the
presence of the formyglycine functional group. Finally, when high concentration of this
Fgly-AB construct was analyzed by SDS-PAGE and Coomassie blue staining, additional
contamination bands were discernible on the gel. These were from the residual MBP-
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His10 fusion protein that had not been completely removed by Ni-NTA resins. However,
these contamination bands showed no fluoresecence in the in gel fluoresecence test.
Therefore, it was suspected that the observed fluoresecently labeled contamination band
is related to the degradation of the MBP-Fgly-AB construct during purification. Because
this contamination problem happened occasionally, purification by size exclusion
chromatography was often included as the last step in the Fgly-AB protein purification
protocol.
While Alexa Fluor dye was used in the initial stage of the single molecule
experiments, it was found that this fluorescent probe exhibited poor photostability under
the single molecule platform used in our experiments. Therefore, the fluorescent probe
was switched to the Cy3 and Cy5 FRET pair. As a fluorescent donor, Cy3-hydrazide was
used to label Fgly-AB proteins for all later experiments.
3.3.3. DNA binding abilities of the Cy3-labeled Fgly-AB protein constructs
The Fgly-tag was introduced into domain AB through mutagenesis. To test
whether these mutational changes had any effect on the DNA binding abilities,
electrophoretic mobility shift assays (EMSA) were performed using the Cy3-labeled
protein constructs and the Cy5-labeled 66G1 DNA (Figure 3-1). The EMSA results from
all Fgly-AB constructs are shown in Figure 3-6, with the wild type domain AB serving as
a positive control for comparison. While the unbound free DNA migrated to the bottom
of the gel, distinct band shifts indicated the formation of high affinity protein-DNA
complexes, and the smearing effect during electrophoresis resulted from protein-DNA
complexes that are more dissociable (11). Based on the results shown in Figure 3-6, all
Fgly-AB protein constructs are capable of interacting with 66G1 DNA to some extent, as
indicated by the observation of similar protein-DNA band shifts as well as smearing
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effects. Due to the smearing nature arised from the protein-DNA complex dissociation, it
is hard to accurately quantify the fraction of DNA bound with protein in this assay.
Therefore, dissociation constants (Kd) were not determined. The EMSA assays presented
here serve as a qualitative assessment of the effect of mutation. In conclusion, the
introduction of the Fgly-tag at different positions of domain AB does not affect its DNA-
binding ability; therefore, these protein constructs are suitable for the single molecule
experiments in the protein-DNA interaction studies.
A.   B.  C.  D.
Figure 3-6. DNA-binding ability test of different Fgly-AB protein constructs using Cy5-
labeled 66G1 as the DNA counterpart. DNA concentration (4 nM) stayed constant in all
lanes, and the protein-DNA titration ratios increased from left to right of the gel (0:1, 2:1,
4:1, 8:1, 16:1, 32:1, 64:1, 128:1, 256:1, 512:1). A. wild type domain AB; B. Fgly-AB; C.
Fgly-AB-CT; D. Fgly-150AB.
3.3.4. Fluorescence colocalization experimental set up of domain AB and DNA
To study the DNA binding process of domain AB in a single molecule platform,
both protein and DNA were first labeled with different fluorescent dyes. The biotinylated
Cy5-labeled DNA was then immobilized onto the glass surface through a biotin-
streptavidin complex (Figure 3-7). After immobilization, Cy3-labeled AB protein was
loaded onto the slide surface; and Cy3-labeled AB protein was excited by a 532 nm laser
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source in a pulse manner (2 s on, 2 s off), with a total excitation time of 300 s. Positions
of the Cy3-labeled AB molecules were monitored in real time, and localized fluorescent
signals were recorded for both Cy3 and Cy5 channels simultaneously. After 300 s Cy3
excitation, the locations of DNA molecules were determined by Cy5 excitation with a
637 nm laser for 10 s. The latter step causes photobleaching of the Cy5 dye; this was then
used to count the number of DNA molecules within a given spot for later data analyses.
The colocalized Cy3 and Cy5 signals were matched based on a calibration file generated
using fluorescent nanobead markers (Figure 3-7B). Once the colocalization spot was
determined for each molecule, Cy3 and Cy5 fluorescent intensity trajectories can be
generated for a given spot. An example is shown in Figure 3-7C.
Based on the Cy3 and Cy5 intensity trajectories, multiple pieces of information
can be obtained associated with each individual binding event. Duration (ton) of the
protein binding event (i.e., dwell time “on”) (Figure 3-7C) is defined by the appearance
and disappearance of either Cy3 or Cy5 signal compared with a background signal
threshold. While the appearance of Cy5 signals indicated the presence of a high FRET
state, majority of the binding events showed no FRET signal, with only Cy3 signals being
observed. But they were still counted as binding events. This is because the appearance of
Cy3 fluorescent signal came from the Cy3-labeled protein molecule that colocalized with
a single DNA molecule immobilized on the glass surface (13). For each individual
binding event, the corresponding Cy3 and Cy5 intensities were obtained and used to
calculate the FRET efficiency. The calculated FRET efficiency provides information on
the relative distance between the Cy3 and Cy5 fluorophores. When the Cy3 labeling
position of the Fgly-AB is near the zinc finger II region, the FRET efficiency thus allows
identification of the interaction region between domain AB and the DNA lesion site for
an individual binding event. Finally, by counting the number of photobleaching steps as
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well as analyzing the change of total intensity for a given binding event, protein
stoichiometry for each binding events can be extracted from the data set (13).
A.  B.
C.
Figure 3-7. Single molecule colocalization experimental set up. A. Once the Cy5-labeled
DNA was immobilized, Cy3 (or Cy5 if FRET occurs) signals would show up if domain
AB binds to the DNA molecule during Cy3 pulse excitation. B. During data recording,
both Cy3 and Cy5 signals were reported in a field of view and the colocalized signals
between two channels were mapped (gray lines) using a calibration file. C. Cy3 and Cy5
signals associated with a given spot were extracted as intensity trajectories over time. The
existence of DNA was confirmed by direct Cy5 excitation at the end of the movie.
As a selection criterion, time trajectories with no associated Cy5 signal through
out the experimental time course were excluded for data analyses because no DNA
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molecule was identified. Furthermore, to check whether Cy3-labeled domain AB would
bind nonspecifically to the glass surface and generate artifact data, a control experiment
was done by loading fluoresecently labeled AB under the same experimental condition,
except that no DNA was immobilized. Movies were taken under Cy3 continuous
excitation. It was noted that no Cy3 signal was localized and retained within the field of
view, indicating that domain AB does not bind to the glass surface in the absence of
immobilized DNA.
3.3.5. Binding kinetic studies of Cy3-AB-CT and 32BI DNA
Data present in this section was collected using an Fgly-AB-CT protein construct
labeled with Cy3 at the C-terminal end (i.e., Cy3-AB-CT), and a 32-base pair blunt end
DNA construct with a Cy5 fluorophore labeled internally at the phosphate backbone
between the 3rd and 4th residues (i.e., Cy5-32BI) (Figure 3-8A). During the Cy3 pulse
excitation experiment, binding and dissociation of Cy3-AB-CT was observed as the
fluctuating of Cy3 and Cy5 signals between the elevated “on” state and the baseline “off”
state (Figure 3-7C). The goal here was to see if there are multiple DNA-binding modes
that are discernible from the “on” state in this data set, and if so, what mechanistic
information does each binding mode reveal. From the initial screenings of all intensity
trajectories, different signal response patterns could be detected (Figure 3-8B to K). It is
hard to account for all these observations by a simple one- or two-step DNA-binding
model. However, from all binding events identified, it was clear that some of events have
high FRET signals with only Cy5 signals being detected (i.e., acceptor only, Figures 3-8J
to K, and M). The rest of the binding events are associated with no FRET or low FRET
signals, with an average FRET efficiency of a given binding event being less than 1
(Figures 3-8B to H, and L). For those binding events, their colocalization with DNA
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molecules were confirmed by the presence of DNA molecule at the same spot through
direct Cy5 excitation at the end of the movie (Figure 3-7C).
With little information regarding the details in binding mechanism of domain AB
toward blunt end DNA in published literatures, it was hard to postulate how many
different binding modes would be observed from the single molecule experiment. To
initiate data sorting, simple criteria were set for categorizing the observed binding events
from the intensity trajectories. Images shown in Figure 3-8B to M are simplified signal
response patterns representing different binding events observed in the Cy3-AB-CT/Cy5-
32BI data set. All binding events were separated into two groups: donor events (shaded
green in Figures 3-8B to I, and L) and acceptor events (shaded red in Figures 2-8I to K,
and M). In the cases of Figures 3-8G and H, there were rapid changes between high
FRET and low FRET states, and they were correlated with each other. As there were no
proper models proposed that can account for these observations, they were treated as
donor events for the time being. In the case of Figure 3-8I, since there was no direct
correlation between the low FRET and high FRET state, they were treated as individual
donor only and acceptor only events. Observed binding events like in Figure 3-8I may be
due to two proteins binding to the same DNA, which will be discussed in more detail in a
later section. Furthermore, binding events with multiple photobleaching steps were also
observed (Figure 3-8L-M). This signal response patterns indicated that there were two
protein molecules binding to a single DNA strand, with one protein dissociated (or
photobleached) followed by another. For simplification, they were considered as a single
binding event in our analysis. It should be note that, based on this signal response pattern,
it can not distinguish whether the disappearance of the fluorophore signal is due to
photobleaching or protein dissociation.
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A.      B.      C.
D.      E.      F.      G.
H.      I.      J.      K.
L.      M.
Figure 3-8. A. The Cy3-labeled AB and the Cy5-labeled DNA constructs used for this
study. B to M. Cartoon representations of signal response patterns being observed in the
intensity trajectories from this study, with hypothetical background intensity shown as
1000.
Following the criteria for binding event identification as described above, duration
(i.e., dwelling time ton) of all identified binding events were recorded, and the number of
events were counted based on their corresponding dwelling time intervals. The numbers
of accumulative binding events were then plotted against duration time. The
accumulative dwell time distribution plot was fitted with exponential growth curves in
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order to identify different modes of protein binding state. The data fitting also allows
estimation of the dissociation rate constants for the identified binding modes. In this
protein-DNA binding system, two different states are expected if this is a single step
transition system: an off state and a single on state (Scheme 3-1). The off state was
referred to the time period when no protein binding is occurred on a DNA molecule, and
the on state was referred to the time when protein associates, as indicative by the
appearance of Cy3 or Cy5 intensity signals in the time trajectories. Each state is
characterized by the off time (toff) and the on time (ton), respectively (Figure 3-7C).
Based on the sedimentation velocity experiments discussed in Chapter 2, there are
two protein molecules interact with a blunt end DNA. This leads to the proposal that two
different binding states may exist for the on state: with one binding state having a single
protein binds to the DNA, and the other binding state having two protein molecules
associated with the DNA. Because it is unknown whether the second protein binding
event is dependent on the DNA association with the first one, two different protein
binding schemes are proposed here. Scheme 3-2 suggests that the second binding state
(i.e., binding state b) depends on the existence of the first state a. Scheme 3-3 suggests
that the binding state b is independent of the state a. Also, it should be noted that, for the
kinetic analyses here, the numbers of AB protein molecules in binding states a or b are
not known because the total Cy3 intensity of each binding event was not taken into
account in this kinetic analysis.
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Figure 3-9. Proposed binding mechanisms of domain AB toward blunt end DNA (Cy5-
32BI).
The dwell time (ton) distribution analyses performed in this section may provide
information that helps to distinguish the different protein binding schemes shown above.
To identify the number of binding states from the collected data, dwell time (ton)
distribution histogram was generated using ton data collected in different protein loading
concentrations. Each binding state indentified is characterized by a dissociation rate
constant koff, and the lifetime τ of the corresponding binding state is defined as 1/koff.
Based on the schemes shown in Figure 3-9, it is expected that there can be either one or
two binding states. Since each protein binding happens at random, the life time of a given
binding state is described by a probability distribution. The lifetime of a given binding
state would follow an exponential probability distribution with a mean at 1/koff (13). In a
system having N states, the dwell time distribution is characterized by a sum of N
exponentials (13). The dwell time (ton) distribution was plotted, with the Y-axis
representing the accumulative numbers of all binding events. Assuming there is a single
binding state, the data was fitted with a single exponential growth curve. For comparison
purpose, the data was also fitted with double exponential growth curves assuming the
121
existence of two different binding states. Single and double exponential fittings of dwell
time distribution for all four Cy3-AB-CT loading concentrations are shown in Figures 3-
10A to D.
As shown in Figure 3-10A to D, the dwell time (ton) cumulative distributions fit
better with the double exponential growth curve across different protein loading
concentrations, indicative of two different protein binding states. These two binding
states showed different kinetic behaviors. One of the binding state showed fast
dissociation kinetics, with a dissociation rate koff ranging from 0.420 s-1 to 0.626 s-1
deduced from fitting different protein concentrations. The other binding state exhibited
slow dissociation kinetics, with a koff value ranging from of 0.014 s-1 to 0.008 s-1 fitted
from different protein concentrations. The observation of two binding states is consistent
with the proposed Scheme 3-2 and Scheme 3-3.
In addition, the number of events associated with each binding state is reported as
amplitude (A1 and A2) from the data fitting. This allows calculation of population
percentage of events associated with each binding state, and can also be used to
investigate how the population changes between the two states when the protein
concentration is increased. As shown in Figure 3-10F, the population percentage of a
binding state that exhibiting fast dissociation decreased as the protein loading
concentration increased; in contrast, the binding state which dissociated slowly became
predominant as protein concentration increased. These observations suggest that the
occurrence of these two binding states is dependent on the protein concentration.
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A. B.
C. D.
E.     F.
Figure 3-10. A-D. Dwell time (ton) accumulative distribution fitting of different Cy3-AB-
CT protein loading concentrations with single or double exponentials. Data points were
shown as red dots. E. Equations used for distribution. F. Concentration-dependent
occurrences of two different on states.
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A.    B.
C.    D.
Figure 3-11. A-D. Dwell time (ton) accumulative distribution fitting of acceptor binding
events from different protein loading concentrations. Data points are shown as red dots,
and they are fitted with single exponential equation.
Showing in Figures 3-8I to K and M, there is a significant fraction of binding
events having a high FRET state (with FRET efficiency ~1). They were categorized as
acceptor events because only the Cy5 acceptor signal was observed. To see if these high
FRET events are associated with either fast or slow dissociating binding states, the dwell
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time (ton) distribution of acceptor binding events were fitted again with single or double
exponentials. Interestingly, the data fit better with a single exponential in different protein
concentrations (Figure 3-11), and the switch between the fast and slow dissociation
phases was again dependent on the protein concentration (Figure 3-11). In low protein
concentration loadings, the high FRET binding events dissociated rapidly; while protein
was loaded in 5 or 10 nM concentrations, dissociation process slowed down. Taken all
these observations together, the occurrence of the two different binding states is protein
concentration dependent. This observation brings up a question of whether protein
oligomerization happening during the DNA-binding process of domain AB.
3.3.6. Protein oligomerization analysis of Cy3-AB-CT and 32BI DNA
While the dwell time distribution analyses suggested that there are two different
binding states, the protein stoichiometry associated with each state is not known since the
total Cy3 donor or the Cy5 acceptor intensity were not taken into account for the
analyses. The occurrence of the two states depends on the protein loading concentration,
and a stable binding state (average koff = 0.010 s-1) was dominant when protein loading
concentration increases. These observations may indicate that oligomerization of protein
takes place and contributes to the formation of the stable, long-live protein-DNA
complex. To test this hypothesis, average Cy3 donor intensity and multi-step
photobleaching analyses were carried out.
Because Cy3 hydrazide reacts specifically with the formyglycine residue within
the FGly-AB-CT construct, it is expected that each protein is labeled with a single Cy3
fluorophore. For data collected under the same conditions, if a protein dimer was formed
upon binding to DNA, and none of Cy3 fluorophore was photobleached during
excitation, the resulting Cy3 donor intensity would be doubled when compared with the
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DNA-binding event with a single protein. Therefore, if protein oligomerization happens,
it would show up as a distinct population in the Cy3 intensity analysis when compared
with single protein binding events. In this study, only the donor binding events were
analyzed (Figures 3-8B to H, and L). Furthermore, because the Cy3 excitation was
paused every two seconds during experiments, the Cy3 intensity signal was only
considered when the laser excitation was turned on. With the criteria discussed above,
average Cy3 intensity from each donor-only-binding-event was recorded, and the
numbers of events were counted and binned in intervals of every 1000 intensity signals.
The population distribution histograms are plotted as population fraction versus average
Cy3 intensity shown in Figure 3-12.
A. B.
C. D.
Figure 3-12. A-D. Population distribution analyses based on average Cy3 intensity for
donor-only-binding-events observed in different protein concentrations.
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When 100 or 500 pM of protein was loaded, majority of the binding events had
the average Cy3 signal ranging from 2000 to 6000 AU. As protein loading concentration
was increased to 5 and 10 nM, the population fraction of binding events became
dispersed ranging from 4000 to 18000 AU. As the protein concentration increases, the
average Cy3 intensity associated with the individual binding events also increases,
consistent with the occurrence of protein oligomerization. The increase in average Cy3
intensity is about 2 to 3 fold, suggesting dimer or trimer formation.
A.   B.
Figure 3-13. Simulations of average Cy3 intensity distribution histograms. A. Simulated
histogram with probability of dimer formation setting at 0.2. B. Simulated histogram with
probability of dimer formation setting at 1.
Fluctuations on the average Cy3 intensity signal associated with a given binding
event are affected by the following factors: percentage of protein labeling, the noise level,
and the probability of oligomer formation. To see how these factors influence the
population distribution of the average Cy3 intensity and check for the likelihood of dimer
formation within each protein loading concentration, data simulation was performed
using a program written by Dr. Brian Cannon. Data simulation was done with a typical
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protein labeling yield of 0.6. Figure 3-13 shows the simulation results for the probability
of dimer formation setting at 0.2 and 1, which match quite well with the observed
distribution in Figure 3-12. When the protein concentration is low (Figure 3-12A and B),
the majority of the protein binding events are associated with protein monomer. When
protein concentration increases (Figure 3-12C and D), a significant fraction of the binding
events is associated with two protein molecules, as predicted in Figure 3-13B. Again,
simulations together with the average Cy3 intensity analyses support the hypothesis that
protein dimerization takes place in the DNA-binding process.
A.  B.
C.  D.
Figure 3-14. Population distribution analyses for multi-step photobleaching events. A.
Quantification of the binding events for more than 1 step of photobeaching. C-D.
Quantification of population fractions with different numbers of photobleaching steps.
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A single-step photobleaching process is due to the dissociation of a single protein
or the irreversible destruction of one fluorescent dye during Cy3 excitation (i.e.,
photobleaching of the fluorescent dye) (13-14). When multiple protein molecules interact
with the same DNA molecule, multi-step photobleaching of Cy3 or Cy5 (in acceptor
events) signal is expected as they dissociates at different time points, or one of the dyes is
photobleached. Examples of signal response pattern from two-step photobeaching events
are shown in Figures 3-8 L and M. To facilitate this study, the number of photobleaching
steps was counted for each binding event. When there is no photobleaching happening for
a given event, it is counted as one molecule binding step. Then the fraction of the event
population is plotted based on the number of steps observed.
Figure 3-14 displays the multi-step photobleaching analyses of binding events
collected from protein loading concentrations of 500 pM, 5 nM, and 10 nM. Data from
100 pM protein loading was not analyzed, because less than 5% of the binding events
exhibited multi-step photobleaching behavior. As shown in Figure 3-14A, there are
higher percentages of multi-step photobleaching observed in elevated protein
concentrations. Taking a closer look, these events were mostly associated with two- or
three-step photobleaching, as shown in Figures 3-14 B-D. This is consistent with the
dimer and trimer formation of domain AB.
As the majority of the binding events did not photobleach during Cy3 excitation,
the next question is whether the observed one-step photobleaching event arised from
DNA bound with a single protein, or bound with two protein molecules without
photobleaching. To answer this question, the highest Cy3 intensity of each binding event
was correlated with the number of photobleaching steps for each donor-only-binding-
event (i.e., 3000 in Figure 3-8B for a one-step event; 3000 in Figure 3-8L for a two-step
event), and the average value of the highest Cy3 intensity was calculated for binding
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events associated with one, two or three photobleaching steps, and are plotted with
standard deviations, as shown in Figure 3-15.
A. B.
C.
Figure 3-15. Correlation analyses of the highest Cy3 intensity and the number of
photobleaching steps identified from the donor-only-binding-events. A. 500 pM AB-CT.
B. 5 nM AB-CT. C. 10 nM AB-CT.
In the case of 500 pM AB-CT protein loading, one-step photobleaching events
have an average intensity signal at around 3600 AU; and the two-step photobleaching
events have an average intensity signal at around 7700 AU (Figure 3-15A). As the
average Cy3 intensity of the two-step photobleaching events is about two-folds as the
one-step photobleaching events, it is consistent with one and two protein molecules
130
bound with a single DNA. A similar trend was observed in the case of 10 nM AB-CT
loading concentration (Figure 3-15C). The higher Cy3 intensity in the case of 10 nM AB-
CT for both one and two step photobleaching events is possibly due to the increase of
overall background signal coming from high concentration of protein loading. The data of
the three-step photobleaching events have large standard deviations, which makes it hard
to draw a clear conclusion. In the case of a 5 nM protein loading, the intensity difference
between one- and two-step photobleaching is small. Here, the average Cy3 intensities of
both one- and two-step photobleaching events are about 10000 to 12000 AU. This
suggests that within the population of the one-step photobleaching events, some of these
events actually arised from DNA with two proteins bound, but did not photobleach
during the excitation process.
Finally, to make sure the observed oligomerization is not due to two DNA
molecules collocated at the same spot, correlation analyses were carried out between the
average Cy3 intensity and the average Cy5 intensity coming from direct Cy5 excitation at
300 s (Figure 3-7C) for each binding events. It is expected that if the projected protein
dimerization is not due to two DNA molecules coexisted at the same spot, there should be
no correlation between the intensity of Cy3 and Cy5 signals, because the signals are
coming from two different laser excitations; and data points should be spread out in one
region. However, if the projected protein dimerization is due to the presence of two DNA
molecules positioned too close to each other, and not being well resolved in
colocalization experiments, the Cy3 and Cy5 signals would be correlated with each other.
In this case, it is expected that as Cy3 intensity gets higher, so does the Cy5 signal; and
two distinct populations may result in this case. As shown in Figures 3-16 A-C, under all
protein loading concentrations, most data points are found in one region of the plot, and
there is no increase in the Cy5 signal as the Cy3 signal increased. Because there is no
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direct correlation between the intensity of the Cy3 and Cy5 signals, the observed protein
dimerization is most likely due to two protein molecules interacting with a single DNA,
not due to two DNA molecules being spotted at the same position.
A. B. C.
Figure 3-16. Correlation analyses of Cy3 intensity and Cy5 intensity signals. The Cy5
intensity used here was recorded from direct excitation of the Cy5-labeled DNA. A. 500
pM AB-CT. B. 5 nM AB-CT. C. 10 nM AB-CT.
3.3.7. FRET analyses of Cy3-AB-CT and 32BI DNA
As discussed in Section 3.3.5., there is a significant fraction of protein binding
events that show a strong FRET signal (Figures 3-8I to K and M) as well as a medium
FRET signal, with the FRET response pattern showing in Figure 3-8F. Also, some of the
protein binding events show fast transition between a high FRET and a low FRET state
(Figures 3-8G and H). Based on these observations, the FRET responses resulted from
protein binding are highly complex. With current knowledge, it is hard to propose a
protein-DNA interaction mechanism that can sufficiently account for all these different
binding states. Therefore, it is unrealistic to consider all of them at the initial stage of
FRET analyses. This is especially true when some of these FRET transitions are with less
than 5% occurrence which may be due to artifacts (15).
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f (x; a, µ, σ) = expa1
One Gaussian distribution fitting:
Two Gaussian distributions fitting:
• ( )2σ12
- (x-µ1)2
f (x; a, µ, σ) = expa1• ( )2σ12
- (x-µ1)2 + expa2• ( )2σ22
- (x-µ2)2
x : FRET efficiency
a : amplitude
µ : mean
σ : standard deviation
To overcome this problem, and get a general idea of the true FRET states that can
be identified from this protein/DNA pair, an average FRET efficiency value is calculated
for each DNA molecule. Specifically, a value of FRET efficiency was first calculated for
each time frame (in sec) where a protein binding event was observed, and an average
FRET efficiency for each DNA molecule is obtained by summing the all the FRET
efficiency values and divided by the total time of a DNA bound by proteins. This means
that if multiple binding events with different FRET states are observed on a single DNA
molecule during the 300 s excitation time course, the final calculated FRET efficiency is
the averaged value for all these binding events, and it is weighted by the duration of the
occurrence for each FRET state. In this way, the FRET responses with low occurrence
may have little contribution to the average FRET efficiency per DNA molecule. By
performing the data analysis discussed above, it would facilitate the identification of the
most predominant FRET states, which are likely to be the true binding state. So, in turn,
this allows an establishment of a minimal mechanistic model on how domain AB
interacts with the double stranded break that can be tested further.
Figure 3-17. Equations used for FRET efficiency calculation and the fitting of the
different FRET distributions. Definitions of all parameters are shown on the right.
FRET efficiency =
IA
IA + ID
IA : Cy5 acceptor intensity
ID : Cy3 donor intensity
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Figure 3-18. Population distributions of FRET efficiency are fitted with double Gaussian
distributions.
Table 3-2. Parameters derived from double Gaussian distribution fitting shown in Figure
3-18.
 AB-CT <FRET Efficiency>
µ1
 Amplitude
(a1) σ12
<FRET Efficiency>
µ2
Amplitude
(a2) σ22
100 pM 0.284 0.024 0.183 0.767 0.078 0.132
500 pM 0.248 0.033 0.136 0.695 0.076 0.132
5 nM 0.252 0.015 0.076 0.652 0.114 0.114
10 nM 0.149 0.024 0.057 0.570 0.087 0.147
Here, average FRET efficiencies are calculated based on the equation shown in
Figure 3-17, and the plotted FRET distribution is fitted with double Gaussian
distributions. The number of distributions is determined based on the two observed
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binding states discussed in the binding kinetic studies section. Based on the fitted data
shown in Figure 3-18 and Table 3-2, two distinct protein binding states could be observed
with average FRET efficiencies of 0.233 and 0.671, respectively. The average FRET
efficiencies are calculated using values obtained from different protein concentrations
(Table 3-2).
3.4. DISCUSSION
To study the recognition mode of domain AB toward double stranded break DNA,
single molecule colocalization studies were carried out using Cy3-labled domain AB and
Cy5-labeled 32BI DNA (Figure 3-8A). Except to crystal structures and DNA-binding
affinity studies discussed in Chapter 1, limited information is available regarding the
DNA recognition mechanism of PARP-1. Work done in this chapter was intended to
provide mechanistic details regarding the DNA recognition process of domain AB in
real-time, which may be hard to extract from ensemble studies. The results allow the
extractions of three different kinds of information: binding kinetics, protein binding
stoichiometry, and the relative position between the domain AB zinc fingers and the
DNA lesion site.
3.4.1. Identification of two DNA-binding states
The dwell time (ton) distribution analyses reveal the presence of two different
binding states of domain AB toward DNA, with one binding state that dissociates rapidly
(average koff = 0.51 s-1) and one long-lived state which is relatively stable (average koff =
0.010 s-1). Compared with the koff value reported by Jorgensen et al. from a SPR study
using full-length PARP-1, our result is different (16). In the case of SPR measurement, a
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single dissociation phase was observed, and it is more stable when compared with the two
on states identified from the single molecule studies.
Table 3-3. Comparison of the dissociation kinetic results obtained from single molecule
and SPR studies.
Protein used DNA used Averaged dissociation constant koff (s-1)
SPR Full-length PARP-1 28mer 0.0034+0.0026
Single molecule Domain AB 32mer 0.010+0.003 0.531+0.085
Cy3 photophysics: kblink off = 0.0096 s-1
While the difference in kinetics can be explained by the different form of PARP-1
protein used, it is also possible that there is a third binding state which is missed in the
single molecule studies. Because the total observation time in the single molecule
experiments is 300 s, based on the koff value from the SPR measurement, it is expected
that the protein molecule would stay bound for about 294 s (τ = 1/koff). Judging from the
single molecule data, there are about 3 to 6% of the binding events staying longer than
290 s. This percentage is rather low to suggest whether this is a true binding state, or just
an artifact.
When comparing the photo-physical properties of Cy3 with the dissociation rate
constants obtained under the single molecule platform, the data suggests that there are
only two binding states. During excitation, Cy3 dyes would occasionally undergo a
reversible blinking process. This process causes the excited Cy3 dye to go to a dark state
and then back to the fluorescent state. This photophysical property of Cy3 can be mis-
interpreted as a unique binding state. In a control experiment, the blink off rate kblink off of
Cy3 dye was measured using the immobilized Cy3-labeled DNA molecules provided by
Dr. Russell’s lab under the exact same experimental condition, and the value is reported
in Table 3-3. This value is close to one of the reported dissociation constants (0.010 s-1),
136
indicating that this observed binding state is likely due to the blinking of Cy3 dye. Thus,
even blinking events of Cy3 were observed, domain AB remained bound to the DNA
molecule without dissociation. This means that this stable binding state has a life-time
longer than 105 s (1/kblink off). Based on this information, it is concluded that there exist
two binding states for domain AB to interact with DNA. Due to the experimental set up
and the photophyical property of Cy3 dye, the long lived state is not fully captured, and
only the lower limit of the dissociation rate is obtained.
In addition, the population distribution between the two binding states is
dependent on the protein concentration (Figure 3-10F). This observation favors the
proposed binding scheme 3-2, where the second binding state is dependent on the first.
In this scenario, it is expected that when protein concentration is low, most of the binding
events are in a low population fraction of binding state a. The occurrence of binding state
b is less likely under such condition if this state requires protein dimerization. As protein
concentration increases, majority of the protein molecules may be in binding state a by
forming a 1:1 protein-DNA complex, which in turn favors the occurrence of binding state
b, where dimerization of protein molecule happens on a single DNA. In scheme 3-3, the
occurrence of the two binding states is expected to be less effected by the protein loading
concentrations.
3.4.2. Protein dimerization on the double stranded break
The concentration dependency of the two binding states suggests that there is a
possibility of protein oligomerization. The dimer formation is supported by both the
average Cy3 intensity analyses as well as multi-step photobleaching analyses. The results
obtained are consistent with the conclusion drawn in Chapter 2 from the sedimentation
velocity experiments, where PARP-1 forms a 2:1 protein complex with double stranded
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blunt end DNAs. In addition, the occurrence of protein dimerization is dependent on the
protein concentration, indicating that the binding state b in Scheme 3-2 is likely a 2:1
protein-DNA complex.
3.4.3. Identification of different FRET populations
With a Cy3 FRET donor labeling at the C-terminal end of domain AB, interaction
of domain AB with blunt end DNA (32BI) resulted in two distinct FRET populations,
with average FRET efficiencies of 0.233 and 0.671, respectively. Here, the Cy3 dye is
located close to zinc finger II, and observation of a high FRET state indicates the close
proximity between the zinc finger II and the double stranded lesion site.
The low FRET state may result from the interaction of the lesion site with zinc
finger I at the N-terminus. This conclusion is drawn based on the following observations.
First, from the crystal structures reported by Ali et al., both zinc finger I and zinc finger II
interact directly with DNA at the lesion site containing a single-base overhang, which is a
mimic of the blunt end DNA structure. The two zinc fingers that interacts with the same
DNA lesion site come from two separate peptides, suggesting dimer formation at the
lesion site (Figure 1-8) (17). This is consistent with the two observed FRET states
reported here. Secondly, as the Cy5-labeled 32BI DNA is immobilized on the glass
surface (Figure 3-7A), this makes the second lesion site less accessible for protein
binding. Therefore, it is unlikely that the low FRET state is due to the protein interaction
to this biotinylated end.
Finally, when looking at the high FRET efficiency as protein concentration
increases (Table 3-2), there is a decreasing trend in the high FRET signal. This
observation may possibly result from increasing dimer formation as the protein
concentration increases. When a protein dimer is formed, one of the two protein
molecules shows a high FRET signal, and the other protein molecule shows a low FRET
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state, the average FRET signal should be an average of the two FRET states. If this
hypothesis is true, it is expected that under high protein concentration, there are three
FRET states that can be identified. To test this possibility, the FRET population
distribution obtained from 10 nM protein loading was fitted with three Gaussian
distributions, and the result is presented in Figure 3-19 and Table 3-4. The FRET
population distribution is actually fitted better with three Gaussian distributions. Here, the
values of the observed high and low FRET states are similar to the reported values from
other binding events obtained in different protein concentrations (Table 3-2). The
additional medium FRET state has a FRET efficiency similar to the average value
calculated from the high and low FRET states (average FRET efficiency = 0.445). The
observation is consistent with the proposed model that, upon protein dimerization, one
protein molecule results in a high FRET state, possibly through interaction with zinc
finger II; and the other protein molecule results in low FRET state, possibly due to the
interaction with zinc finger I.
Figure 3-19. Population distribution of FRET efficiency of 10 nM AB loaded. Data was
fitted with triple Gaussian distributions.
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Cy5-32BICy3-AB-CT
FI FII
FI
FIIFI
FII
Step 1Step 1
FI
FIIFI
FII
Step 2 Step 2
low FRET
state
(rapid dissociation)
High FRET
state
(rapid dissociation)
Medium FRET
state
(long-live)
Table 3-4. Parameters derived from three Gaussian distribution fitting shown in Figure 3-
19.
3.4.4. Proposed model of DNA-recognition mechanism of domain AB
Based on the results and discussion above, a minimal model regarding how
domain AB recognizing double stranded DNA break is proposed (Figure 3-20). In step 1,
domain AB can interact with the double stranded break lesion either through zinc finger I
or zinc finger II. This is proposed based on the observations that a fast dissociation step
can be observed from both donor and acceptor binding events (Figure 3-10 and Figure 3-
11). Upon dimerization, a stable long-lived protein-DNA complex was formed at the
lesion site. This may result in a medium FRET state with an FRET efficiency of 0.46.
Figure 3-20. A proposed model for recognition of double stranded break DNA by domain
AB.
distribution <FRET Efficiency>
µ
Amplitude
(a)
σ2
1 0.222 0.039 0.092
2 0.463 0.057 0.041
3 0.668 0.078 0.104
140
While the data analyses done here allow the establishment of a minimal double
stranded break binding model of domain AB, it should be noted that there are different
signal response patterns (Figures 3-8B to M) discernible from the intensity trajectories.
Based on this model, the intensity trajectories can now be further analyzed in more details
based on a three binding state system shown in Figure 3-20. In addition, the FRET
distribution analysis carried out here is based an average FRET efficiency from each
DNA molecule. As three different FRET states are proposed according to the model
shown in Figure 3-20, FRET distribution analyses can now be conducted based on
individual binding events. Once the different FRET states are identified, their dwell time
distribution can also be analyzed.
As a future direction, this model can be further tested using protein constructs
with Cy3 labeled at different positions, such as the Fgly-AB, where Cy3 is labeled near
zinc finger I, and the 150Fgly-AB with Cy3 labeled internally in zinc finger II. In
addition, this model can be extended further in the context of full-length PARP-1, and
provide understanding on how other DNA-interacting domains, such as WGR and DsBD
domains, participate in the DNA-dependent activation process.
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Chapter 4. Mechanistic Investigation of Human PARP-1
Automodification
4.1. INTRODUCTION
As most of the PARP-1 research efforts are focusing on the aspects of its
biological functions, the enzymatic reaction carried out by PARP-1 is not well-
established today. Human PARP-1 can produce a nucleic acid like polymer, called
poly(ADP-ribose) (i.e., PAR) through enzymatic polymerization process using NAD+ as
the ADP-ribose donor. The generated PAR polymers are covalently attached to protein
substrates (i.e., heteromodification), and also PARP-1 itself (i.e., automodification). This
polymerization process occurs in a single active site located at the C-terminal domain F
of PARP-1, and proceeds in three distinct reaction steps: initiation, elongation and
branching (Figure 1-4). The polymers being generated from these three reactions are
heterogeneous in terms of chain length and branching points. The difficulty to fully
characterize the reaction products generated by PARP-1 hampers the mechanistic studies
of PARP-1 catalysis.
Most of the current understanding of PARP-1 reaction comes from the studies of
PARP-1 automodification. It has been shown that the minimal catalytic fragment domain
F alone exhibits low automodification ability in the presence of NAD+, with less than 1%
of the isolated protein being modified (1). In terms of DNA-dependent PARP-1
activation, both zinc finger I and domain C are required in addition to domain F (2-3).
The majority of polymer acceptor sites in PARP-1 are located in the automodification
domain D (4-5), and new acceptors sites outside domain D have also been identified
recently. However, the total number of PAR acceptor sites in PARP-1 is currently
uncertain (5). Finally, as discussed in Section 1.5.1, several amino acid residues within
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the active site of PARP-1 have been established to be important for modulating the
elongation and branching processes.
Based on the studies presented above, there is limited information regarding the
regulatory elements of PARP-1 which controls its polymerization process. For the three
reactions catalyzed by PARP-1, different ADP-ribose acceptor substrates are expected.
During initiation, amino acid residues within a protein substrate, such as glutamate,
aspartate or lysine residues serve as the substrates of PARP-1 for accepting the first ADP-
ribose unit. In this process, a specific protein substrate or a domain within PARP-1 needs
be recognized by the catalytic domain F. In the elongation process, a new ADP-ribose
unit is added to either the initiated ADP-ribose or pre-established PAR polymers. This
process can proceed through a distal or proximal mechanism (Figure 1-13). In the case of
distal elongation mechanism, addition of new ADP-ribose unit happens at the terminal
end of the PAR polymer, with the PAR polymer serving as the acceptor substrate. In the
case of proximal elongation mechanism, addition of new ADP-ribose unit happens at the
protein end of the PAR polymer, where the protein molecule serves as the acceptor
substrate. Finally, for the branching reaction, one of the 2''-OH groups within the PAR
polymer serves as the acceptor substrate. As these acceptor substrates are
macromolecules, their recognition by PARP-1 may require large and diverse interaction
surfaces. Currently, there is no satisfactory model that can account for the change of
substrate specificity as the reaction progresses during PAR formation.
In an attempt to understand the structural requirements and to establish a
mechanistic model for PARP-1 automodification, the truncated N- and C-terminal
fragments (i.e., ABC and DEF, respectively) were tested for their activities in PAR
formation using denaturing gel electrophoresis in combination with 32P autoradiography.
Current data suggest that DEF alone has poor initiation ability, whereas ABC together
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with DNA serves as the regulatory elements for catalysis. DEF modified with different
sizes of PAR polymers were also purified and tested for activity. It was observed that
elongation of short PAR polymers requires ABC and DNA; however, incorporation of
NAD+ into DEF which was previously modified with larger polymers required no ABC
and DNA.
Furthermore, accompanying the initiation reaction catalyzed by DEF/ABC,
significant amounts of NAD+ were hydrolyzed by water to generate ADP-ribose. This
process was attenuated during the elongation reaction where modified-DEF/ABC were
employed. Based on these observations as well as the crystal structure of PARP-1
domains bound with DNA solved by Langelier et al. (Figure 1-10) (6), a mechanistic
model of PARP-1 automodification is proposed by our post-doctoral fellow Dr. Mark
Ruszczycky.
This mechanistic model favors an intramolecular, distal elongation of PAR
formation in PARP-1 automodification. As PARP-1 exhibits a flexible and elongated
conformation in solution, addition of DNA causes a structural compaction of PARP-1,
which brings the automodification domain D close to the active site in domain F. This
structural perturbation results in formation of an active conformation, and allows PAR
initiation to take place in domain D. When ABC/DEF/DNA is used in forming the active
complex, even though the complex is catalytically active, the overall conformation is less
confined as compared with the wild type PARP-1. Therefore, water may enter the active
site and directly hydrolyze NAD+ to generate free ADP-ribose. This observation is
consistent with an intramolecular initiation process, where domain D within DEF serves
as the acceptor substrate. During PAR elongation in the case of modified-DEF/ABC, the
direct hydrolysis of NAD+ slows down when compared with the rate of NAD+ hydrolysis
during initiation. This should not be observed if domain D is still the as the acceptor
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substrate, as in the case of proximal elongation. However, this phenomenon can be
explained by PAR polymers or a newly initiated ADP-ribose unit serving as the acceptor
substrates during elongation. In this case, the less constrained conformation of
ABC/DEF/DNA complex is not a serious problem as in the case of initiation, where
domain D is the acceptor substrate. The fact that PAR polymers are the acceptor
substrates during elongation leads to the proposal that elongation happens at the distal
end.
Finally, a mechanism of forming branching polymers is also included in the
proposal. Because the extensively modified-DEF (i.e., lmDEF) can incorporate ADP-
ribose into PAR in the absence of ABC and DNA, the pre-established PAR polymers are
likely the reactive substrates for DEF. As the PAR polymer keeps elongating, the local
concentration of 2''-OH from the polymer increases near the active site in domain F.
Hence, it is more likely to get into the active site, and serves as the substrate acceptor to
form a branch point.
Distal elongation process is further tested by a PAR transfer assay and a pulse-
chase experiment. Preliminary results are both consistent with the distal elongation
mechanism. While current data supports the proposed model, additional control
experiments are needed to confirm the current observation.
4.2. MATERIALS AND METHODS
4.2.1. Cloning, expression and purification of human PARP-1 protein constructs
The cloning, expression and purification of protein constructs ABC, DEF (i.e., as-
purified DEF), and full-length PARP-1 used in this study had been discussed in details in
Section 2.2. The C-terminal His6-tagged version of domain ABC (i.e., C-His-ABC) was
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expressed using the ABC/pET-24b(+) vector constructed by our previous group member
Dr. Peng Gao. The expression and purification of this protein were similar to those used
in generating the tag free ABC protein construct. After the C-His6-ABC protein was
eluted from Ni-NTA agarose resin (Qiagen) with 20 mM HEPES, 300 mM NaCl, 250
mM imidazole, 1 mM β-mercaptoethanol and 10% glycerol at pH 7.5, the eluted protein
fractions were pooled and dialyzed against the dialysis buffer containing 20 mM HEPES,
300 mM NaCl, 1 mM β-mercaptoethanol and 10% glycerol at pH 7.5. The purified
protein was flash frozen with liquid nitrogen and stored at -80 oC.
4.2.2. Generation of the free-DEF protein construct
It was found that the as-purified DEF produced by the E. coli overexpression
system contains endogenous PAR polymers. Removal of the endogenous PAR polymers
was achieved by the addition of His6-PARG during DEF purification under mild basic
condition (pH 9.5). The resulting free-DEF was devoid of endogenous PAR polymers.
Here, the plasmid for His6-PARG protein overexpression was kindly provided by our
group member Dr. Yung-nan Liu. This plasmid encodes amino acid residues 448-976 of
PARG, which constitute the catalytic domain of human PARG protein. MBP-DEF and
His6-PARG protein constructs were overexpressed separately in 6L LB broth based on
the expression protocol described in Section 2.2.1. Cells were harvested by centrifugation
at 4500 x g for 15 min, and stored at -80 oC until purification.
To prepare free-DEF, both MBP-DEF and His6-PARG cells were thawed and
resuspended in lysis buffer containing 100 mM Tris, 300 mM NaCl, 10 mM imidazole, 1
mM β-mercaptoethanol and 10% glycerol at pH 9.5. The two cell suspensions were
combined, mixed, and ruptured by sonication. Cell debris was removed by centrifugation
at 20000 x g for 30 min, and the resulting supernatant was incubated at 4 oC for 1 hr with
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20 mL of Ni-NTA agarose resin, which had been pre-equilibrated with the lysis buffer.
After that, the mixture was loaded onto a column, drained, and washed with the wash
buffer containing 20 mM imidazole and 1.5 M NaCl. The MBP-DEF fusion protein and
the His6-PARG protein were coeluted with buffer containing 250 mM imidazole and 300
mM NaCl. The eluted protein fractions were pooled and dialyzed against the lysis buffer.
After 2 h of dialysis, 5% (w/w) His6-tagged TEV protease was added in, and the protein
mixture was incubated for 24 hr at 4 oC to cleave the His10-MBP tag to generate the tag-
free DEF construct. The protein mixture was then incubated with 30 mL of Ni-NTA resin
at 4 oC for 1 hr. The mixture was loaded onto a column, and the protein solution was
allowed to drain slowly. The collected flow through was passed through the Ni-NTA
resin slowly for a second time. The free-DEF protein recovered from the second flow
through was concentrated using an Amicon ultra-15 centrifugal filter unit with a 10 kDa
cut off membrane (Millipore). The concentrated free-DEF was exchanged into a storage
buffer containing 20 mM HEPES, 300 mM NaCl, 1 mM β-mercaptoethanol and 10%
glycerol at pH 7.5 using the same centrifugal filter. The resultant protein was flash frozen
with liquid nitrogen and stored at -80 oC.
4.2.3. Automodification assay of the as-purified DEF
Automodification activity of the as-purified DEF was determined by measuring
the amount of 32P incorporation in protein using [α-32P] NAD+ (American Radiolabeled
Chemicals, Inc.) as substrate. The reaction mixture (6 µL) containing 25 µM of the as-
purified DEF, 100 µM NAD+, 0.6 µCi of 32P-NAD+, 300 mM NaCl, 1 mM MgCl2 in 100
mM Tris buffer at pH 7.5 was incubated at room temperature. For all samples, NAD+ was
added last to initiate the reaction; and the reaction was quenched at different time points
using 2X SDS-PAGE loading buffer. After that, samples were separated using a 12%
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SDS-polyacrylamide gel (16 cm x 16 cm). The gel was run at 30 mA at room temperature
for 2 hrs with an ice water cooling system. After electrophoresis, the wet gel was rinsed
with tap water, drained, and wrapped by saran wrap. The wrapped gel was exposed using
a storage phosphor image screen (Molecular Dynamics) at 4 oC overnight. The image on
screen was then visualized using a Typhoon Scanner (GE Healthcare), and the image was
quantified using Quantity One software (Bio-rad).
To visualize the less abundant initiation process catalyzed by the as-purified DEF,
different concentration ratios of cold: hot 32P-NAD+ was prepared, and a final
concentration of 100 µM NAD+ was added to each reaction sample (6 µL). The reaction
samples were prepared as described previously, and they were quenched after 5 min
incubation. Quenched samples were separated using a 12% SDS-polyacrylamide gel
(mini gel) and were visualized in the same way as described before.
4.2.4. Automodification assay of the free-DEF
Automodification activities of the free-DEF with or without ABC were also
determined by the 32P incorporation assay. The experimental details including
concentrations of all major components used in the reaction mixture (6 µL) were
specified in the result section for each individual assay. In general, all samples were
prepared in a reaction buffer containing 300 mM NaCl, 1 mM MgCl2 and 100 mM Tris at
pH 7.5. After 1 hr incubation at room temperature, reaction was terminated by 2X SDS-
PAGE loading buffer. Samples were then separated using a 12% SDS-polyacrylamide gel
(16 cm x 16 cm). Visualization of gels was carried out under the same conditions as
described in Section 4.2.3.
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4.2.5. Pulse-chase experiment for PAR extension
To monitor the PAR extension in the presence of free-DEF, ABC and 8-mer
DNA, automodification reaction was initiated using 32P NAD+. After 20 min, the initially
formed polymers were extended through multiple replenishments of cold NAD+ chases.
Concentrations for each major components as well as numbers of cold chases added are
listed for each sample in Figures 4-7, 4-8 and 4-10 in Section 4.3.4. For samples that had
fewer numbers of cold chases added, their volumes were adjusted by adding the reaction
buffer containing 300 mM NaCl, 1 mM MgCl2, and 100 mM Tris at pH 7.5. After the
final chase step, all samples were quenched at the same time and analyzed by SDS-
PAGE.
4.2.6. PAR polymer hydrolysis monitored by high-performance liquid
chromatography
To test if the pre-established PAR polymer can be hydrolyzed by DEF, an
automodication assay was set up, and the PAR hydrolysis by the modified-DEF was
monitored by HPLC (i.e., high-performance liquid chromatography). First, an
automodification reaction (200 µL) was set up using 12.5 µM free-DEF, 12.5 µM ABC,
25 µM 8-mer DNA, 100 µM NAD+ in a reaction buffer containing 100 mM Tris at pH
7.5, 1 mM MgCl2, and 300 mM NaCl. The reaction sample was incubated at room
temperature for 20 min. After that, 200 µM of NAD+ chase was added every 20 min.
After a total of six chase steps, the reaction was stopped by filtration using 10 kDa Cutoff
Amicon® MLtra 0.5 mL filters (Millipore), and washed five times with the reaction
buffer. All filtrates were collected separately and stored at -80 oC freezer before HPLC
analysis. The retaining portion of the modified-DEF and ABC protein was diluted to a
final volume of 200 µL using the reaction buffer. This protein sample was stored at room
temperature, and 50 µL of the sample was taken out after 30 min, 60 min, and overnight
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incubations. The 50 µL sample was filtered using YM 10 filter, and the filtrate was stored
at -80 oC freezer before HPLC analysis.
Filtrate samples collected above were analyzed by HPLC using a Dionex
CarboPac PA1 anion exchange column (4 x 250 mm) coupled with UV detection at 258
nm. The solvent system used here was water (solvent A) and 1 M NH4OAc (solvent B).
The column was first pre-equilibrated with 30%B. With a flow rate of 1 mL/min, samples
were eluted using a gradient method as following: the method started at 30% B; after 2
min, solvent B was increased linearly to 90% in 8 min; isocratic run with 90% B for 5
min; solvent B was brought back to 30% in 2 min. At the end, the column was re-
equilibrated with 30% B for 7 min before the next run.
4.2.7. Preparation, purification and activity test of smDEF
To generate smDEF, which is the modified-DEF containing mono-ADP-ribose or
short oligo- PAR polymers, modification reaction (1 mL) was set up using 12.5 µM free-
DEF, 2.5 µM C-His6-ABC, 5 µM 8-mer DNA, 5 mM NAD+ in a reaction buffer
containing 100 mM Tris at pH 7.5, 1 mM MgCl2, 300 mM NaCl and 10% glycerol. The
reaction sample was incubated at room temperature for 1 hr. After that, small molecules
within the sample was filtered by YM 10 filtration using a 0.5 mL YM10 filter cell, and
was washed five times with 300 µL of reaction buffer. After that, the reaction sample was
diluted back to 1 mL volume using reaction buffer, with fresh NAD+ added in a final
concentration of 5 mM. The reaction mixture was incubated for another 1 hr and the same
cleaning procedures were performed again. This NAD+ replenishment procedure was
repeated for seven times. After the last replenishment was done, the reaction mixture was
exchanged to a buffer containing 10 mM imidazole, 800 mM NaCl, 100 mM potassium
phosphate at pH 6.5, and 10% glycerol. This reaction mixture was then incubated with
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500 µL of Ni-NTA resin that had been pre-equilibrated with the same buffer. After
incubation at 4 oC for 2 hr, the mixture was loaded onto a column, and the protein
solution was allowed to drain slowly. The collected flow through was passed through
another column that was pre-packed with 500 µL of the Ni-NTA resin. This was done to
ensure that all C-His6-ABC protein was removed. The purified smDEF protein recovered
after the second Ni-NTA column was exchanged to a storage buffer containing 100 mM
Tris at pH 7.5, 300 mM NaCl and 10% glycerol. The resulting smDEF was flash frozen
and stored at -80 oC. Protein concentration of smDEF was determined based on its
absorbance at 280 nm (extinction coefficient for DEF= 63,940 M−1 cm−1, obtained from
Vector NTI software) using a nanodrop instrument (Nanodrop®).
To test the activity of smDEF, reaction samples were prepared and analyzed in the
same way as described in Secction 4.2.4, and concentration details for each added
components are listed in Figure 4-13. Samples were incubated at room temperature, and
quenched after 60 min.
4.2.8. Preparation, purification and activity test of lmDEF
To generate lmDEF, a modified-DEF form containing large PAR polymers, the
automodification reaction (1 mL) was carried out using 12.5 µM free-DEF, 12.5 µM C-
His6-ABC, 25 µM 8-mer DNA, 5 mM NAD+ in a reaction buffer containing 100 mM Tris
at pH 7.5, 1 mM MgCl2, 300 mM NaCl, and 10% glycerol. After 1 hr incubation, the
sample was cleaned up and replenished with fresh NAD+ in the same way as described in
the case of smDEF. After the last replenishment was done, the reaction mixture was
exchanged to a buffer containing 10 mM imidazole, 800 mM NaCl, 100 mM potassium
pyrophosphate at pH 6.5, and 10% glycerol. The subsequent removal of C-His6-ABC
protein from the reaction mixtures was conducted in the same way as described in the
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case of smDEF using pyrophosphate buffer. Finally, the recovered lmDEF protein was
stored in a buffer containing 100 mM Tris at pH 7.5, 300 mM NaCl, and 10% glycerol at
-80 oC until future usage. Due to the high level of modification, concentration
determination of lmDEF could not be done using the absorbance signal at 280 nm
because it was not the absorbance maximum. Instead, concentration was determined
based on quantitation of the ADP-ribose unit measured at 260 nm absorbance maximum
using nanodrop (extinction coefficient for ADP-ribose = 15,400 M−1 cm−1). For activity
test of lmDEF, the experiments were done under the same condition as described in the
case of smDEF.
4.2.9. Western blot analyses
To determine if protein samples containing PAR polymers or C-terminal His6-tag,
western blot analyses were carried out. After protein separations were achieved using
12% SDS-PAGE gels, the proteins were electrophoretically transferred to a nitrocellulose
membrane. This transfer process was carried out with a voltage setting at 100 V for 1 hr
in cold transfer buffer containing 25 mM Tris base, 192 mM glycine, and 20% ethanol at
pH 8.3. After transfer blotting, the membrane was blocked with 5% nonfat dry milk in
TBST buffer containing 20 mM Tris-HCl at pH 7.5, 150 mM NaCl, and 0.05% v/v
Tween 20. The blocking procedure was conducted at room temperature for 1 hr, and the
membrane was washed three times with TBST buffer. After that, the membrane was
incubated with either anti-PAR polyclonal antibody produced in rabbit (Trevigen) for
PAR polymer detection, or anti-His (C-term) antibody produced in mouse (Invitrogen)
for C-terminal His-tag detection. After overnight incubation at 4 oC, the membrane was
washed three times with TBST buffer. The membrane was then incubated with the
secondary antibodies using either goat anti-rabbit IgG horseradish peroxidase (HRP)-
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conjugate (Novex®), or goat anti-mouse IgG horseradish peroxidase (HRP)-conjugate
(Novex®) for 1 hr at room temperature. After three washes with TBST buffer, antibody
signal was visualized using 1-step TMB-Blotting substrate solution (Pierce).
Alternatively, it could also be visualized using chemiluminescence detection system
(Pierce) based on the manufacture’s protocol.
4.2.10. Heteromodification of histone H1 by PARP-1
To study the heteromodification process of histone H1 catalyzed by PARP-1, a
time course assay was carried out. Reaction samples were prepared in 6 µL aliquotes.
Each reaction sample contained 1 µM PARP-1, 1 µM 8-mer DNA, 5 µM histone H1
(Santa Cruz Biotechnology), 5 mM NAD+, and 0.6 µCi 32P-NAD+. The
heteromodification reaction was carried out in the reaction buffer of 4 mM MgCl2, 300
mM NaCl, 15% glycerol, and 50 mM Tris at pH 7.5. Addition of NAD+ initiated the
heteromodification process. After incubation at room temperature, samples were
quenched at different time points using 2X SDS-PAGE loading buffer including 50 mM
EDTA. For samples that underwent PARG treatment, 0.5 µL of His6-PARG (1.5 mg/mL)
was added to each sample after 60 min of heteromodification. The purified His6-PARG
used in this section was kindly provided by Dr. Yung-nan Liu. The PARG treated
samples were incubated at room temperature and quenched at different time points. After
reaction, the protein samples were analyzed in the same way as described in Section
4.2.3.
4.2.11. PAR transfer assay
To see if modified-PARP-1 can transfer its pre-established PAR polymers to
histone H1, the modified-PARP-1 labeled with 32P ADP-ribose (i.e., 32P-mPARP-1) was
first prepared. A reaction mixture (200 µL) of PARP-1 automodification contained 2 µM
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PARP-1, 2 µM 8-mer DNA, 2 mM NAD+, and 45 µCi 32P-NAD+ in a reaction buffer
consisting of 300 mM NaCl, 4 mM MgCl2, 15% glycerol, and 50 mM Tris at pH 7.5.
After incubating the reaction mixture at room temperature for 1 hr, the reaction was
filtered through a YM 10 filter cell and washed with the reaction buffer ten times to
remove the unreacted NAD+ and byproducts. The protein concentration of the purified
32P-mPARP-1 was determined by Bradford assay.
To test the PAR transfer from 32P-mPARP-1 to histone H1, a reaction sample (6
µL) containing 1 µM  32P-mPARP-1 and 5 µM histone H1 was coincubated at room
temperature for 1 hr with or without the addition of 3 mM cold NAD+. For samples
treated with PARG, 0.5 µL of 1.5 mg/mL His6-PARG was added to the reaction mixture
and the incubation was continued for another hr. After samples were quenched, they were
separated by SDS-PAGE and analyzed in the same way as described in Section 4.2.3.
4.2.12. Pulse-chase experiment for studying distal vs. proximal elongation
To study whether the PAR elongation happens at the distal polymer end, or at the
proximal protein end, a pulse-chase experiment was carried out. Before setting up the
assay, 1 mM NAD+ stocks with different 32P specific activities were prepared prior to the
experiments. These preparations were based on the following concentration ratios of
cold: hot NAD+: 400:1, 800:1 and 200:1. Their corresponding specific activities were
denoted as α0 (or α1 for 400:1), α2 (for 800:1), and α3 (for 200:1). At the same time, 1 mM
cold NAD+ stock was also prepared and used in the experiments.
First, a 32P pulse step was carried out. This was done by labeling PARP-1 with 32P
NAD+ to generate PAR polymers in an automodification reaction, and the labeled PARP-
1 was denoted as the pulsed product in Figure 4-17. To generate 32P-mPARP-1, a reaction
mixture (200 µL) containing 1 µM PARP-1, 1 µM 8mer DNA and 100 µM 32P NAD+ (α0)
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was prepared with a reaction buffer composed of 10 mM DTT, 8 mM MgCl2, 300 mM
NaCl, 15% glycerol, and 50 mM Tris at pH 8.0. The reaction mixture was incubated at
room temperature for 30 min; after that, 50 µL of His6-PARG (11.4 ug/uL) was added
and the sample was incubated an additional 3 hrs. The reaction mixture was then cleaned
up by washing with the reaction buffer eight times using YM 10 filtration. After washing,
the concentration of the resulting monoADPribosylated-PARP1 (i.e., species A in Figure
4-17) was determined using Bradford assay. The final concentration of species A was
corrected for the presence of His6-PARG, which was not removed at this point.
After that, a chase step was set up using different NAD+ stocks prepared
previously. In one set of the samples (6 µL), 0.1 µM of species A and 10 µM 32P NAD+
with different α0 values were prepared in the reaction buffer, and they were incubated at
room temperature for 30 min. After that, 2 µL of His6-PARG was added to the sample,
and the PARG treatment was carried out for 60 min in order to generate species B (Figure
4-17). Finally, the reaction was quenched with 2X SDS-PAGE loading buffer including
50 mM EDTA. For another set of samples, rather than adding the PARG at the end of the
chase step, 2 µL of His6-PARG was added to the sample together with 10 µM 32P NAD+
with different α0 values in the chase step, and the samples were quenched after incubation
at room temperature for 1 hr.
After the pulse-chase experiment was done, the protein samples were separated
and analyzed by SDS-PAGE under the same condition as described in Section 4.2.3.
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4.3. RESULTS
4.3.1. Activity studies of as-purified domain DEF from E. coli
To study the catalytic activity of PARP-1’s minimal active fragment, domain DEF
was heterologously expressed and purified from E. coli. This C-terminal portion of
PARP-1 protein contains the catalytic domain F and the automodification domain D that
harbors acceptor sites for PAR polymers. The activity of the as-purified DEF was tested
in a time course manner using 32P-NAD+ as the substrate. Based on the SDS-PAGE
autoradiography shown in Figure 4-1A, as-purified DEF was capable of incorporating
NAD+, and the incorporated 32P signal increased overtime. However, this catalytic
activity was not very efficient, and majority of the substrate remained unreacted after
reaction.
Poly(ADP-ribosyl)ation of PARP-1 is known to consist of three steps: initiation,
elongation and branching reactions. First of all, if automodification of DEF is initiated
and mono(ADP-ribosyl)ation takes place, it is expected that 32P-signal would appear at
the DEF region in the SDS-PAGE autoradiography. Secondly, when poly(ADP-
ribosyl)ation takes place and forms long, branched polymers that covalently attach to
protein, this would cause the protein shifting upward to be at the stacking/running gel
interface and the well regions in the SDS-PAGE.
 Here, there was no indication of initiation shown from the SDS-PAGE. This is
based on the lack of signal shown in the DEF region even at the early reaction time points
(Figure 4-1A). Instead, majority of the incorporated 32P signal was detected at the gel
interface region, indicative of PAR polymer formation. However, when the activity gel
was stained with a highly sensitive SYRPO RUBY protein gel stain, there was no
detectable protein signal in the gel interface region (Figure 4-1C). The observation here
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suggested that the amount of protein associated with 32P signal, if any, was very low, and
it was under the detection limit.
A.     B.
C.
Figure 4-1. A time-course activity test of the as-purified DEF (25 µM) using 32P-NAD+
substrate (100 µM). A. Autoradiography of the activity assay. Lane 1 is a control without
protein added. B. A plot of 32P signal quantification at the gel interface region at different
time points. The 32P signal was reported as signal volume (i.e., count*mm2). C. The
extended time-course assay was done using cold NAD+ as substrate, and it was stained
with SYPRO® Ruby protein stain.
It was not clear why no initiation process was captured in the time course assay,
but only formation of long PAR polymers was observed. The failure of detecting the
initiation process shown in Figure 4-1 may be due to its low occurrence under the
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experimental conditions, or perhaps it undergoes elongation quickly preventing
accumulation of the initiation products. To test this possibility, an end point assay was
carried out by varying the 32P specific activity of NAD+ used, and the samples were
quenched after 5 min of reaction. It was assumed that if initiation products only
accumulate at low concentration, it may become discernible when the 32P specific activity
of NAD+ increases at the early reaction time points. As shown in Figure 4-2, the initiation
events catalyzed by the as-purified DEF were indeed visible when 32P specific activity
was high enough.
Figure 4-2. Observation of the initiation events in the DEF region is dependent on the 32P
specific activity of NAD+ used. Here, sample was run in duplicate with the same
concentrations of as-purified DEF (25 µM) and 32P-NAD+ substrate (100 µM) with
various 32P specific activities.
Furthermore, by comparing the 32P signals associated with DEF, the gel interface
and the well regions, it was clear that majority of the 32P activities resided at the gel
interface and well regions, indicating the accumulation of PAR polymers generated from
elongation and branching reactions. However, since the polymer elongation and
branching can only happen after the initiation step, these results raised a doubt on
whether the observed 32P-labeled bands on the top of the gel were really PAR related. If
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the observed 32P signal was due to the formation of PAR polymers, then the elongation
and branching process appeared to be highly processive, and was more efficient than
initiation.
To verify the identity of the 32P labeled bands at the gel interface and well regions,
and to determine whether its formation is truly due to the enzymatic activity of the as-
purified DEF, the following assays were performed. First, by titrating increasing amounts
of the 32P labeled substrate NAD+, the amounts of radioactivity incorporated at the gel
and interface regions also increased (Figure 4-3A), suggesting that the incorporated 32P
radioactivity was derived from the as-purified DEF substrate, NAD+. To test whether the
increase in 32P incorporation was due to the catalytic activity of the as-purified DEF or
other protein contaminants, 3AB (i.e., 3-aminobenzamide), a competitive PARP-1
inhibitor which binds to its catalytic active site (7), was used to pre-incubate with proteins
for 30 min before substrate addition. As shown in Figure 4-3B, with increasing
concentrations of 3AB added, the 32P incorporation at the well and interface region
became less, indicative of the observed 32P signals coming from the catalytic activity of
as-purified DEF. Furthermore, to check if the 32P incorporation was due to the formation
of PAR polymers, poly(ADP-ribose) glycohydrolase (PARG) was added after the
incubation of as-purified DEF with 32P NAD+ for 2 hrs. As PARG can cleave off PAR
polymers, showing in Figure 4-3C, after addition of PARG, the radioactive signal
diminished from the gel and interface regions. Taken all these together, the 32P signal
shown at the well and gel interface regions must be due to formation of PAR polymers
generated by the as-purified DEF.
However, the assays shown in Figure 4-3 did not provide any clue on why only a
small amount of initiation products was detected, and the subsequent elongation step
appeared to be much more robust in comparison with the initiation process.
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A. B.  C.
Figure 4-3. Confirmation of PAR formation at the gel and interface regions catalyzed by
the as-purified DEF. A. Increase of 32P NAD+ concentration caused elevation of the 32P
radioactivity incorporation. B. Increasing amount of PARP-1 inhibitor 3AB resulted in
decrease of 32P incorporation. C. Addition of PARG caused disappearance of 32P signal at
the well and gel interface regions.
Figure 4-4. Coomassie blue staining and anti-PAR western analyses of as-purified DEF
under different treatments. Lane 1. as-purified DEF with no treatment. Lane 2. as-
purified DEF subjected to PARG and mild basic treatment. Lane 3. as-purified DEF
under PARG treatment. The overload of protein in lanes 2 and 3 was intentional to make
sure both treatments were sufficient for cleaving off PAR polymers.
Later on, it was found that the as-purified DEF protein from E. coli expression
system contains endogenous PAR polymers conjugated to proteins, which could be
detected by anti-PAR western blot analysis (Figure 4-4). It was also noted that even the
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anti-PAR western signal was strong, the amount of protein associated with these PAR
polymers was very low, because it could not be detected by the Coomassie blue staining
(Figure 4-4, lane 1). The presence of endogenous PAR polymers was further confirmed
by PARG treatment. PARG degrades the polymer into ADP-ribose units, leading to
mono-ADPribosylated proteins, which showed no PAR signal in the anti-PAR western
blot (Figure 4-4, lane 3). After that, a mild basic treatment (pH 9.5 buffer) would
hydrolyze the last ADP-ribose unit off protein (Figure 4-4, lane 2).
The identification of endogenous PAR polymers conjugated to as-purified DEF
proteins raised a question of whether the observation of 32P signal at the well and gel
interface catalyzed by as-purified DEF was due to the presence of endogenous PAR
polymers. This question was based on the findings that both endogenous PAR polymers
and the 32P incorporation by the as-purified DEF are associated with a small amount of
as-purified DEF that was invisible to Coomassie blue stain, or a more sensitive dye
SYPRO® Ruby protein stain. Furthermore, the 32P signal was mainly detected at the well
and gel regions after incubation of the as-isolated DEF and 32P NAD+. Protein conjugated
PAR polymers appeared at these regions are usually associated with large and branched
PAR polymers which could not migrated into the complex gel matrix (8). While not
much signal associated with initiation process was detected under the same condition,
intensive 32P signals at the well and gel interface can be explained by the followings
hypotheses: either the elongation is a highly processive process which outcompetes the
initiation process, or the elongation is due to the modification of the pre-existed PAR
polymers in the as-purified DEF and requires no initiation. To test these two hypotheses,
DEF with no endogenous PAR polymers attached (i.e., free-DEF) was generated and
tested for activities in the following section.
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4.3.2. Activity studies of free-DEF purified from E. coli
To generate the so-called the free-DEF protein that contains no endogenous PAR
polymers after purifying from the E. coli expression system, the as-purified DEF was
treated with His6-PARG in pH 9.5 buffer. This treatment could remove the endogenous
PAR polymers from proteins by hydrolyzing the ribose-ribose linkages of PAR polymers,
and the ester linkage between the last ADP-ribose residue covalently linked to each of the
carboxyl amino acid acceptor of proteins, respectively. After treatment, the His6-PARG
proteins were removed by Ni-NTA resin, and resulting free-DEF was dialyzed against
HEPES buffer at pH 7.5 before activity tests. A typical Coomassie blue protein stain and
anti-PAR western analysis of the resulting free-DEF protein are shown in Figure 4-4,
Lane 2. Its activity was tested in comparison with as-purified DEF, and the results were
shown in Figure 4-5.
A.  B.
Figure 4-5. Activity assays of free-DEF and the as-purified DEF with or without addition
of ABC/8-mer DNA. A. Activities was compared between free-DEF and the as-purified
DEF. B. Activities was compared between free-DEF (same as in A), free-DEF (the
second batch) and the as-purified DEF.
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From Figure 4-5A, while the as-purified DEF showed similar activities as
described before using 32P labeled NAD+ as substrates, the removal of endogenous PAR
polymers from the as-purified DEF resulted in no 32P signal incorporation, as shown in
case of free-DEF alone (Figure 4-5A, Lane 4). This result suggested that the previous
observation of 32P signal at the well and interface regions when using as-purified DEF in
the incubation were due to the presence of endogenous PAR polymers. While the
removal of endogenous PAR polymers was incomplete (e.g., free-DEF batch 2), it still
resulted in reduction of 32P incorporation at the gel and well interface regions (Figure 4-
5B, Lane 6) when compared with the as-purified DEF (Figure 4-5B, Lane 2). Taken
together, one may conclude that the as-purified DEF incorporates 32P ADP-ribose units
into the endogenous PAR polymers, possibly through polymer elongation and branching
reactions, giving the observed radioactive signals on top of the gel. In addition, domain
DEF alone is not very efficient in carrying out initiation process in PAR formation, but it
is capable of modifying the pre-existed PAR polymers, likely through elongation and
branching processes.
It should be noted here that, generation of free-DEF was not always successfully,
such as in the case of preparing free-DEF batch 2. The failure of producing free-DEF was
due to the incomplete removal of endogenous PAR polymers during the PARG and mild-
basic treatments. This was possibly ascribed to the activity variations from different
batches of His6-PARG proteins. In this study, it was later found out that, the His6-PARG-
CD (i.e., only the catalytic domain) protein constructs provided by Dr. Yung-nan Liu
usually worked better than the full-length His6-PARG protein, possibly due to higher
protein stability. Accordingly, free-DEF used in assays reported in the later sections are
true free-DEF whose endogenous PAR polymers had been removed completely, like the
batch shown in Figure 4-5A, Lane 4.
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4.3.3. PAR initiation requires the presence of ABC and DNA
As shown in Figure 4-5, robust 32P labeling was observed in the DEF region only
when domain ABC and 8-mer DNA were both present. Direct labeling in the DEF region
was a result of initiation and oligomerization (i.e., formation of short PAR polymers).
Information provided here confirmed the requirement of domain ABC and DNA for the
initiation process of PAR formation. To see if DNA is needed for the initiation reaction,
8-mer DNA was omitted from the reaction mixture. As shown in Lane 3 of Figure 4-6,
elimination of DNA from the reaction mixture resulted in no labeling of DEF using 32P
NAD+. The above observations indicated that robust initiation of PAR formation by free-
DEF requires the presence of domain ABC and 8-mer DNA.
Figure 4-6. Initiation process requires the presence of 8-mer DNA.
Furthermore, in the presence of ABC and 8-mer DNA, fast hydrolysis of NAD+
was observed to generate free ADP-ribose units. In comparison, when only as-purified
DEF or free-DEF was used, this process was much slower. Based on several control
experiments, PAR polymers will not be hydrolyzed during the electrophoresis process.
Furthermore, DEF will not hydrolyze its conjugated PAR polymers within the
experimental time scale. This will be discussed in more details in the later section.
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Therefore, the above observations suggested that formation of ADP-ribose were resulted
from direct hydrolysis of NAD+, not the PAR polymers.
4.3.4. PAR polymer extension requirements in the presence of ABC/ 8-mer and
free-DEF
Based on the results obtained using the as-purified DEF as catalyst described in
Section 4.3.1., it was hypothesized that domain DEF alone is capable of further extending
conjugated PAR polymers possibly through elongation and branching reactions. To test
this hypothesis, a heavily modified DEF was needed and its elongation and branching
activity could be tested for 32P incorporation using 32P NAD+ without addition of ABC/8-
mer DNA. If the hypothesis is true, it is expected that similar result would be obtained as
in the case of the as-purified DEF alone. Therefore, using free-DEF, it was of interest in
generating DEF that is heavily modified with conjugated PAR polymers large enough
causing the modified DEF retained at the well and gel interface regions.
While the initiation process was observed when ABC/8-mer DNA were added to
free-DEF in the presence of NAD+, the resulting PAR units in this initiated-DEF did not
get further extended under the experimental conditions shown above. This was likely due
to the fast hydrolysis of NAD+ to ADP-ribose. In order to generate the heavily modified
DEF, one needed to overcome the direct hydrolysis problem. Therefore, a pulse-chase
experiment was carried out to see if the initiated-DEF can get further extended in the
presence of ABC/8-mer DNA by replenishing fresh NAD+ every 10 min. Showing in
Figure 4-7, the initiation process was monitored by the addition of 32P labeled NAD+ to
the reaction mixture containing free-DEF and ABC/8-mer DNA (i.e., the pulse step).
After 20 min, fresh cold NAD+ (i.e., the cold chase step) was added every 10 min, and the
extent of DEF modification was monitored by the 32P labeled protein band upshift as
more chase NAD+ was added over time. While the modified-DEF was shifted up toward
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the gel interface under consecutive chasing steps, this process was not efficient. This was
indicated by the attenuation of the protein band shift, and the modified-DEF was never
able to reach to the gel interface region. In attempting to solve this problem, fresh free-
DEF or ABC/8-mer DNA was added during the chase, but none of them seems to help
(Figure 4-8).
Figure 4-7. PAR polymer extension requires continuous replenishment of NAD+. Here,
reaction was initiated by adding 250 µM of 32P NAD+ into a reaction mixture containing
12.5 µM of free-DEF, 12.5 µM of ABC, and 25 µM of 8-mer DNA. After 20 min, 500
µM of cold NAD+ (1x) was added every 10 min, and the 32P labeled protein migration
was monitored by SDS-PAGE.
Figure 4-8. Addition of fresh free-DEF to the pulse-chase experiment did not help further
PAR polymer extension. Here, reaction was initiated by adding 200 µM of 32P NAD+ into
a reaction mixture containing 10 µM of free-DEF, 10 µM of ABC, and 20 µM of 8-mer
DNA. After 20 min, 400 µM of cold NAD+ (1x) was added every 10 min. After 30 min
chase, fresh free-DEF was added together with the cold NAD+, and the reaction progress
was compared with the case where no free-DEF was added.
As demonstrated by a control experiment monitored by high-performance liquid
chromatography (i.e., HPLC), modification attenuation of DEF was not due to the
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hydrolysis of the pre-established PAR polymers. Showing in Figure 4-9, modified-DEF
generated under the pulse-chase condition did not produce significant amount of ADP-
ribose that was released from the pre-established PAR polymers within the experimental
time scale (Figure 4-9, trace G). Small amount of ADP-ribose was detected after
overnight incubation of the modified-DEF (Figure 4-9, trace H), possibly due to the
degradation of the PAR polymers. Also, ADP-ribose was mainly generated during the
modification process of DEF from hydrolysis of NAD+, as shown in Figure 4-9, trace C.
This is consistent with the observation from the radioactivity assays (Figure 4-5). Overall,
the result suggested that DEF did not hydrolyze the pre-established PAR polymers under
the experimental conditions.
Figure 4-9. Monitor PAR polymer hydrolysis of modified-DEF. A. NAD+ standard. B.
ADP-ribose standard. C. Reaction filtrate collected from the reaction mixture of DEF
modification under a pulse-chase condition. D. Modified DEF was washed with reaction
buffer to remove the unreacted NAD+ or ADP-ribose byproducts. Trace D showed the
first wash of the reaction. E. The last wash of the modified-DEF. F. Pure modified-DEF
incubated at room temperature for 30 min. G. Pure modified-DEF incubated at room
temperature for 1 hr. H. Pure modified-DEF incubated at room temperature overnight.
Because the PARP-1 inhibitor 3AB is similar to nicotinamide, it is not surprise
that nicotinamide also has inhibitory effect toward PARP-1 (7). Based on this
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information, it was suspected that the built up of nicotinamide byproduct during the
modification reaction may be responsible for the attenuation of generating heavily
modified-DEF. To test this hypothesis, similar pulse-chase experiment was done using
higher concentration of NAD+ in each chase step to cut down the total experimental time.
Furthermore, before addition of fresh NAD+ in the chase step, the reaction sample was
first subjected to buffer exchange using YM10 filter cells to remove the nicotinamide
byproducts. Under this condition, the DEF conjugated PAR polymer could be extended
more efficiently as the nicotinamide was excluded. This was demonstrated by the
presence of modified-DEF at the gel interface region. This heavily modified-DEF was
named as lmDEF, meaning that the modified-DEF was conjugated with large PAR
polymers. In the case where DEF was conjugated with mono- or oligo- PARs, this form
of modified-DEF was named as smDEF, meaning that DEF was decorated with small
PAR polymers.
Figure 4-10. DEF conjugated PAR polymers can be extended more efficiently under the
pulse-chase conditions when the nicotinamide byproducts were removed before each
chase step. The experimental condition was similar to that described in the previous
experiments.
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4.3.5. Purification of smDEF from reaction mixture
As both smDEF and lmDEF could be generated using free-DEF incubated with
ABC/8-mer DNA, the next goal of this work was to purify the two different forms of
modified-DEF free of domain ABC, which could then be tested for activities. This had
been a challenging task, since domain ABC was difficult to remove from the reaction
mixture. MBP-His10-ABC protein provided a good handle for the later removal step;
however, the activity of this protein construct was pretty low. Therefore, a C-terminal
His6-ABC protein construct (i.e., C-His-ABC) was used in our experiments. Showing in
Figure 4-11A, the modification level of DEF was less when using C-His-ABC in
comparison with wild type ABC. Nevertheless, it showed reasonable activity level that
allowed generation of smDEF. Furthermore, in our attempt to remove C-His-ABC from
the modified-DEF, it was observed that C-His-ABC has strong affinity toward the
modified-DEF, possibly through interaction with the conjugated PAR polymers (9).
Therefore, free DEF: C-His-ABC ratio of 5:1 was used to generate the smDEF. As shown
in Figure 4-11B, under the pulse-chase condition, the modified-DEF was not shifted
toward the gel interface, suggesting that the majority of the modified-DEF was in the
smDEF form. After the pulse-chase experiment, C-His-ABC was removed by Ni-NTA
resin using potassium phosphate buffer. The recovered smDEF was confirmed by anti-
PAR western analysis to show the presence of conjugated PAR polymers (Figure 4-11D).
The low intensity signal of the western blot was possibly due to repetitive uses of the
same anti-PAR antibody solution in this case. The complete removal of C-His-ABC from
the recovered smDEF was confirmed by Coomassie blue stain as well as anti C-terminal
His-tag western blot (Figure 4-11 B and C, Lane 4). Based on the assays done here,
smDEF was prepared successfully in our experiments.
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It should be noted that, while C-His-ABC could be completely removed from the
smDEF, unreacted free-DEF was not removed from smDEF in this case. However,
according to the observed activity level of C-His-ABC/8-mer and free-DEF (Figure 4-
11A, Lane 3), seven rounds of 5 mM NAD+ chases would have converted the majority of
the protein to the smDEF form (Figure 4-11B, Lane 4). In addition, the recovered smDEF
protein was not pure because two contamination protein bands were observed (Figure 4-
11B). These two contamination bands have lower molecular mass comparing with free-
DEF or lmDEF, and they are possibly resulted from degradation of DEF. This conclusion
was drawn because these two proteins were discernible when high concentration of free-
DEF is loaded (Figure 4-12A, Lane 7), and their intensities increased after reaction and
purification (Figure 4-11B). Degradation of DEF may be caused by the prolong
processing of the pulse-chase experiments and C-His-ABC removal.
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A. B.
C.     D.
Figure 4-11. A. Comparison of the modification level of DEF using wild type ABC and
different amounts of C-His-ABC. B. A pulse-chase experiment to generate smDEF. Here,
the pulse step was done under the same condition as shown in A, Lane 3. The amount of
cold NAD+ and the number of chase steps were indicated for each lane. The sample
labeled Lane 3 is the smDEF reaction mixture, and the sample labeled Lane 4 is the
recovered smDEF after removal of C-His-ABC. C. Complete removal of C-His-ABC
from recovered smDEF was confirmed by anti C-terminal His-tag western analysis. D.
The presence of PAR polymers within smDEF was confirmed by anti PAR western
analysis. For both C and D, the identities samples loaded in each lane were shown on the
right.
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4.3.6. Purification of lmDEF from reaction mixture
To generate the lmDEF, free-DEF and C-His-ABC in 1:1 ratio were used in the
pulse step (Figure 4-11A, Lane 2). After that, six rounds of NAD+ chase steps were
carried out to generate lmDEF (Figure 4-12A, Lane1). The removal of C-His-ABC using
Ni-NTA resin was achieved using potassium pyrophosphate buffer. The successful
generation of lmDEF and its purity was verified by Coomassie blue stain, anti C-terminal
His-tag and anti PAR western analyses.
A.
B.  C.
Figure 4-12. A. Coomassie blue stained SDS-PAGE showing the generation of lmDEF
and its subsequent purification steps. Here, the pulse step was done under the same
condition as shown in Lane 2 of Figure 4-11, and the chase step was done similarly as in
the case of smDEF generation. B. Complete removal of C-His-ABC from the recovered
lmDEF was confirmed by anti C-terminal His-tag western analysis. C. The presence of
PAR polymers within lmDEF was confirmed by anti PAR western analysis.
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4.3.7. Activity test of the purified smDEF
The purified smDEF is the modified-DEF form which contains mono-ADP-ribose
or short oligomers of PAR. Its structure is supported by the observation that PAR signal
could be detected on the protein sample, and the corresponding protein band shift in the
SDS-PAGE gel was moderate. A set of assays were carried out using smDEF to address
the following question: after DEF gets initiated, does further elongation of the initiated
unit require the presence of domain ABC and 8-mer DNA?
As shown in Figure 4-13 Lane 1, smDEF itself exhibited low activity, similar as
what had been seen in the case of as-purified DEF. The small amount of 32P incorporation
at the well and gel interface regions may be resulted from further extension of the short
PAR polymers in smDEF. Addition of free-DEF did not help to enhance the 32P
incorporation process (Figure 4-13, Lane 2). Interestingly, when domain ABC was
incubated together with smDEF, the DEF region showed 32P signal incorporation, as
shown in Figure 4-13, Lane 3. It was also observed that, when smDEF was used instead
of free-DEF, the direct hydrolysis of NAD+ slowed down when ABC was present. Here,
ABC formed an active complex with smDEF, which in turn caused further modification
of smDEF, possibly through extension of the short PAR polymers or of the initiated units.
It is also possible that this active complex carried out initiation. However, the observation
of slow NAD+ hydrolysis in Lane 3 when compared with as-purified DEF incubated with
ABC/8-mer DNA (Figure 4-6, Lane 4), was more consistent with the involvement of
ABC/smDEF in elongation process, where slow hydrolysis was observed (Figure 4-5,
Lane 2). Addition of ABC/8-mer DNA had stronger influence than ABC alone.
Comparing Lane 3 and Lane 6 in Figure 4-13, it was clear that higher amount of
radioactive signal was incorporated when 8-mer DNA was included. In addition, the
smDEF band shifted slightly upward in Lane 6, indicating that the short PAR polymers
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on smDEF were extended. Based on the above observations, the results demonstrated that
further extension of the short PAR polymers conjugated with DEF requires the presence
of domain ABC and 8-mer DNA to form the active complex.
Furthermore, when free-DEF was added to the smDEF/ABC/8-mer DNA reaction
mixture (Figure 4-13, Lane 7) Direct hydrolysis of NAD+ became more pronounced.
Similar results were also observed in the initiation reaction of free-DEF with ABC/8-mer
DNA (Figure 4-6, Lane 4). Unlike the case where free-DEF was absent (Figure 4-13,
Lane 6), the 32P labeled DEF band did not shift upward. Furthermore, significant amount
of 32P radioactivity was shown at the well and gel interface regions, similar to what had
been observed when only smDEF was tested (Figure 4-13, Lane 1). These results
suggested that three active protein complexes were formed. One of them is smDEF itself,
which contributes to the signal observed at the well and gel interface regions, the second
one is the free-DEF/ABC/8-mer DNA active complex, which contributes to the 32P signal
appearing at the DEF region, as well as the fast NAD+ hydrolysis to generate ADP-ribose.
The third one is the smDEF/ABC/8-mer DNA complex, which causes further
modification of smDEF. However, because this is a competition process between smDEF
and free-DEF for the complex formation with ABC/8-mer DNA, the protein band shift is
less apparent in this case.
As 32P signals associated with these three different forms of active complex can be
identified in Lane 7 of Figure 4-13, the result shown here is consistent with an
intramolecular elongation process of DEF. This conclusion was drawn because if the
short PAR polymers conjugated to the smDEF can be modified by the free-DEF/ABC/8-
mer DNA complex intermolecularly, it is expected that the 32P signal at the DEF region
would appear as a smear due to different sizes of PAR polymers generated at that region.
Instead, signal shown in Lane 7 is more like a superposition of Lane 1, Lane 5 and Lane
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6. Within each of these three lanes, different forms of active complexes described above
are expected to be visible. Therefore, data obtained from smDEF activity supports a
hypothesis that modification of DEF happens intramolecularly.
Figure 4-13. Activity test of smDEF. Reaction conditions are listed for each sample lanes.
4.3.8. Activity test of the purified lmDEF
Once lmDEF was generated in Section 4.3.6, its activity was tested. It should be
mentioned that because of large amounts of PAR are conjugated to lmDEF, concentration
determination by nanodrop measuring absorbance at 280 nm is not accurate. This is
because the absorbance signal of proteins overlapped with the absorbance maxima at 260
nm arising from ADP-ribose. Furthermore, as shown in Lane 2 of Figure 4-12A, the
lmDEF sample contains other protein contamination which could not be removed based
on the current purification protocol. Due to the reasons cited above, lmDEF concentration
was determined based on the concentration of ADP-ribose units. When testing lmDEF
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activity, 200 µM of lmDEF was used. This means that lmDEF containing 200 µM of
ADP-ribose units was employed, and the total protein concentration was about 32 µM. As
the protein purity was nearly 40% based on the gel shown in Figure 4-12A, pure
modified-DEF protein was about 12.8 µM, which was roughly similar to the amount of
smDEF (12.5 µM) being used. The results of lmDEF activity tests are shown in Figure 4-
14.
Figure 4-14. Activity test of lmDEF. Reaction condition was listed for each sample lanes.
Shown in Lane 1 of Figure 4-14, lmDEF itself is capable of incorporating 32P
signal at the well and gel interface regions, like the case of as-purified DEF. Since
lmDEF is mainly conjugated with large PAR polymers (Figure 4-12A, Lane 2), this
observation suggested that DEF itself is capable of further modifying large PAR
polymers. Addition of ABC (Lane 5) or 8-mer DNA (Lane 11) had little effect on the 32P
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incorporation into lmDEF. Addition of ABC/8-mer DNA (Lane 7) also showed no strong
influence of 32P incorporation at the well region; however, signal at the gel interface
region was increased in this case. Again, this observation is consistent with the previous
conclusion drawn with smDEF, where ABC and 8-mer DNA are needed in extending
short PAR polymers. When polymers become significantly large and retain at the well
region, the participation of ABC/8-mer DNA is not required for PAR polymer extension.
Furthermore, when free-DEF was added to lmDEF, an inhibitory effect was
observed in this case (Figure 4-14, Lane 1 versus Lane 3). This observation is not
consistent with an intermolecular modification process, where addition of active DEF
should accelerate the 32P incorporation. Instead, the result indicated free-DEF is not
capable of extending PAR polymers that are conjugated to another protein molecule.
Finally, when free-DEF/ABC/8-mer DNA was added to lmDEF (Figure 4-14, Lane 9),
initiation took place on the newly added free-DEF followed by fast NAD+ hydrolysis.
Here, modification of lmDEF with signal shown at the well and gel interface regions was
not observed. These observations suggest that the major active complex is the
DEF/ABC/8-mer DNA complex.
Another interesting piece of information obtained in this study is the effect of
Mg2+. For conventional assays done in this section, 1 mM of MgCl2 was always added to
all reaction samples. In this study, the effect of Mg2+ was examined by adding additional
100 mM of MgCl2 in the reaction mixture. As shown in Lane 2, Lane 4 and Lane 10 of
Figure 4-14, supplementation of Mg2+ caused increase of 32P incorporation at the well and
gel interface regions. This observation suggests that addition of Mg2+ ions can stimulate
the elongation process of large PAR polymers.
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4.3.9. PAR transfer assay
Based on the biochemical studies presented in the previous sections, a
mechanistic model of PARP-1 automodification can be proposed, and details are
provided in the Discussion section in this chapter. According to the proposed model,
PARP-1 catalyzes PAR polymer elongation through distal addition, meaning that the new
ADP-ribose unit of PAR is added to the polymer terminal that is not attached to the
protein. In another possible scenario, the new ADP-ribose unit is added to the protein end
during PAR elongation. The latter is called proximal addition. For the proximal
elongation model, at least two amino acid residues in the active site of protein may
involve as ADP-ribose/PAR acceptors, so the ADP-ribose unit can be added on one site
and the PAR polymer grown on another site is then transferred to where the newly added
ADP-ribose unit resides during the elongation process. This process is called the PAR
transfer process. Therefore, if elongation of PAR polymers happens distally, no PAR
transfer is expected; in contrast, when elongation of PAR happens through proximal
addition, the PAR transfer process is expected to occur and may be observed.
Detection of the potential PAR transfer process was carried out using modified-
PARP-1 and histone H1. The basic experimental design is to generate modified-PARP-1
using 32P NAD+. Then, the 32P labeled modified-PARP-1 (i.e., 32P-mPARP) is incubated
with histone H1, which is a heterosubstrate of PARP-1. The process of PAR transfer is
then monitored by the relocation of 32P signal from PARP-1 to histone H1. Since these
two proteins have different molecular mass, it can be analyzed by SDS-PAGE
electrophoresis. While modification of histone H1 is a heteromodification process
catalyzed by PARP-1, one assumption made here is that, the mechanism of PAR
elongation carried out by PARP-1 is the same for automodification and
heteromodification.
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Figure 4-15. A control experiment demonstrating 32P labeling of modified-PARP-1 and
modified-histone H1. Here, heteromodification of histone H1 was carried out using 1 µM
PARP-1, 5 µM histone H1, 1 µM 8-mer DNA and 5 mM 32P-NAD+. The
heteromodification was monitored by a time course assay (Lane 1 to Lane 5). After 60
min of heteromodification, 0.5 µL of 1.5 mg/mL of PARG was added and formation of
monoPARP-1 and monoH1 were also monitored by a time course assay (Lane 6 to Lane
14).
Before carrying out the group transfer experiment, a control assay was done to see
if the 32P-mPARP and 32P labeled modified-histone H1 (i.e., 32P-mH1) can be clearly
differentiated from each other. Based on the results shown in Figure 4-15, PARG
treatment was required after the PAR transfer assay to show clear 32P labeled protein
bands for the mono-ADP-ribosylated PARP-1 (i.e., monoPARP-1) and mono-ADP-
ribosylated histone H1 (i.e., monoH1) that can be resolved by the SDS-PAGE. This was
done because when the protein conjugated PAR polymers are large and branched, they
tend to retain at the well and gel interface regions. In this case, modified PARP-1 and
modified histone H1 can not be differentiated from each other. Therefore, PARG
treatment is necessary to show the modified protein band with expected molecular mass
for both PARP-1 and histone H1. As shown in the control experiment (Figure 4-15), the
PARG treatment did not go to completion after 2 hr incubation because some PAR
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conjugated protein was shown in the well region. However, it does not affect the result in
this assay because the 32P labeled protein bands showed up at the PARP-1 and histone H1
regions, indicating both PARP-1 and histone H1 was modified.
An unexpected phenomenon observed here is that there was a time delay between
the PARP-1 automodification process and the heteromodication process. Showing in
Figure 4-15 Lane 1 to Lane 5, it is clear that automodification was predominant at the
early time, and getting saturated at around 40 min. It was also found that histone H1
heteromdification occurred in a slower rate when compared with the automodification
reaction. As automodification level started to get saturated, histone H1 modification
continued, as shown by the mH1 protein band shifting upward. The time difference
between first occurrence of automodification and heteromodification raised an interesting
question of whether automodification of PARP-1 is a pre-requisite for heteromodification
to take place.
Figure 4-16. PAR transfer from the 32P labeled modified-PARP-1 was tested using
histone H1 as the polymer acceptor substrate. PAR conjugation to the target proteins was
confirmed by PARG treatment (0.5 µL of 1.5 mg/mL stock).
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Based on the information shown in Figure 4-15, a PAR transfer assay was
designed as followed. First, PARP-1 automodification was carried out and the unreacted
32P-NAD+ was washed off through YM10 filtration. The purified 32P-mPARP-1 was then
incubated with histone H1 under various conditions for 1 hr. After incubation, the
samples were treated with PARG for another hour, and the protein samples were
separated by SDS-PAGE electrophoresis (Figure 4-16).
As shown in Lane 3 of Figure 4-16, histone H1 incubated with modified-PARP-1
(32P-mPARP-1) did not show any detectable 32P signal below the PARP-1 region, where
the modified histone H1 would be located. This was further confirmed by the same
sample after PARG treatment, there was no monoADP-ribosylated histone H1 detected in
this case (Figure 4-16, Lane 4). Addition of cold NAD+ to the reaction mixture helped to
further elongate the pre-existed PAR polymers associated with PARP-1, but did not
facilitate PAR transfer from 32P-mPARP-1 to histone H1 (Figure 4-16, Lane 5 and Lane
6). Based on the results shown above, it was concluded that no PAR transfer occurred. If
PARP-1 catalyzes PAR elongation using the same mechanism for both automodification
and heteromodification, the current result is consistent with the distal elongation process
of PAR, where no PAR transfer is required.
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4.3.10. Proximal vs. distal elongation: pulse-chase experiment
Figure 4-17. A general experimental set up for the pulse-chase experiment. Species being
quantified are denoted as species A and species B.
A more straight forward way to test whether PAR polymer elongation happens at
the distal end of the polymer terminus (i.e., distal addition) or at the protein ends (i.e.,
proximal addition) is a pulse-chase experiment where different substrate forms are added
during the reaction process. The basic experimental plan is shown in Figure 4-17, and the
quantitative theory discussed below was developed by our post-doctoral fellow Dr. Mark
Ruszczycky. This quantitative theory accounts for the numbers of new initiation sites
during the chase step and the fraction of initiated sites during the pulse step which will
get further elongated during the chase step.
In the pulse step, PARP-1 was first modified by excess 32P NAD+ with a known
amount of specific activity denoted as αo. This pulse condition allows generation of large
PAR polymers, and also have one or more than one initiation site per protein molecule
(i.e., E(No)≥1, with E(No) denoted as numbers of initiation site per PARP-1 molecule).
Then this modified-PARP-1 (i.e., pulsed product in Figure 4-17) was treated with PARG.
As PARG hydrolyzes PAR polymers, and leaves only one ADP-ribose unit attached to
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protein, this would yield a mono-ADPribosylated-PARP-1 (i.e., species A in Figure 4-
17). This species A has an E(n) value equals to 1, where E(n) denoted as the average
number of ADP-ribose units per PAR polymer chain. After pulse and PARG treatment
steps, the species A would have radioactivity intensity denoted as Io which can be
quantified from the 32P autoradiography. The intensity Io of species A depends on the
concentration of PARP-1, the specific activity used during the pulse step as well as
numbers of initiation sites. The overall dependence is described by equation (10).
After cold NAD+ chase (or any NAD+ chases with known specific activities) and
PARG treatment (step 5 and step 6 in Figure 4-17), the resulting species B would have
32P intensity of I1 given by equation 11.
In equation 11, the (1-q)αoE(N0) term reflects the initiated sites which does not get
further elongated during the pulse step; the qα'1E(N0) terms reflects the initiated sites
which gets further elongated during the pulse step; and the α1∆E(N0) reflects new
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initiation site during the chase step. Under this case, the radioactive signal of species A
and species B can be compared and resulted in RI = I1/Io.
Here, if elongation happens through distal addition, the resulting RI is defined by
equation (12). If elongation happens through proximal addition, the resulting RI is defined
by equation (13).
During this pulse-chase experiment, different specific activity of 32P NAD+ was
used in the chase step, such that αi/αo= 0, 0.5, 1 and 2 for this experiment. For this
experimental trial, it was assumed that all initiated sites in the pulse step would get
further elongated during the chase step, where q≈1. Based on this assumption, the
equations can be re-arranged as followed. For a distal elongation process, equation (14)
will be applied, and for a proximal elongation process, equation (15) will be applied. In
both cases, the observable RI -1 would be linear.
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Based on the quantitative theory discussed above, a pulse-chase experiment was
carried out using specific activity ratios (αi/αo) of 0, 0.5, 1 and 2. Intensity values I0 of
species A and Ii of species B were obtained and the corresponding RI -1 values were
plotted against its αi/αo ratio. Results are presented in Figure 4-18 and 4-19.
Figure 4-18. A 32P autoradiography was used for quantification of the pulse-chase
experiment. Here, the pulse step (denoted as P in the gel) was carried out using 1 µM of
PARP-1, 1 µM of 8-mer DNA and 100 µM of hot NAD+ with specific activity of αo. For
the chase step carrying out in Lane 3 to Lane 8, 0.1 µM of species A (denoted as A in the
gel) was incubated with 10 µM of NAD+ with specific activity of αi for 60 min, 2 µL of
PARG was also added during the chase step, and the resulting species B was denoted as
B in the gel. For the chase step carrying out in Lane 9 to Lane 14, 0.1 µM of species A
was incubated with 10 µM of NAD+ with specific activity of αi for 30 min, and then 2 µL
of PARG was added and incubated for another 60 min to generate species B. Here, A*
and A** were control samples of species A that went through the same treatments in the
chase step, except that no chase NAD+ was added.
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A.     B.
C.
Figure 4-19. Plots of RI -1 versus αi/αo for the pulse chase experiments. A. Data points are
plotted for Lanes 5-8. B. Data obtained from Lanes 5-8 are fitted linearly, and one outlier
data point was excluded from the fit. C. Data points obtained from Lanes 11- 14 are
plotted and fitted linearly.
Based on the 32P autoradiography shown in Figure 4-18, the pulse condition was
sufficient to generate large PAR polymers, as indicated by the protein band shift (Figure
4-18, Lane 1). While it was not done in this preliminary study, a complete protein band
shift needs to be confirmed by Coomassie blue stain to ensure E(No)≥1. Here, PARG
used after the pulse step was not removed. Based on previous trials of pulse-chase
experiments, the removal of PARG was found to be difficult and caused large protein
loss. Reported in the literature, the presence of PARG does not inhibit PARP-1 activity
(10). As PARP-1 continued to generate PAR polymers, the presence of PARG would
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hydrolyze these newly generated PAR polymers at the same time. To see if the presence
of PARG would have any effect on the outcome of this experiment, the second PARG
treatment (step 6) was combined with the chase step (step 5), by adding PARG during the
chase step (Lane 3 to Lane 8 in Figure 4-18).
Lanes 5-8 in Figure 4-18 are the chase results using different αi values of NAD+ in
the chase in the presence of extra PARG. In the case where αi=αo, RI – 1 =∆E(N0)/E(N0),
which reflects the fraction increase of the new initiation sites during the chase step. For
Lanes 5-8, when αi=αo, and RI – 1 = 0.27. This indicated that there was about 27%
increase of new initiation during chase. A plot of RI -1 vs. αi/αo for Lanes 5-8 is shown in
Figure 4-19A. There is a point where αi/αo = 0 appeared to be an outlier. When the rest of
the data points are fitted linearly (Figure 4-19B), it has a y-intercept of 0.0071, and a
slope of 0.2221. This result is consistent with what is expected for the distal addition.
Lanes 11-14 in Figure 4-18 are the chase results using different αi values of NAD+
in the chase where extra PARG was added after the chase step. In the case where αi=αo, RI
– 1 = 0.05, suggesting that about 5% increase of the new initiation sites during the chase
step. When the data points of RI – 1 vs. αi/αo is fitted linearly (Figure 4-19C), it had a y-
intercept of -0.0977, and a slope of 0.1488. This result is again consistent with the
expectation of a distal addition process.
4.4. DISCUSSION
4.4.1. Domain ABC and DNA serve as initiation regulators for PAR formation
To investigate the catalytic activity of PARP-1, a minimal C-terminal catalytic
fragment, domain DEF of PARP-1, was first prepared. Consistent with the results
reported by Mendoza-Alvarez et al. (1, 11), the as-purified DEF showed low 32P NAD+
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incorporation in the absence of DNA (Figure 4-1A). Interestingly, the majority of the 32P
labeled species appeared at the well and gel interface regions, and little initiation products
were detected unless NAD+ with high 32P specific activity was used (Figure 4-2). These
observations suggested that the as-purified DEF is not efficient in catalyzing initiation
reaction by itself. When the N-terminal fragment of PARP-1, the domain ABC was added
together with 8-mer DNA to the incubation mixture, the initiation process was clearly
observed to occur on the as-purified DEF (Figure 4-5). Similar results were also obtained
when ABC/8-mer DNA were incubated with free-DEF (Figure 4-5). These findings
demonstrate that, domain ABC and 8-mer DNA serve as induction elements which
directly affect the initiation process of PAR formation.
In addition to promoting the initiation process, fast NAD+ hydrolysis to generate
ADP-ribose was also observed in the presence of ABC and 8-mer DNA. A control
experiment showed that formation of ADP-ribose in this process is not due to the
cleavage of pre-established PAR polymers (Figure 4-9). While this hydrolysis
phenomenon is also observed for the wild type PARP-1, the effect is less pronounced for
the wild type enzyme when compared with the ABC and DEF complex (12). This
observation can be explained by the protein conformational change during DNA-
dependent activation proposed by Langelier et al. (6). Specifically, PARP-1 may adapt a
compact active conformation upon binding to DNA, where the BRCT domain (i.e.,
automodification domain) is positioned closed to the active site in domain F. This
compact conformation of PARP-1/DNA active complex is achieved through multiple
sites of interaction centered about the WGR motif within domain DEF (Figure 1-10).
Because DEF/ABC/8-mer DNA complex is catalytically active, it may exhibits similar
conformation as the PARP-1/DNA complex. However, as ABC/DEF represents a
truncated construct of PARP-1, its conformation may be less confined than the wild type
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PARP-1, and allows easy access of water to the active site, and thus fast hydrolysis of
NAD+.
4.4.2. Catalytic activities of DEF
As discussed before, DEF itself is not efficient in catalyzing the initiation reaction
of PAR formation. However, the as-purified DEF is capable of incorporating 32P signal
and the modified DEF appears at the well and gel regions, where the large PAR polymers
conjugated to protein are typically reside. Later, it was found that the as-purified DEF
obtained from the E. coli expression system contains endogenous PAR polymers (Figure
4-4); however, their origins remain elusive at this point. Based on a series of control
experiments, 32P incorporation into the PAR polymers was shown to be catalyzed by the
as-purified DEF (Figure 4-3). This led to a proposal that DEF is capable of catalyzing the
extension of large PAR polymers in the absence of ABC/8-mer DNA. To test this
hypothesis, lmDEF, a modified-DEF conjugated with large PAR polymers was generated
from free-DEF, and its catalytic activity was tested. Consistent with the hypothesis,
lmDEF was shown to be able to increase 32P incorporation at the well and gel-interface
regions, similar to in the case of as-purified DEF (Figure 4-14). This result suggested
that, as a PAR polymer reaches to a certain length, it can serve as a substrate of DEF, and
this catalysis is not regulated by domain ABC and 8-mer DNA. However, this catalysis is
not very efficient either, possibly due to the negative charges built up during PAR
polymer formation. As the size of a PAR polymer gets larger, the overall negative
charges also increase. This may cause repulsion of PAR polymers from the active site in
domain F. Consistent with this thought, addition of Mg2+ stimulates 32P incorporation of
lmDEF (Figure 4-14). Therefore, Mg2+ may serve as counter ions of the phosphate groups
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of PAR polymers, which in turn reduces the overall net charge of PAR, rendering it a
better substrate for DEF.
4.4.3. Domain requirements for PAR extension
As initiation of PAR formation on DEF requires ABC/8-mer DNA, short PAR
polymer elongation also requires the presence of ABC and 8-mer DNA. This was
demonstrated by the smDEF activity test. This modified-DEF form contains mono-ADP-
ribose or short PAR oligomers (Figure 4-11 and Figure 4-13). Polymers conjugated to
smDEF are expected to be short because smDEF appears at the same position as DEF on
the SDS-PAGE gel. The presence of PAR polymers on smDEF was confirmed by anti-
PAR western analysis (Figure 4-11). Therefore, it is expected that the polymers on
smDEF are relatively short comparing with the polymers conjugated with lmDEF.
However, for both smDEF and lmDEF, the exact polymer size distributions are not
known at this point. It requires further analysis to learn the PAR polymer distribution of
these two different modified-DEF forms in future studies.
4.4.4. Proposed model for modification of PARP-1 automodification
As the catalytic activity of DEF/ABC/DNA is similar to that of the wild type
PARP-1/DNA, based on the biochemical studies discussed above, and the crystal
structure of PARP-1 complexed with DNA (Figure 1-10) (6), a mechanistic model of
PARP-1 automodification is proposed by Dr. Mark Ruszczycky.
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Figure 4-20. A proposed model of PARP-1 automodification.
According to the proposed model, the active conformation of PARP-1 is formed
in the presence of DNA. The locations and the interaction surfaces between individual
domain and DNA are postulated based on the crystal structure of PARP-1 domains
complexed with DNA (6). Upon formation of the active conformation, the
automodification domain D is positioned near domain F. This allows initiation of PAR
formation to occur at domain D. As illustrated by step 2 and step 3, initiation and
elongation of PAR polymers happen intramolecularly. This explains why free-DEF alone
shows low initiation ability. Without ABC and 8-mer DNA, domain DEF may exist in a
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flexible conformation, just like PARP-1 (6). In this case, the automodification domain D
is not positioned closely to the active site in domain F, making initiation difficult to take
place. Furthermore, addition of fresh DEF to smDEF and lmDEF does not stimulate
additional 32P incorporation (Figures 4-13 and 4-14). If elongation/ branching are
intermolecular processes, it is expected that addition of fresh DEF would help to
incorporate more 32P signal as the active enzyme concentration increases.
Another key point of this proposed mechanism is that PAR elongation happens in
a distal fashion. Showing in steps 3-5, the terminal unit of the PAR polymer is bound to
the active site, and serves as the acceptor site for the incoming ADP-ribose during PAR
elongation process. This is proposed based on the observed difference in the rates of
NAD+ hydrolysis during initiation and elongation. As discussed previously, during
initiation process, direct NAD+ hydrolysis is fast in the case of DEF/ABC/8-mer DNA
when compared with the wild type PARP-1. This can be explained by the suboptimal
conformation when truncated protein (i.e., ABC and DEF) is used in the incubation.
During initiation, domain D serves as the ADP-ribose acceptor substrate in PAR
formation catalyzed by domain DEF. While ABC and DEF can form an active complex
with DNA, this complex is less stable than the full-length PARP-1, which may allow
water to get into the active site and cause hydrolysis of NAD+ to generate ADP-ribose.
This effect would be more pronounced in the case where a protein is the substrate in PAR
formation. However, when lmDEF or as-purified DEF alone is tested for its capability to
extend the pre-established PAR polymers, the direct hydrolysis of NAD+ slows down
significantly (Figure 4-1 and Figure 4-14). If a protein molecule serves as an acceptor
substrate in the elongation process, the same hydrolytic rate is expected to observe in
these cases; however, this is not what was observed. While proximal elongation of PAR
uses a protein as the acceptor substrate for the incoming ADP-ribose unit, distal
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elongation uses a pre-established PAR polymer as the substrate, which is independent of
the conformation of the protein being modified. The slower hydrolytic rate of NAD+
during polymer elongation when compared with the initiation process indicates that the
reactive substrate is switched from a protein acceptor to a polymer acceptor, consistent
with the distal elongation mechanism.
In steps 6-7, a mechanism for forming a branched PAR polymer is proposed. In
the case of lmDEF, which is the modified-DEF decorated with large PAR polymers, the
lmDEF itself is capable of incorporating 32P signal during elongation/branching reactions.
This process does not require ABC and DNA (Figure 4-14). Furthermore, when the
endogenous PAR polymers are removed from the as-purified DEF, the extent of 32P
incorporation during the elongation/branching reactions decreases (Figure 4-5B). All
these observations indicate that PAR polymers are the reactive substrates for DEF. This
leads to another proposal suggesting that DEF catalyzes the branching reaction as
polymers getting larger. It is well known that the 2''-OH groups within PAR polymers
function as the nucleophiles in the branching reactions. As the polymer grows larger, the
local concentration of 2''-OH from the conjugated polymer increases near the active site.
Consequently, they may become acceptor sites for the incoming ADP-ribose unit. Once a
branch point is formed, it can be elongated in a similar fashion as described before.
4.4.5. Proximal versus distal PAR elongation
Based on the proposed mechanism discussed in Section 4.4.4, a distal elongation
mechanism of PAR formation is proposed. To test whether PAR elongation happens
distally or proximally, two different assays were carried out.
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For a proximal elongation mechanism, at least two amino acid residues are
required to serve as acceptor sites for the pre-established PAR polymer and the incoming
ADP-ribose unit. As the incoming ADP-ribose is attached to one of the amino acid
residues, the 2'-OH group of this ADP-ribose unit can serve as a nucleophile to attack the
ester linkage between the pre-established PAR polymer attaching to protein. This ester
bond cleavage reaction transfers the pre-established PAR polymer to the newly initiated
ADP-ribose unit. Namely, the new ADP-ribose unit is added to the polymer from the
protein end. Hence, in the case of proximal elongation mechanism, PAR transfer is
expected. However, based on the study done using modified-PARP-1 incubated with its
heterosubstrate histone H1, no PAR transfer was observed (Figure 4-16). This result is
more consistent with a distal elongation mechanism, where no PAR transfer is required.
As an alternative approach to study distal versus proximal elongation process, a
pulse-chase experiment was carried out, and a quantitative theory was developed for data
analysis in this assay. Discussed in Section 4.3.10., current result is consistent with the
distal elongation mechanism. However, it is assumed that all initiation sites generated
during the pulse step would get further elongated during the chase step, with q≈1. In
reality, this may not be true. Therefore, a control experiment is needed to get an
estimation of the q value in this case.
4.4.6. Automodification versus heteromodification
In a time course study of PARP-1 heteromodification using histone H1 as the
substrate, it is observed that there is a delay of occurrence between the automodification
of PARP-1 and the heteromodification of histone H1 (Figure 4-15). This raises several
interesting questions of whether automodification of PARP-1 is a pre-requisite step for
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heteromodification. As histone H1 is known to interact with PAR polymers (13), it would
be interesting to study whether the pre-established PAR polymers on PARP-1 helps to
bring in the heterosubstrate close to the active site in domain F.
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